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inding an effective treatment for intra
abdominal infections has become much
easier since the advent of cephalosporins.
Their broad spectrum of activity has greatly
improved the prognosis for many patients
with serious infections.
The trouble is, the cost of cephalosporins has
been making many hospital pharmacists
(and cost control staff) see red. It is also now
increasingly more difficult for many hospital
formulary committees to be able to strike an
agreeable balance between effectiveness
and cost control.

New Cefizox™ may be the answer everyone's
been looking for. Not only does it give much
wider pathogen coverage* (including B.
fragilis) than cefoxitin,1'2but its superior
dosage schedule (example: q!2h vs q6h)
may make Cefizox™ much less expensive?'4
It even has packaging designed for easy
identification.
So if the cost of effective cephalosporin
therapy isjust too much for your hospital to
handle, consider new Cefizox™ Its
combination of efficacy and low cost may
just be what everybody ordered.

C e fizo x ”
ceftizoxime sodium

A cephalosporin that plays favourites with everybody.
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QUILL ON SCALPEL

This section provides a medium through which
Canadian surgeons can declare themselves,
briefly and informally, on the day-to-day affairs of surgery.

B one Banking, 1989: Challenges and
Opportunities
Richard L. Cruess, MD, FACS, FRCSC
Dean, Faculty o f Medicine, McGill University. Montreal, PQ

or surgical procedures involv
ing the musculoskeletal system,
a bone bank is of great benefit and
sometimes essential. In general,
bone from banks is used to provide
structural stability, to replace recip
ient tissue, in surgery for malignant
disease, during complex reconstruc
tive procedures and, finally, to in
duce new bone formation by means
which are now becoming clearer. As
in so many other fields of clinical
endeavour, research into methods
of procuring and preserving bone
and utilizing bone banks has pro
ceeded in stepwise fashion rather
than in a logical and orderly one. In
many instances, research appears to

F

The Canadian Journal of Surgery
1867 Alta Vista Dr.
Ottawa, Ont. K1G3Y6

follow the emergence of clinical
problems.
It is firmly established that a
properly utilized autograft repre
sents the method of choice whenev
er feasible. The absolute lack of
immunologic response and the pos
sibility of new-bone formation by
the recipient’s own cells drawn from
the grafted material represent ad
vantages that can never be
matched, aside from the relatively
rare opportunity for fresh grafts
from a genetically identical individu
al (i.e., an identical twin). The ideal,
however, is not always possible. At
times, the amount of bone required
is greater than can be harvested
Tel.: (613) 731-9331
Telex: 053-3152
Fax: (613) 523-0937

from the patient, the type of bone
required is not available, the pa
tient’s bone is not suitable because
of disease or the risk to the patient
is too great. In an attempt to over
come these difficulties, many alter
native methods have been tried.
Artificial substances and bone from
different living species have been
used, but both methods have been
associated with an unacceptable
rate of failure from both mechanical
and biologic causes. Thus, bone
banking has remained the standard
alternative to the autograft. Howev
er, such a bank must conform to
contemporary standards, otherwise
the recipient may be seriously
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harmed. In addition, the bank must
adhere to contemporary legal and
ethical standards, or the institutions
and individuals involved run the
risk of losing public trust, or worse.
Russell, Hu and Raso, the au
thors of an article on bone banking
in this issue (pages 231 to 236)
deserve our thanks. They have dem
onstrated that a large number of
Canadian hospitals are maintaining
bone banks and that a disturbingly
high percentage are not doing so in
a way that fully utilizes present-day
scientific knowledge. Moreover,

there does not appear to be enough
inter-institutional collaboration, re
sulting in a disturbingly high num
ber of “casual” bone banks. At the
very least, every institution main
taining a bank should look at its
present methods and their longrange implications. Great oppor
tunities are apparently available for
inter-institutional collaboration and
for regional banks, which would
not preclude the maintenance of
sub-banks in smaller hospitals, so
that some material would be avail
able to the unfortunate surgeon

(and patient) who requires it in the
middle of the night. The study by
Russell and colleagues provides a
baseline for evaluating Canadian
performance in the future, and it is
not irrational to hope that a mul
ticentre study could be instituted to
look prospectively at the results of
large numbers of procedures carried
out according to standardized (Ca
nadian) methodologies. Clearly, it is
timely to do this, as the next inte
resting results will be partly mecha
nical and biologic, but, more impor
tantly, in part epidemiologic. ■

index which is reasonably thorough,
and an index of operations and surgical
ly important anatomic relationships.
The 233 illustrations, mostly in col
our, are lucidly drawn and beautifully
reproduced with appropriate labelling of
anatomical structures; indeed, the work
of the medical artist, Adita Shubert, is
very much a feature, as it should be.
With the illustrations, the authors have
provided a commentary of the anatomi
cal structures depicted, usually with
reference, en passant, to surgical con
cerns, but also including a distinct
paragraph covering operative proce
dures only by name. References to the
various areas depicted are also given for
further perusal.
The lofty ambition of this book
serves to remind the reader of its con
tinuing deficiencies. Its great breadth
militates against what could have been
a detailed explanation of many head and
neck procedures, for it is unlikely, as
the authors wished, that the neurosur
geon will use this book alone in prepar
ing for neurosurgical procedures. A
greater integration of the anatomy as
depicted in detailed application to the
relevant surgical procedures would have
been of more practical use than a mere
listing under the various sections of
procedures that take place in the area.

The parathyroid anatomy, which has
important current application because
of the growing frequency of hyperpara
thyroidism is particularly lacking in this
respect. Much work has been done on
delineating abnormal parathyroid anato
my, knowledge of which is so important
to effective surgical treatment and
which is not well covered in this atlas.
Similarly, the sections dealing with de
monstration of the facial nerve should
have provided more detail of the dissec
tion on which the success of parotidec
tomy depends and should have included
reference to the work of Hayes Martin,
a pioneer in facial nerve-sparing ma
neuvers. The section on recurrent laryn
geal nerve demonstration would also
have been enhanced by more detail as
would that on the superior laryngeal
nerve, the demonstration of which is
important in safe thyroid surgery.
There are other such areas and, al
though this volume does not purport to
be an atlas of surgery, its purpose could
have been subserved by at least demon
strating the anatomy of some of the
standard head and neck procedures that
are firmly established in the surgical
armamentarium.

BOOK REVIEWS

SURGICAL ANATOMY OF HEAD
AND NECK. Jelena Krmpotic-Nemanic, Wolfgang Draf, Jan Helms. 331 pp.
Illust. Springer-Verlag New York,
Inc., New York, 1988. $214.50 (US).
ISBN 0-387-17414-1.

The idea of an anatomy atlas with a
special orientation to surgical proce
dures has, I believe, always held a
special appeal for surgeons.
The authors of this atlas, an anato
mist with otolaryngologic clinical train
ing and two practising otolaryngolo
gists, appear well suited to the task of
integrating anatomy with surgical pro
cedures of the head and neck area,
which frequently has been viewed as
problematic because of the compression
of vital anatomical structures in a rela
tively restricted anatomical space. They
have divided their chapters into the
neck and thorax, the larynx and thyroid
gland, the face, the oral cavity and oral
pharynx, the nose, the paranasal sinus
es and maxillary space, the eye and its
orbital adnexa, the ear, the middle and
posterior cranial fossae, the skull and
gross anatomy of the central nervous
system, the topography and variations
of extra- and intracranial vessels, and
the paraganglia. Other sections of the
book deal with references, a subject
228
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Doctor or Mister?
To the editors. Possessing the de
grees and thus the associated titles
discussed by Eibel (Can J Surg
1988; 31: 452-453) and Cairns
(Can J Surg 1988; 32: 83-84), I
believe I am in a position to add
some further insight. Having spent
5 years at medical school to earn
the MB, BS (Bachelor of Medicine
and Bachelor of Surgery), with its
purely honorary title “ Dr.” , I can
still remember the enormous pride
one felt when, 4 years later, earning
the FRCS entitled one to reassume
the title of “Mr.” (surely a case of
inverted snobbery?). Of course, re
verting to “Dr.” took place when
ever restaurant tables needed book
ing, bank managers needed sweet
ening or garage mechanics needed
persuading that your car was the
most important on the road and its
repair warranted a little queue
jumping!
The surgical mastership (MS) and
its equivalent doctorate of medicine
(MD) are offered by the University
of London and several other British
universities (Oxford and Cambridge
award similar degrees but with dif
ferent letters, e.g., MChir). These
are thesis degrees awarded follow
ing a viva voce, for 1 or more years
of unsupervised original research
presented in bound form to the
three examiners. These are called
advanced degrees to differentiate
them from the PhD which is called
a higher degree, since work for the
latter has been supervised. It is with
typical British understatement that
the degrees of MD and MS, the

highest the university can award
(DSc is awarded by peer election),
carry no honorary title.
C.J. de Gara, MB, MS, FRCS(Edin),
FRCS
Surgical resident,
McMaster University,
1200 Main St. W,
Hamilton, Ont.
L8N 3Z5

To the editors. I read with interest
Eibel’s paper entitled “Doctor or
Mister” in the November 1988
issue of the journal (pages 452 and
453) and thought it excellent.
However, I must challenge the
comments of Cairns in his letter on
the same subject (Can J Surg 1989;
32: 83-84). The granting of the
degree of Bachelor of Medicine and
Bachelor of Surgery (MB, ChB) by
the excellent Scottish universities
or (MB, BS) by those lesser institu
tions south of the border(!) entitles
the individual to call himself “Doc
tor”. Should that individual then
submit a thesis for the degree
“MD” — this is, indeed, a “higher
degree” — the title remains “Doc
tor”. If he then pursues a career in
internal medicine, he will seek his
membership in the Royal College of
Physicians (MRCP) and after a
number of years is elevated to fel
lowship (FRCP), which is an added
honour. Alternatively, if the individ
ual pursues a surgical career, he
will obtain his fellowship (FRCS)
and will then become “Mr.”. The
latter designation is entirely along
the lines as described by Eibel.

Contributions to the Correspondence section
are welcome. They should be typewritten
and double spaced.

Accordingly, Dr. Cairns is mis
taken in the points which he enu
merates in his letter, apart from the
fact that, indeed, a London surgeon
would be somewhat “put out” to be
referred to as “ Dr.”!
As one who has been “Mr.” ,
“Dr.”, “Mr.” and now “ Dr.” again
— I should know!
Graham C. Fraser, MB, ChB, FRCS,
FRCS(Edin), FRCSC, FACS, FAAP
Ste. 210,
Medical-Dental South Tower,
Oakridge Centre,
650 West 41st Avenue,
Vancouver, BC
V5Z 2M 9

To the editors. I found Eibel’s
article in the November 1988 issue
(pages 452 and 453) and Cairns’
subsequent letter in the March issue
(pages 83 and 84) very interesting.
I believe I can add some informa
tion.
First, I would explain that one
can get onto the British Medical
Register in three different ways.
• By obtaining a university de
gree in medicine. Different universi
ties give different “letters” , but
basically they represent the degrees
of Bachelor of Medicine and Bache
lor of Surgery. Variations include:
MB, BS; MB, BCh; MB, ChB; BM,
BCh. The Irish universities grant an
MB, BCh, BAO, the last letters
standing for Bachelor in the Art of
Obstetrics.
• By passing “conjoint” . This is
a diploma issued conjointly by the
Royal College of Physicians and the
CJS, VOL. 32, NO. 4, JULY 1989
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Royal College of Surgeons and can
be taken in London or Dublin. The
“letters” for this are LRCP, MRCS
(Licentiate of the Royal College of
Physicians, Member of the Royal
College of Surgeons).
• By passing an examination
conducted by the Society of Apoth
ecaries (London or Dublin). The
Society was founded by James 1 and
given powers of examination and
the right to grant licences to prac
tise medicine by an act of Parlia
ment in 1815. Here, the “letters”
are LMSSA (Licentiate in Medicine
and Surgery of the Society of
Apothecaries) or LSA for short.
At this stage three points should
be made: (a) all of the above, on the
registry, are entitled to the courtesy
title of doctor; (b) the British MB,
BCh (or similar) is equivalent to the
North American MD; (c) the MD in
Great Britain and Ireland is a higher
degree, which can be obtained ei
ther by examination or by thesis,
according to the regulations of the
university concerned.
With regard to the title “ Doctor
or Mister?” , the historical back
ground must be examined. The
Company of Barber-Surgeons was
incorporated in 1461, but it had no
disciplinary powers. It was reincor
porated in 1540 with disciplinary
powers. In 1745, as Dr. Eibel cor
rectly states, the barbers and the
surgeons were separated by George
II. I have always been under the
impression that when the surgeons
were “turned loose” , the physicians
of London, who were incorporated
in 1518, didn’t regard these sur
geons as “proper doctors” and re
fused to call them “doctors” , using
instead the title of “ mister”. At first
this was regarded as a slur, but
subsequently became used with
pride. A good analogy is the story
of how in World War I the Kaiser
referred to the British Expedition
ary Force as “This contemptible
little army...” — later the veterans
230
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were proud to call themselves “The
Old Contemptibles” .
Another historical term of inter
est is that of apothecary, which was
a term used for those who prepared
and sold drugs. This meaning is
maintained in the United States,
Scotland and in continental Europe.
As seen, in England the term came
to refer to a general medical practi
tioner, and many of the older dis
pensary doctors were qualified
LMSSA.
G. Keith Thomas. MB, BCh, BAO,
FRCS, FRCSC
Medical Arts Building,
17 Dunedin St..
Orillia. Ont.
L3V5T3

To the editors. Further to the
Dr./Mr. appellation of British sur
geons so eruditely explained by
Eibel (Can J Surg 1988; 31: 452453) and taken up by Cairns (Can J
Surg 1989; 32: 83-84), I was
pleased to see that Cairns finds
these “curious customs...have a
certain charm” but sorry that he
considers them “perverse...rather
like driving on the left hand side of
the road”.
There is usually a good reason
for these curious customs that orig
inate in “the old country”. For
example, it is a lot easier to mount
a horse from the left side when
girded with one’s sword (unless of
course one is left-handed) than to
do so from the right, something 1
would not advise Dr. Cairns to
attempt lest he end up performing
an operation upon himself that he
might regret!
Peter Rees-Davies, FRCS, FACS,
FRCSC
8444 Yank Gulch,
Talent.
OR 97540.
USA

This list is an acknowledgement of
books received. It does not preclude
review at a later date.
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REVIEW ARTICLE

B o n e Banking in Canada: a Review
Gordon Russell, MB, ChB, MSc, FRCS;* Richard Hu, MD;* V. Jim Raso, MASct
Transplantation of human tissues has become increasingly popular, and associated
with this increase are reports of the transmission of diseases including acquired
immune deficiency syndrome. To reduce the risk of transmitting disease through
transplantation, careful scrutiny of current tissue transplantation procedures is
necessary. Bone banking in Canada was evaluated by questionnaire, sent to the head
operating room nurse of every Canadian hospital listed in the 1986 Canadian
Medical Directory as having 100 or more beds. From this questionnaire, the authors
identified 60 bone banks in Canada, many of which failed to meet recommended
guidelines. The authors review the literature relating to bone banking procedures
and present in detail the results of their survey.

ment, processing, storage and dis
tribution have been suggested.5-21
To evaluate the present status of
bone banking in Canada in relation
to published protocols, we sent out
a comprehensive questionnaire to
404 Canadian hospitals.

La transplantation de tissus humains est de plus en plus populaire. On rapporte
maintenant en rapport avec cette pratique, la transmission de diverses maladies,
dont le syndrome d’immunodeficience acquise. Afin de reduire le risque de
transmission de maladies, il devient necessaire de scruter soigneusement les
techniques actuelles de transplantation de tissus. Les banques d’os du Canada ont
ete evaluees a l’aide d’un questionnaire, lequel fut adresse a l’infirmiere chef du
service de chirurgie de chacun des hopitaux canadiens inscrits dans l’edition 1986
du Canadian Medical Directory comme possedant 100 lits ou plus. A partir de ce
questionnaire, les auteurs ont identifie 60 banques d’os au Canada, dont plusieurs
qui ne rencontrent pas les exigences des lignes directrices recommandees. Les
auteurs commentent la litterature relative aux techniques de conservation des os et
ils presentent le detail des resultats de leur enquete.

The questionnaire (Fig. 1) was
sent in March 1987 to the head
operating room nurse of every Ca
nadian hospital listed in the 1986
Canadian Medical Directory as hav
ing 100 or more beds. It was de
signed to evaluate present practices
for donor selection, procurement,
storage, record keeping and donor
and recipient consent in relation to
the use of allograft bone.

llier1 established the scientific
basis for bone transplantation
in the mid-19th century with his
studies on the osteogenic properties
of bone and periosteum, and the
beneficial influence of freezing in
preserving these characteristics. In
a report dated 1881, Macewan,2 a
Glasgow surgeon, described the use
of bone grafts to reconstruct the
lost bone of a child’s humerus. In
1907, Lexer3 transplanted a whole

O

knee joint. The first reported use of
preserved bone in orthopedic sur
gery was by Inclan in 1942.4 Since
then, the use of allograft bone and
bone banking have become com
mon.
The function of a bone bank is to
supply safe and efficacious donor
bone. Suggested protocols for es
tablishing and maintaining bone
banks are numerous. Procedures
for donor selection, bone procure
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Methods

Findings
The questionnaire results were
analysed in January 1988, by which
time 284 (70.3%) of the 404 ques
tionnaires had been returned.
Regional response rates are
shown in Table I. The poor re
sponse from Quebec is probably a
result of the questionnaire being
sent in English only.
Sixty bone banks were identified;
approximately one in every five Ca
nadian hospitals with more than
100 beds had a bone bank. The
number of banks in each province
as a percentage of responders is
listed in Table II. There was a
substantially larger proportion of
bone banks in Alberta than in the
CJS, VOL. 32, NO. 4, JULY 1989
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other provinces, and this was re
flected in that the smallest hospital
in Canada to have a bank is in
Alberta (Table III).
Of the 60 hospitals that had a
bone bank, 4 returned insufficient
information in the questionnaire,
leaving 56 for analysis. Of these, 43
(77%) bone banks had existed for
more than 5 years, 10 (18%) for 1

to 5 years and 3 (5%) for less than 1
year. Bone banks were classified as
regional if they supplied bone to
other cities, institutional if they
supplied bone to other hospitals in
the same city and casual if they
used the bone only in their own
hospital. In this survey, 77% were
casual, 14% institutional and 9%
regional.

Do you have a Bone Bank in your hospital?

Yes

No —

10.

Supervision
Table IV identifies the person or
persons who were in charge o f the
banks. Eighty-eight percent were
operated, at least in part, by nurs
ing staff. Physicians were involved
in the operation o f 80% of regional
banks, 25% o f institutional banks
and only 9.3% o f casual banks.

If you procure cadaver bone, is it retrieved in:

If Yes, please answer the following questions.

a)

The operating room

Yes

No

If No, please return the questionnaire in the envelope
provided.

b)

The morgue

Yes

. No

c)

Either of the above

Yes

. No

d)

Another site (specify)

Yes

, No

How long have you had a Bone Bank?
_____ Less than 1 year
11.
_____ 1 - 5

years

Who harvests the cadaver bone?
a)

Surgeon

b)

Resident

Yes ___ No ___

c)

Technician

Yes

d)

Nurse

Yes ___ No ___

e)

Other

Yes ___ No ___

_____ More than 5 years
Who is responsible for looking after it?
_____ Doctor
_____ Nurse
_____ Technician
12.

_____ Other

Regional (e.g., you procure bone from
cadavers and supply the bone to other
hospitals in other cities)

(b)

Institutional (e.g., you procure bone
from cadavers and supply bone to other
hospitals in your city)

(c)

Casual (e.g., you procure bone from
cadavers or living donor, such as femoral
heads, and use them in your own hospital
only)

Yes __

No

Yes __

Do you obtain consent from the donor's next of kin
in the case of cadaver bone retrieval?

Yes ___ No —

No

-

14.

Do you screen the donor (dead or alive) for the
following:
Yes __

Malignancy anywhere?
Infection anywhere?

Yes

Yes

Freeze to -70<>C or -80oc

Yes ___ No

Yes __

c)

Freeze-dry

Yes —

No —

Other (specify)

Yes —

No ___

What is the maximum time after death that you
would retrieve cadaver bone?
a)

Less than 12 hours

Yes

No

b)

12 - 24 hours

Yes —

No —

c)

More than 24 hours

Yes ___ No ___

What is the longest time you would keep the
bone for?
a)

Less than 1 month

b)

1 - 3

months

Yes ___ No ___

c)

3 - 6

months

Yes —

No —

d)

More than 6 months

Yes —

No —

No —

No

Yes ___ No

What is your procedure for record keeping?

No

Metabolic bone disease (e.g., osteomalacia,
osteoporosis)

Yes

Diseases of unknown etiology (e.g., rheumatoid
arthritis, ankylosing spondylitis, avascular
necrosis)

Yes ___ No ___

No ___

ABO blood groups

Yes __

No ___

Rhesus factor

Yes __

No ___

16 .

a)

Computer

Yes —

b)

Notebook

Yes ___ No ___

c)

Flow sheet

Yes ___ No ___

d)

Other

Yes ___ No ___

e)

None kept

Yes —

No ___

No ___

What is the bone used for?

AIDS virus

Yes __

No —

a)

Tumour surgery

Yes —

Venereal disease

Yes __

No —

b)

Reconstructive surgery

Yes ___ No ___

Hepatitis

Yes __

No ___

What is the age limit for your donors? (Underline one in each
colu m n )

Any Age
Skeletally immature
Skeletally mature
Over 15 years

Any Age
75 years
70 years
65 years

Do you screen the allograft for infection
- on collection

Yes

No

- on implantation

Yes

No

c)

Trauma

d)

Other (specify)

Yes —

No ___

17.

Do you obtain informed consent from any patient
receiving or expected to receive any allograft
bone?

Yes

No

18.

Do you have any feedback as to whether the bone
graft was successful, infection rates, and other
complications?

Yes

No

19 .

How many orthopedic surgeons do you have on staff?

FIG. 1. Allograft survey questionnaire sent to all Canadian hospitals having more than 100 beds.
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No

d)

No
15.

Toxic substances (drugs, etc.)

_

Regular freezer

b)

Yes ___ No

Do you obtain consent from the donor in the case
of living donors (femoral heads, etc.)?

No

a)

No

13.
Yes __

Yes ___ No ___

How do you preserve the bone?

How would you describe your Bone Bank?
(a)

_
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Screening Procedures

Procurement o f Donor Bone

Discussion

Screening procedures for donor
selection varied (Table V). Regional
banks screened more than institu
tional or casual banks. Rhesus fac
tor was surveyed least (25%); less
than 50% of centres screened for
blood type, human immunodeficien
cy virus (HIV), venereal diseases or
potentially toxic substances. Fiftytwo percent screened for metabolic
bone disease, 55% for hepatitis and
71% for malignancy. Most banks
(93%) excluded endogenous infec
tion on collection; cultures were
repeated at the time of implantation
in 80% of hospitals.

Sixteen of the 56 bone banks
(29%) procured cadaver bone; in 15
(94%) of these, this was performed
in the operating room. Bone was
retrieved within 12 hours of death
in 12 (75%) of the cases and within
24 hours in the remainder. Skeletally immature individuals and those
older than 70 years were not ex
cluded as donors in the majority of
centres.

Our results indicate that changes
are needed in the running of many
Canadian bone banks. Similar find
ings were reported from Australia.17
It has been estimated,12 probably
conservatively, that bone grafts are
used 200 000 times annually in the
United States. It is obviously impor
tant that the use of allograft bone
in orthopedic surgery be kept as
safe as possible for the recipient’s
well-being and to avoid possible
medicolegal problems.

Preservation

Bone was stored in a regular
freezer at colder than —25 °C in
57% of banks, and in deep freezes
at approximately —75°C in the
remainder. None of the respondents
used freeze-drying as a method of
storage. Sixty-one percent stored
bone for longer than 6 months,
even when a regular freezer was
used.

Consent

All banks that harvested cadaver
bone obtained consent from the
next of kin. In contrast, only one
hospital obtained consent from liv
ing donors (such as those who
donate femoral heads during hip
surgery). Nineteen (34%) of hospi
tals obtained informed consent from
patients who were expected to re
ceive allografts.
Strict records were kept in all but
one bone bank. Thirty-eight (68%)
obtained additional information on
the outcome of the graft in each
case.

Table 1. P ro v in c ia l R e sp o n se R ate to th e Q u e s tio n n a ire
Province/territory

No. of
respondents

No.
surveyed

Response
rate, %

A tla n tic p ro v in c e s
Q uebec
O ntario
M a n ito b a
S aska tch e w a n
A lb e rta and N W T
B ritis h C o lu m b ia

27
55
106
13
16
23
44

36
119
143
16
17
23
50

75
46
74
81
94
100
88

Canada

284

404

70

Donor Selection

Criteria for excluding donors can
be divided into three categories:
transmitting infection, transferring
noninfective disorders and other
factors.
Transmitting infection. To mini
mize the risk of infecting a recipi
ent, donor bone should come from
a living donor or cadaver with no
active systemic infection and an
afebrile course while in hospital.
Patients who were on a respirator
for more than 72 hours14 or who
died within 72 hours of major sur
gery, ran a higher risk of bacter
emia1618 and should be excluded as
Table III. S m a lle s t H o s p ita l in E ach
P ro v in c e to H ave a B o n e B a n k

Province/territory

No. of hospital beds

A tla n tic p ro v in c e s
Q uebec
O n ta rio
M a n ito b a
S a s k a tc h e w a n
A lb e rta a n d N W T
B ritis h C o lu m b ia

162
241
165
320
299
100
340

Table II. N u m b e r o f B one B a n k s b y P ro v in c e
Province/territory

No. of
bone banks

No. of
respondents

% of respondents
with bone banks

A tla n tic p ro v in c e s
Q uebec
O ntario
M a n ito b a
S aska tch e w a n
A lb e rta and N W T
B ritis h C o lu m b ia

7
11
17
2
4
13
6

27
55
106
13
16
23
44

26
20
16
15
25
57
14

Table IV. P e rs o n s P a rtia lly o r W h o lly
R e s p o n s ib le fo r th e B o n e B a n k

Person
P h y s ic ia n
N u rse
T e c h n ic ia n
O th e r

No. in
category

Proportion of
respondents, %

11
6

20
88
11

4

7

49
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donors. Severe trauma, causing
skin damage (such as major burns
or multiple puncture wounds), is a
contraindication for the same rea
son. Chronic parenteral drug abus
ers should also be excluded.
High-dose steroids administered
for longer than 7 days increase the
risk of infection and patients sub
ject to this therapy should be ex
cluded.
Other contraindications to dona
tion are: a history of viral hepatitis
or unexplained jaundice,1416-21-22 ve
nereal disease,14'1648'21 tuberculosis,
leprosy or other granulomatous dis
ease,14-18-23 malaria,14'16 slow-virus
diseases (e.g. Creutzfeldt-Jakob
disease),16'21-24 rabies16-24'25 and
AIDS.1625-28
Despite testing of donors for HIV
antibody using enzyme immunoas
say, HIV transmission has been re
ported.26 Revisions were made to
the American Association of Tissue
Banks Standards for Bone Banking
in January 1988.27 There has now
been a confirmed case of the trans
mission of AIDS by banked bone.28
These reports led representatives
from the American Association of
Tissue Banks, the American Acade
my of Orthopaedic Surgeons, the
Food and Drug Administration and
Centers for Disease Control to meet
in August 1988 to make recommen
dations for preventing HIV trans
mission by bone transplantation.
They are as follows: for donors of
bone allografts, as well as other
organ and tissue allografts, the as
sessment of risks of HIV infection
should include reviewing the do
nor’s medical record, testing the
donor for HIV antibody and inter
viewing living donors. The inter
view should consist of standardized
questions that identify risks for HIV
infection. The donor’s responses to
these questions should be recorded
on a form signed by the donor
acknowledging that the recorded
responses are correct. The complet
23 4
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ed form should be kept in the tissue
bank with other records from the
donor.
All living donors of bone should
be retested at least 90 days after
tissue procurement, and only bone
from living donors negative for HIV
antibody on this repeat testing
should be distributed for transplan
tation. Bone from donors not avail
able for retesting, including cadav
eric donors, should be used when
bone from retested living donors is
not available or is not appropriate
for use in the anticipated surgical
procedure.

Transferring noninfective disor
ders. Any malignant lesion except
basal cell carcinoma is a contraindi
cation to bone donation.16 It has
been shown that a tumour can be
passed to a recipient in renal trans
plants and these tumours can con
tinue to grow and metastasize.29
Inflammatory disease, such as rheu
matoid arthritis, or ankylosing
spondylitis, disease of unknown eti
ology, metabolic bone disease and
autoimmune disease are also con
traindications to bone donation.16
In cases of death from unknown
cause, a complete autopsy must be
performed on potential donors. Fail
ure to do so excludes them as
donors because of the risk of occult
disease.16
Other factors. Donor death from
poisoning, and previous radiothera
py to the tissues to be harvested are
both contraindications.1621 Certain
laboratory tests must be conducted

on potential donors and their bone.
In addition to the tests for viral
hepatitis, syphilis and AIDS, rhesus
typing should be performed because
of the risk of rhesus immunization
from allograft bone.30 The American
Association for Tissue Banking also
recommends that ABO and tissue
typing be performed for future as
sessment of graft failures. Tissue
should be cultured for aerobic and
anaerobic bacteria and, in the case
of cadaver retrieval, blood, urine
and pleural fluid should be cul
tured.
The age of the donor is impor
tant if massive allografts are re
trieved. Long bones from skeletally
immature donors have open epiphy
ses, and in bones from older pa
tients with osteopenia, the intrinsic
structural properties may be com
promised. The age of the patient is
not important if the retrieved bone
is processed into chips or pow
der.1516'31
Cadaver bone should be taken
within 12 hours of death or 24
hours if the body has been refriger
ated since death. Implementing
these criteria will minimize the risks
of transmitting disease to recipi
ents.

Procurement of Bone
There are two basic methods of
procuring bone: sterile retrieval in
an operating room using full aseptic
technique and unsterile retrieval fol
lowed by sterilization of the bone.

Table V. Current Screening Procedures Performed in Canada
Screening for

Malignancy
Infection
Toxic substances
Metabolic bone disease
Disease of unknown etiology
ABO blood group
Rhesus factor
Human immunodeficiency virus
Venereal disease
Hepatitis

No. of
bone banks

Proportion of
respondents, %

40
52
26
29
36
15
14
19
27
31

71
93
46
52
64
27
25
34
48
55

BONE BANKING IN CANADA

Methods of sterilization include
boiling, autoclaving or treatment
with /3-propriolactone, ethylene
oxide or antibiotic solutions. These
can either alter the bone’s biologic
or biomechanical properties or re
sult in the formation of toxic sub
stances which must be removed
from the bone before it is used.732
Radiation sterilization has been rec
ommended but also has a detrimen
tal effect on bone.33 Ideally, bone
should be retrieved using an aseptic
technique to avoid the problems
associated with sterilization.
At the time of procurement, cul
tures must be taken, and after ca
daver procurement a full autopsy
must be performed to exclude oc
cult diseases. Bone must be pack
aged in a suitable sterile container
in preparation for storage.541-14’16'31
Storage

Each of the three methods of
storage has advantages and disad
vantages. Canadian bone banks use
either a regular or a deep freezer. If
a regular freezer is used, some
autolysis occurs, so the bone
should not be kept longer than 6
months.12 If a deep freeze is used,
autolysis is reduced and bone can
be kept longer; bone kept for over 2
years in this way has been used
successfully.14 The use of freeze
drying has definite advantages —
storage at room temperature, indefi
nite shelf life and earlier transporta
tion. The disadvantage of this meth
od is the costly equipment required
for the process.34-35 For most bone
banks, the best method of storage
is deep freezing to -70°C or be
low. Close monitoring of the freezer
temperature is required, a tempera
ture-monitoring system linked to an
alarm is recommended, and bone
should be discarded if the freezer
temperature rises above —15°C.14
Problems resulting from the an
tigenicity of bone are not clear, and

much research in this area is in
progress.36~43 No recommendations
can be made at present in regard to
tissue typing of bone grafts. There
seems to be little doubt that fresh
allograft causes a host immune re
sponse,41-43 but in a study compar
ing freeze-dried allograft to frozen
allograft there was little difference
in outcome.44 Freeze-drying may re
duce the antigenicity of bone more
than deep freezing, which in turn
may be better than regular freez
ing.42
Informed Consent

In the US, the Uniform Anatomi
cal Gift Act45 authorizes donation
by any person 18 years of age or
older before death, and donation by
next of kin after death.
Donation of bone from living do
nors also requires consent,16-31 but
we found that this is obtained in
only 2% of Canadian bone banks.
Any person who may receive allo
graft bone should sign an informed
consent preoperatively.16-31 Again,
this is not routinely done in Cana
da.
Record Keeping

Finally, it cannot be stressed
enough that good record keeping is
essential. All donor and recipient
information must be recorded, to
gether with information on date of
retrieval, storage and use of the
allograft. Feedback regarding infec
tion, failure or other problems
which may be associated with the
allograft should be meticulously re
corded.
It is also important that a physi
cian be involved in the operation of
every bone bank.
Summary
Our questionnaire showed that

many inadequacies exist in the op
eration of Canadian bone banks. We
have summarized the recommended
guidelines for the successful and
safe operation of a bone bank, and
hope that this information will help
to improve the quality of bone
banking in Canada.
We thank Donna O'Brien, Drs. D.W.C.
Johnston, M. Lavoie and L. Davis and
Pauline McCormick for their help dur
ing the preparation of this paper.
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SESAP VI Question
Item 300
The serum abnormality LEAST likely to occur during total parenteral
nutrition (TPN) is an elevated
(A) aspartate amino transferase (SGOT)
(B) alkaline phosphatase
(C) alanine amino transferase (SGPT)
(D) gammaglutamyl transferase (GGT)
(E) bilirubin
For the incomplete statement above, select the one completion that is
best of the five given.
For the critique of Item 300 see page 270.
(Reproduced by permission from SESAP VI Syllabus; Surgical Educa
tion and Self-Assessment Program No. 6. For enrolment in the Surgical
Education and Self-Assessment No. 6, please apply to the American
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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In spite of its shortcomings, this
book goes a long way to fulfilling its
goal of showing the surgical anatomy
of the head and neck. It is beautifully
produced with excellent illustrations,
glossy paper, and printing that is clear,
uncrowded and easy to read. Few other
such books are available, and leafing
through its pages is both enjoyable and
generally edifying. This book will be
well used by head and neck surgeons,
otolaryngologists, plastic surgeons,
general surgeons and neurosurgeons to
some extent. For residents in these
specialties it will help in preparing them
for their operative experience. Institu
tional libraries should obtain this book
to permit senior students with develop
ing clinical exposure an anatomical in
sight into procedures they are being
called upon to assist at and help them
understand the anatomy from the view
point of effective treatment.
Irving B. Rosen, MD, FRCSC, FACS
Ste. 445,
Mount Sinai Hospital,
600 University Ave.,
Toronto, Ont.
M5G 1X5

CURRENT OPERATIVE SURGERY:
UROLOGY. Edited by A.R. Mundy.
225 pp. Illust Balliere Tindall, Lon
don; W.B. Saunders Company Canada
Limited, Toronto, Ont., 1988.
$145.25. ISBN 0-7020-1141-X.

This is yet another text on operative
urologic surgery, and the author asks
“why another?”. This book is devoted
to newer techniques; it is not a com
plete textbook since many well-estab
lished procedures are not mentioned.
The text is well written by recognized
experts. Each of the excellent diagrams,
which make up the numerous illustra
tions, clearly demonstrates a stage in a
procedure.
Two chapters make this text worth
having — one is by Patrick Walsh on
radical retropubic prostatectomy and
the other by Richard Turner-Warrick
on urethral stricture surgery. These are
complete, detailed “how to do it” de
scriptions of complex, infrequently per
formed operations. They offer the sur

geon expert advice on technical details
and should be read before performing
these procedures. There are also two
chapters on pediatric urology and two
on surgery for impotence.
This is a useful book for urologists
because it provides expert advice on
infrequently performed surgical proce
dures. I highly recommend it.
Norman G. Futter, MB, FRCSC
Head o f Urology,
Ottawa General Hospital.
501 Smyth Rd.,
Ottawa, Ont.
K1H 8L6

REOPERATIVE ARTERIAL SUR
GERY. Edited by John J. Bergan and
James S.T. Yao. 620 pp. Illust. Grune
& Stratton, Inc., Orlando, Fla.; W.B.
Saunders Company Canada Limited,
Toronto, 1986. $147.50.
ISBN
0-8089-1789-7.

In the last 30 years, great advances
have been made in vascular surgery.
The natural history of both untreated
and treated disease has been recog
nized. With experience, surgeons have
learned that reoperative arterial surgery
is now less a problem of technical
failure and more a problem of the
progression of the distal disease proc
ess. This is why this multiauthored
book is welcome.
The editors have collected papers
from authors who are experts and write
from personal experience. The book
succeeds in covering basic science con
siderations, including an excellent chap
ter on smooth-muscle-cell proliferation.
Standardized reporting of arterial re
construction, an area that has required
addressing, is the subject of a well-written chapter; its recommendations will
help us evaluate our own results and
those of others. The use of computed
tomography and duplex scanning in
arterial reconstruction are well covered,
and graft thrombosis and its relation to
hematology, especially platelet function,
are discussed. A major gap in the book
is that there is little on heparin-induced
thrombocytopenia. Good insight is
given into causes and treatment of graft

failure and, in particular, the infected
graft, a devastating complication of vas
cular surgery. In-situ bypass is a rela
tively new procedure with a definite
learning curve, because problems have
been common in early experience with
this technique. The postoperative prob
lems of valve cusps and fistulas are
described in detail since the authors of
this section have one of the largest
experiences with this procedure. Al
though the area of repeat surgery is
well covered, a chapter on when not to
operate or to perform amputation as a
primary procedure in patients with endstage vascular disease and including
cost-benefit analysis would have been
helpful. The chapters on special prob
lems in reoperative surgery, including
recurrence of renal artery stenosis, ar
terial trauma and thoracic outlet syn
drome, are informative. Recurrent vas
cular insufficiency is extensively cov
ered, and this section gives more in
sight, and perhaps more controversy,
into the natural history of the treated
disease.
Overall, this is an excellent book
with few limitations; it should be in the
library of all residents and surgeons
who do vascular surgery.
F.M. Ameli, MB, ChB, FRCS, FACS,
FRCSC
Ste. 313,
E.K. Jones Building,
The Wellesley Hospital.
160 Wellesley St. E,
Toronto, Ont.
M4Y 1J3

DERMATOLOGIC SURGERY. Princi
ples and Practice. Edited by Randall K.
Roenigk and Henry H. Roenigk, Jr.
1431 pp. Illust. Marcel Dekker, Inc.,
New York, 1989. $150.00 (US). ISBN
0-8247-7926-6.

This multiauthored text is divided as
follows: 7 chapters each on basic surgi
cal principles and standard dermatolog
ic surgical procedures, 3 on advanced
dermatologic surgical procedures, 7 on
regional dermatologic surgery, 14 on
surgical treatment of skin disease, 4 on
continued on page 286
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Activity against a great majority of significant
pathogens — for most patients, appropriate
bactericidal coverage with single-agent
antibiotic: PRIMAXIN® i.v.
Clinical efficacy — Kager and Nord evaluated
164 patients with intra-abdominal infections
and observed 91% cure or improvement.1
Good tolerability profile —similar to
cefazolin. t Avoids the potential nephrotoxicity
or ototoxicity experienced with the
aminoglycosides.
No cross-resistance has been observed between
imipenem and other beta-lactam antibiotics.3
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Physical Stability of a Total Nutrient
Admixture for Total Parenteral Nutrition
Mervyn Deitel, MD, FRCSC;*t Lloyd C. Smith, MD, FRCSC;* Karen L. Friedman, BSc;t
Peter J. Lea, PhD;$ David J.W. Grant, DPhil;§ Hudson K.H. Giang, MD;*
Battista Calvieri;$ Joseph Go, BSc;§ Toan B. To, MD*
The stability of a total nutrient admixture (TNA) has been postulated to be less than
7 days in refrigerated storage. When a TNA destabilizes, lipid particles coalesce and
enlarge. Liposomes larger than 6 pm can obstruct pulmonary capillaries. A TNA
containing 1500 ml of 7% Vamin, 1000 ml of 50% dextrose and 500 ml of 10%
Intralipid, including the usual electrolytes, minerals and vitamins, was studied.
Liposome size was measured in the original Intralipid and the TNA at intervals up
to 14 days at 4°C followed by 2 days at 22°C. There was a small increase in
liposome size up to 16 days. However, the number of particles larger than 6 /am was
insignificant (by light microscopy, 3.9 ± 2.4 [± SD] per 20 high-power fields; by
Coulter counter, 99.8% smaller than 1.9 /jm, with 0% larger than 6 /xm; and by
electron microscopy, 100% smaller than 2.0 ftm). The osmolality and pH of the TNA
were 1472 ± 31 mOsm/kg and 5.5 ± 0.1 respectively (mean ± SD), with no
significant change during the study times. The authors concluded that this TNA
remains physically stable when refrigerated for 14 days and at room temperature for
a further 2 days.
II a ete postule que la stability des melanges nutritifs complets (MNC) ne depasse
pas 7 jours quand ceux-ci sont conserves au refrigerateur. Quand un MNC devient
instable, les particules lipidiques s’unissent par coalescence et augmentent de taille.
Des liposomes plus grand de 6 peuvent obstruer les capillaires pulmonaires. On
a etudie un MNC renfermant 1500 ml de Vamin a 7%, 1000 ml de glucose a 50% et
500 ml d’lntralipide a 10%, et comprenant les electrolytes, mineraux et vitamines
habituels. La taille des liposomes a ete mesuree dans la solution d’lntralipide
d’origine et dans le MNC, a divers intervalles jusqu’a concurrence de 14 jours
lorsque conserves a 4°C, suivi par 2 jours a 22°C. On a observe une legere
augmentation de la taille des liposomes apres 16 jours. Neanmoins, le nombre de
particules de plus de 6 gm etait insignificant (au microscope optique, 3.9 ± 2.4 [±
ET] par 20 champs a forte puissance; au compteur Coulter, 99.8% avaient plus petit
de 1.9 /xm avec 0% plus grand de 6 /xm; et au microscope electronique, 100% avaient
plus petit de 2.0 /xm). L’osmolalite et le pH du MNC etaient, respectivement, de
1472 =t 31 mOsm/kg et de 5.5 ± 0.1 (moyenne ± ET) et il n’y a pas eu de
changement significatif durant l’etude. Les auteurs concluent que ce MNC demeure
physiquement stable lorsqu’il est refrigere pendant 14 jours, puis conserve a la
temperature embiante pendant 2 autres journees.
From the *Department o f Surgery, fDepartment o f Nutritional Sciences, fDepartment o f
Anatomy and §Department o f Pharmacy, University o f Toronto and St. Joseph’s Health Centre,
Toronto, Ont.
Presented at the 11th annual meeting o f the Canadian Association o f General Surgeons, held in
conjunction with the 57th annual meeting o f the Royal College o f Physicians and Surgeons o f
Canada, Ottawa, Ont., Sept. 25, 1988
Accepted fo r publication Dec. 5, 1988
Reprint requests to: Dr. M. Deitel, St. Joseph's Health Centre Research Foundation, 30 The
Queensway, Toronto, Ont. M6R 1B5
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intravenous nutri
C onventional
tion has been given as a solu

tion of amino acids combined with
dextrose and a separate line deliver
ing a lipid emulsion. This technique
was unsatisfactory because of the
difficulties in managing two sepa
rate administration systems. The
first clinical use of a single solution
containing all the necessary daily
nutrients in one silicone rubber bag
was described by Solassol and col
leagues,1 in 1976. Since then, the
total nutrient admixture (TNA) sys
tem has become popular in Europe,
but it has been slow to gain accep
tance in North America.
Use of the TNA system in North
America became possible when eth
ylene vinyl acetate bags became
available, because they contain no
toxic plasticizer. Before this, the
TNA had to be put in polyvinyl
chloride bags, which contain di-2ethylhexyl-phthalate (DEHP); the
DEHP plasticizer is dissolved by
lipid and has been implicated as a
cause of toxicity in animals and
neonates.2
The use of an “all-in-one” system
has obvious advantages: there is
less manipulation of the infusion
system and a lower potential for
contamination, nursing time is de
creased, as is the number of tubings
and pumps, patient mobilization is
easier, it is a simpler system for
home TPN and it is cost saving.
The disadvantage of the system is
that the components are in a deli
cate balance. If the relative concen
trations of the involved constituents

TOTAL NUTRIENT ADMIXTURE

are not within certain limits, large
lipid droplets may form. Liposomes
greater than 6 /am entering the
circulation have been shown to ob
struct pulmonary capillaries.3 Natu
rally occurring chylomicrons mea
sure 0.5 to 1.0 nm in diameter. The
critical diameter of the liposomes in
a TNA is between 6 and 15 ^m, as
liposomes 15
or larger will be
removed by the standard “in-line”
filter.
The stability of a TNA is there
fore measured by the ability of the
liposomes to remain dispersed with
in the water phase. The time limit
on the stability of a TNA has been
suggested to be less than 7 days.4
The purpose of this study was to
find out how long the TNA remains
stable while in refrigerated storage.

the Coulter counter were used to
gauge liposome size. The studies
were performed on the TNA at 0
hours, after 2 days at 22°C (room
temperature), after 7 days at 4°C
(refrigerator storage) followed by 2
days at 22°C and after 14 days at
4°C followed by 2 days at 22°C.
(The 2 days at room temperature

correspond to patient delivery time.)
The studies were also performed on
standard Intralipid at 0 hours.

Results
On direct observation, we sought
creaming, which indicates the for-

1
■3 '

Method

f
\
►
>
*
►

►
►

t

The TNA studied consisted of
1500 ml of 7% Vamin (KabiVitrum,
Sweden), 1000 ml of 50% dextrose
and 500 ml of 10% Intralipid (Kabi
Vitrum, Sweden). Daily require
ments of electrolytes, trace ele
ments and vitamins were incorpo
rated into the solutions (Table I).
To evaluate the stability of the
TNA, visual observation, light mi
croscopy, electron microscopy and

FIG. 1. Light microscopy. Two larger liposomes each measured 2 jtm, and were
among hundreds of tiny fat droplets, fraction of micrometer in size (X 1000).

T a b le 1. C o m p o s itio n o f th e T o ta l N u trie n t
A d m ix tu re
V a m in -N 7% , m l
D e x tro s e 5 0 % , m l
In tra lip id 1 0 % , m l
S o d iu m c h lo rid e , m m o l
P o ta s s iu m p h o s p h a te , m m o l
M a g n e s iu m s u lfa te , m m o l
C a lc iu m g lu c o n a te , m m o l
M V I-1 2 (U S V ), m l
H e p arin , U
Iro n d e x tra n , m m o l
M T M A (tra c e -4 , IM S ), m l
R a n itid in e , m g

1500
1000
500
40
24
10
44
10
2000
0 .0 36
2
190

T o ta l v o lu m e , m l

3100

M V I = M u lti-V ita m in In fu s io n , U S V = U .S.
V ita m in s In c., M T M A = m u ltip le tra ce
m e ta l a d d itiv e , IM S = In te rn a tio n a l M edicatio n s S y s te m s .

FIG. 2. Scanning electron photomicrograph (day 16) shows increase in particle
diameter to mean of 0.513 /um (range from 0.223 to 0.803 nm) (X 15 000).
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mation of a layer of aggregates at
the admixture surface. No creaming
was noted in any of the solutions at
any of the study times.
Light microscopy was used at
1000 X magnification (Fig. 1). The
stage and eyepiece micrometer
scales were used for measurement.
Liposomes of diameter greater than
5 ^m were found at a rate of 2/20
high-power fields (HPF) at 0 hours,
with a maximum of 6/20 HPF at
16 days, and a mean (± SD) of 3.9
± 2.4/20 HPF over the study times
to 16 days. These rare liposomes
were among thousands of nonmeasurable ones which were seen
to be a fraction of a micrometer in
size. The largest liposome observed
measured 15 jun.
Electron microscopy revealed
that particle size increased up to 16
days (Figs. 25 and 3). However, no
liposomes exceeding 2 /nm in diame
ter were found. Mean (± SD) fatparticle size at 16 days was 0.5 ±
0.3 /um (Fig. 4).
The Coulter counter similarly
demonstrated that liposome size in
creased up to 16 days. However,
99.8% of liposomes remained less
than 1.9 /urn in diameter, with none
greater than 6 /rm (Table II).
The mean pH was 5.5 ± 0.1 and
the mean osmolality 1472 ± 31
mOsm/kg (Table III). There was a
trend toward a very slight decrease
in pH and increase in osmolality
with time, but neither was statisti
cally significant.

some. The fat droplets normally
repel each other because of a nega
tive charge (zeta potential) on their
surface. Thus, the emulsifier acts as
a mechanical and electrical barrier
to coalescence.6
Changes in the pH of the solu
tion will affect the ionization of the
emulsifying agent. These effects
occur at the hydrophilic end of the

molecule. As pH decreases, the elec
trical charge of the emulsifying
agent is lost and the repulsive
forces are decreased.3 A total loss of
repulsive force would occur at a pH
of approximately 2.5.7
Dextrose in solution is acidic and
can markedly decrease the pH of
lipid emulsions, thereby destabiliz
ing the TNA. Aggregation (floccula-

FIG. 3. Transmission electron micrographs (day 16) substantiated variations found
in particle size. Because transmission electron microscopy uses ultrathin section
(70 nm) which slices liposomes at various levels, scanning electron micrographs
were used for accurate measurement of diameters (X 45 000).

Discussion
The main problem with the TNA
is maintaining the lipid in solution.
Phospholipid has been added to the
lipid to act as an emulsifying agent.
The emulsifying agent serves as a
surface film and orients its polar
(hydrophilic) end at the liposome
surface and its nonpolar (hydropho
bic) end in the interior of the lipo242
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FIG. 4. Mean diameter of liposomes (± SD) in TNA at various study times after
storage at 4°C and 22°C. Control Intralipid is represented by hatched bar at left.
Interestingly it has larger liposome diameter but less variation in size than freshly
made up TNA.

TOTAL NUTRIENT ADMIXTURE

Table II. Population Distribution of Fat Particles Analysed by the Coulter Counter TA II Over 16 Days
Percent population of particles
Channel
no.

Size,
^m*

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

0.60
0.76
0.95
1.20
1.51
1.90
2.40
3.02
3.81
4.80
6.05
7.62
9.60
12.10
15.24
19.20

0
0

0
2

7
0

7
2

14
0

14
2

0.00
77.13
16.58
4.15
1.39
0.49
0.16
0.06
0.03
0.01
0.00
0.00
0.00
0.00
0.00
0.00

0.00
76.90
16.56
4.39
1.42
0.48
0.16
0.06
0.02
0.01
0.00
0.00
0.00
0.00
0.00
0.00

0.00
81.71
14.55
2.58
0.78
0.25
0.08
0.03
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00

0.00
90.32
7.25
1.61
0.51
0.19
0.08
0.03
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00

0.00
82.24
14.07
2.47
0.77
0.28
0.10
0.03
0.01
0.01
0.00
0.00
0.00
0.00
0.00
0.00

0.00
83.61
13.39
2.12
0.59
0.19
0.06
0.02
0.01
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Days at 4°C
22°C

'Size indicates the upper threshold of each channel, measuring all liposomes larger than the previous channel.
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Table III. pH and Osmolality of the Total Nutrient Admixture
Days at 4°C
22°C
pH
Osmolality, mOsm/kg

0
0

0
2

7
0

7
2

14
0

14
2

5.5
1420

5.4
1466

5.6
1465

5.6
1510

5.6
1493

5.5
1483

tion) of liposomes creates larger
droplets which rise and coalesce,
leading to separation of the emul
sion. Electrolytes are destabilizing if
added directly to a lipid emulsion.
When added in the TNA, cations
will neutralize the negative charges
of the liposomes, causing a de
crease in repulsive forces and ag
gregation. This reaction is in
creased dramatically with the diva
lent cations, such as calcium and
magnesium.3
The amino acids have a stabiliz
ing effect on the liposomes6 by
acting as a buffer which protects
the pH of the solution. Also, the
amino acids are thought to adsorb
to the liposome-water interface,
thereby increasing the mechanical
barrier. The trace elements do not
destabilize TNA solutions.8 The po
tentially delicate balance of a TNA
demands that different combina
tions of the essential constituents
be tested to ensure that the solution
is stable.

Conclusion
From our findings, we conclude
that the TNA system using 7%
Vamin, 50% dextrose and 10% In
tralipid, with electrolytes, vitamins
and minerals, is stable with respect
to liposome aggregation for at least
14 days at 4°C and a further 2 days
at 22°C.
We thank Judy Chong, Albert Chaiet,
Fred Harris, Sigmund Krajden and
Milan Fuksa and the Department of
Photography of St. Joseph's Health
Centre for their valuable assistance.

Addendum
In subsequent studies, in which
we used 10% FreAmine, 50% dex
trose and 10% Soyacal, we found
that the admixture remained stable
for 28 days at 4°C followed by 2
days at 22°C.
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Comparison of Marlex and Gore-tex to
Repair Abdominal Wall Defects in the Rat
John L. Murphy, MD, FRCSC;* Joel B. Freeman, MD, FRCSC;t Paul G. Dionne, MD, FRCPC$
Marlex and Gore-tex, two prosthetic materials used to close abdominal wounds, were
compared with respect to strength and adhesion formation. A 2.5 X 3.5-cm
full-thickness area of abdominal wall was excised in 32 CD rats. The defect was
repaired using identically sized patches of Marlex or 1-mm Gore-tex, determined by
alternate assignment, and sutured with continuous 4-0 Gore-tex. Adhesion
formation was graded at necropsy and recorded photographically in each animal.
The mean adhesion index (none = 0, maximal = 4) was 1.37 ± 0.12 and 2.62 ±
0.12 (mean ± SEM) for Gore-tex and Marlex groups respectively (p < 0.005,
unpaired f-test). A template was used to fashion 2-cm coronal strips of abdominal
wall for tensile-strength testing. The relative strengths were 2.67 ± 0.14 and 3.02
± 0.16 kg/cm (mean ± SEM) for the Gore-tex and Marlex groups respectively (NS).
Histologically, there were more epithelioid giant cells and less collagen formation in
the Gore-tex group. Abdominal wall reconstruction with Gore-tex resulted in wound
strength equal to that of Marlex and fewer adhesions. Gore-tex is preferred when
prosthetic material and viscera are in close proximity.
Les fibres Marlex et Gore-tex, deux materiaux prothetiques utilises pour refermer
les plaies abdominales, ont ete companies pour leur resistance et leur propension a
former des adherences. On a excise chez 32 rats CD un lambeau pleine epaisseur de
2.5 X 3.5 cm de la paroi abdominale. La breche fut refermee a l’aide de pieces de
dimensions identiques, en alternant Marlex et Gore-tex de 1 mm, suturees avec du
Gore-tex 4-0 continu. Pour chaque animal, la formation d’adherences fut cotee a
l’autopsie et enregistree a l’aide d’un appareil photographique.
L’index moyen d’adherence (aucune = 0, maximum = 4) a ete de 1.37 ± 0.12 et
de 2.62 ± 0.12 (moyenne ± erreur type), respectivement, pour les groupes Gore-tex
et Marlex (p < 0.005, test t pour valeurs non appariees). Un gabarit fut utilise pour
fabriquer des bandes de 2 cm de paroi abdominale en vue d’en mesurer la force de
tension. Les resistances relatives ont ete de 2.67 ± 0.14 et 3.02 ± 0.16 kg/cm
(moyenne ± erreur type), respectivement, pour les fibres Gore-tex et Marlex (NS). A
l’histologie, on a observe plus de cellules epitheloi'des geantes et moins de formation
de collagene dans le groupe Gore-tex. La reconstruction de la paroi abdominale a
l’aide de fibre Gore-tex a permis d’obtenir une resistance de plaie egale a celle de la
fibre Marlex mais avec moins d’adherences. Le Gore-tex est preferable quand le
materiel prothetique et les visceres sont tres rapproches.

bdominal wall defects that can
not be closed primarily may
require patching with prosthetic
material. The major concerns when
using prosthetic materials are infec
tion, hernia recurrence, wound
strength, bowel adherence, fistula
formation and ease of handling. The
ideal characteristics for these pros
thetic materials were clearly defined
in 1953 by Clarke and associates.1
Polypropylene mesh (Marlex), the
primary material utilized in this
clinical situation, has given accept
able results.23 However, we have
noted dense adhesions between
Marlex and abdominal viscera.
These adhesions present serious
technical problems, particularly if
repeat laparotomy is required. Goretex (W.L. Gore & Associates, Flag
staff, Ariz.) is a polytetrafluoroethylene microporous material used
extensively for vascular conduits. A
Gore-tex soft-tissue patch has been
introduced for repairing abdominal
wall defects. The purpose of the
present study was to compare Goretex and Marlex with respect to
strength and adhesion formation.

A

Methods
From the Division o f General Surgery and Department o f Pathology, Ottawa General Hospital,
University o f Ottawa, Ottawa, Ont.
Presented at the 11th annual meeting o f the Canadian Association o f General Surgeons, held in
conjunction with the 57th annual meeting o f the Royal College o f Physicians and Surgeons o f
Canada, Ottawa, Ont., Sept. 24, 1988
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In 32 CD rats weighing between
435 and 718 g, anesthesia was
induced with 5% halothane and
maintained with 1% to 2% halo
thane by mask. The abdominal hair
was clipped and the abdomen pre
pared with iodine solution. Under
sterile conditions, a 4.0-cm midline
incision was made with approxi
mately 3 cm of undermining on
each side. Small bleeders were con
trolled with pressure. A full-thick-

MARLEX VERSUS GORE-TEX

ness abdominal wall defect was de
lineated with a 3.0 X 3.5-cm stain
less steel template and a sterile
marking pen. The outlined area was
then excised. Each rat was alter
nately assigned to receive precut
Marlex or Gore-tex (1 mm thick).
The sterile Marlex or Gore-tex was

I . \
FIG. 1. Diagram showing incision and
orientation of specimen as removed
from each rat at necropsy.

placed in a consistent orientation
and then sutured, beginning in the
midline caudally with continuous
4-0 tapered Gore-tex. The wound
was irrigated with Kefzol (Eli Lilly
Canada, Inc., Scarborough, Ont.),
500 mg in 500 ml of 0.9% saline.
The wound was closed with inter
rupted subcutaneous sutures of 4-0
coated Polyglactin and a continu
ous subcuticular 4-0 monofilament
polypropylene suture. The rats were
then given 1.5 ml of Ringer’s lac
tate solution subcutaneously. They
were marked for identification and
housed in individual cages. They
were fed laboratory food and water
and inspected daily.
After 107 to 140 days, the ani
mals were again anesthetized with
5% halothane and killed with an
intra-cardiac injection of sodium
thiopental. A laparotomy was per
formed through a U-shaped incision
based caudally on the abdominal
wall (Fig. 1). The findings were
documented with numbered photo
graphs.
Adhesions were graded as fol
lows: 0 = none; 1 = minimal,
requiring only gentle gauze dissec
tion; 2 = moderate, gentle dissec
tion augmented with limited sharp
dissection; 3 = extensive sharp dis
section required.
A central 2-cm strip of the patch
and attached muscle was separated
leaving the cranial and caudal ends
for pathological examination (Fig.
1). The central strip was placed in a
thermal container filled with chilled
normal saline. The cranial and cau
dal portions of the sample were
fixed in 10% formalin.
The tensile strength of the cen

tral strips was tested twice within 4
hours of harvesting on a Model
TTLD Instron Tensiometer (Instron
Corp., Canton, Mass.). The tensiom
eter was calibrated and run with a
cross-head speed of 5 cm/min and
a chart speed of 10 cm/min. The
tissue strips were tested at the left
and right junctions (Fig. 1). They
were held in place with a jaw-clamp
placed on the muscle and the patch.
The breakaway strength was calcu
lated from the deflection point doc
umented on the graph paper (Fig.
2). The location of the break was
documented as prosthetic, interface
or muscle wall. The width of the
strip was measured. The results
were calculated as kilograms of
traction required for the width in
centimetres of the central strip. His
tologic studies included hematoxy
lin and eosin staining and examina
tion under polarized light to assess
collagen formation and orientation.
This protocol was reviewed and
approved by the Animal Care Com
mittee of the Health Sciences Cen
tre, University of Ottawa.

Results
There were 10 early seromas in
the Gore-tex group; they resolved
within 3 weeks without interven
tion. One rat in the Marlex group
had a mild cellulitis which resolved
spontaneously.
The adhesion index in the Goretex group was 1.37 ± 0.12 (mean
± SEM) compared with 2.62 ±
0.12 in the Marlex group (p <
0.005, Table I). Two strips could
only be tested once for strength due

Table 1. Adhesion Formation and Strength Testing (Means ± SEM)
Group

FIG. 2. Strength testing on rat no. 19,
experiment rat no. 6. Tracing depicts
force and deflection point (arrow) from
which strength of interface is calculat
ed.

Marlex
Gore-tex

Adhesion index
(n = 16)
2.62 ± 0.12— i *
1.37 ± 0 .1 2 — 1

Strength, kg/cm
(n = 31)
3.02 ± 0 .1 6 — , .
2.67 ± 0 .1 4 — |T

*p < 0.005, f p > 0.05 (unpaired t-test).
Muscle failures (jT = 3.21 kg/cm).
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to inadequate tissue. The point of
disruption was 3.02 ± 0.16 kg/cm
(mean ± SEM) for Marlex versus
2.67 ± 0.14 kg/cm for Gore-tex
(NS). In the Marlex group, 15 strips
separated in the muscle rather than
at the muscle-prosthetic interface.
The samples were studied under
light microscopy and polarized light
microscopy. In the Marlex group,
there were chronic inflammatory
cells, fibroblasts and rare giant
cells. Fine collagen fibres were po
larized in proximity to the Marlex
strands and frequently appeared to
encircle them. The reaction was
diffuse and did not appear to spare
the Marlex material. In the Gore-tex
group there was a focal reaction
predominantly of giant cells. The
fibroblasts were less numerous and
the polarization examination sug
gested less collagen (Figs. 3 and 4).

acted to both materials in a similar
fashion intra-abdominally at 2 and 4
weeks. Their results suggested en
casement of both materials up to 8
weeks. Our data at 14 weeks with
16 animals in each group showed
that the adhesions in the Gore-tex
group would be more easily handled
at repeat laparotomy.
Strength is commonly assessed
by measuring bursting pressure8 or
testing with a tensiometer.9 We
elected to use the latter. After 60
days, bursting-pressure testing
tends to rupture sites other than
the hernia repair, such as the ingui
nal canals.6810 Jenkins and associ
ates6 also used tensiometer testing.

Their data were inconclusive and
their groups small, due to a high
rate of dehiscence. Our data failed
to show significant strength differ
ences between Gore-tex and Marlex.
Both materials formed secure inter
faces with rat abdominal wall. How
ever, there is potential error in this
interpretation. In 15 rats from the
Marlex group, disruption occurred
in the actual muscle rather than at
the muscle-Marlex interface. The
unproven assumption is that the
interface in these strips was strong
er. This suggests that Marlex may
be stronger and more dependable
than Gore-tex, but further experi
mentation is required to prove this.

Discussion
Little criticism can be made of
the efficacy and strength of Marlex
under a wide variety of clinical
conditions.2-5 The purpose of this
study was to assess adhesion forma
tion (the major disadvantage of
Marlex), which may lead to bowel
obstruction or fistula formation. We
postulated that Gore-tex might
offer certain advantages in this re
gard. At the same time, we thought
it crucial to measure the relative
incorporated strength of Gore-tex
compared to Marlex.
The scoring system used to as
sess the degree of adhesion forma
tion was perhaps oversimplified. On
the other hand, it translates easily
to clinical situations. Jenkins and
colleagues6 suggested that there
was no difference in adhesion for
mation between the two materials.
However, only two of the eight rats
in their 8-week Gore-tex group sur
vived to be analysed. Sher and
associates7 found that omentum re
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FIG. 3. Collagen formation in Marlex sample. Collagen fibres are enhanced when
viewed under polarized light (right) (hematoxylin and eosin, original magnification
X 40).

FIG. 4. Giant cell formation (arrow) in Gore-tex sample (hematoxylin and eosin,
original magnification X 40).
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The histologic findings of more
giant cells and less collagen in the
Gore-tex group are important. Calnan11 suggested that giant cell for
mation indicates tissue intolerance.
A marked giant cell infiltrate may
reflect instability of the surrounding
tissue. In a recent review, John
ston12 concluded that the function
of the multinucleated giant cell was
not clear. This cell is still consid
ered a macrophage in the terminal
stage of development as seen in
granulomatous diseases. The factor
interferon gamma, released from
stimulated human T lymphocytes,
may promote this development.13
Sher and colleagues7 found that the
material used did not influence the
degree of giant cell infiltration 2 to
8 weeks after Marlex or Gore-tex
insertion. Increased giant cell prolif
eration was a histologic feature in
our rats implanted with Gore-tex.
The long-term implications are be
yond the scope of this paper. Elliott
and Juler14 compared Gore-tex and
Marlex and found that Marlex tend
ed to be more distorted by dense
scarring but that it lacked both
focal adherence to muscle and a
neofascia. We did not note these
features. However, these authors’
data lend support to our hypothesis
that Gore-tex may lack the strength
that is commonly seen with Marlex.
The early finding of a polymorpho
nuclear infiltrate surrounding the
material was similar in both groups
in the study of Elliott and Juler.14
The early findings were not re
viewed in our study.
Clinical experience with both
materials has been satisfactory.
There was only one colonic fistula
in 94 patients with Marlex implan
tations noted in the follow-up peri
od of recent reports.2' 4 Lewis3 made
an effort to keep the material extrafascial. This technique was rec
ommended by Hedderich and col
leagues5 when Marlex is used in the
septic abdomen. In the absence of

omentum they suggested that
bowel be separated from the materi
al daily to avoid dense adhesion
formation. Some Marlex-related fis
tulas may heal. Macmillan and Free
man15 reported a case of gastrocutaneous fistula which healed in the
presence of Marlex used for a revi
sion gastroplasty.
Experience with Gore-tex as an
abdominal soft-tissue patch is limit
ed. Bauer and colleagues16 reported
reasonable results in 28 patients;
the hernia recurrence rate was 11%
and the infection rate was 7%. In
the infected group there was a
failure to demonstrate healing. The
length of follow-up averaged only
2.3 years.

2.

3.

4.

5.

6.

al: A com parison o f p rosthetic m aterials
used to repair abdom inal w all defects.

Surgery 1983; 94: 392-398
7. S her W, P ollack D, P aulides CA, et al:

8.

Conclusions
In rat full-thickness abdominal
defects, Gore-tex formed adhesions
that were notably easier to dissect
from underlying viscera than those
formed by Marlex. This property
would be ideal in situations where
viscera and the prosthetic material
must be in apposition. Gore-tex
formed an interface with similar
strength. However, the high per
centage of muscle failures in the
Marlex group suggests a stronger
interface. The finding of less colla
gen and increased giant cell forma
tion may portend long-term failures
with Gore-tex. This will require
careful clinical follow-up. Gore-tex
would seem to be best used in clean
abdominal wounds in which omen
tum cannot protect the underlying
viscera from adhesion formation.
We thank Ms. Missa Davie and the staff
of the Animal Care Unit, Health Sci
ences Centre, University of Ottawa.
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BCefizoxsterile ceftizoxime sodium

THERAPEUTIC CLASSIFICATION
Antibiotic
ACTION
In vitro studies indicate that the bactericidal action of ceftizoxime results from in
hibition of cell-wall synthesis in aerobic and anaerobic gram-positive and gram
negative organisms. In vitro, ceftizoxime shows a strong affinity for penicillin
binding proteins la, lbs and 3 of E. coli.
INDICATIONS AND CLINICAL USES
CefizoxTM (sterile ceftizoxime sodium) may be indicated in the treatment of the
infections listed below when caused by susceptible strains of the designated
microorganisms:
LOWER RESPIRATORY TRACT INFECTIONS caused by Streptococcus sp. (includ
ing S. pneumoniae but excluding enterococci); Klebsiella sp.; Proteus mirabilis;
Escherichia coli; Haemophilus influenzae (including ampicillin-resistant strains);
Staphylococcus aureus (including penicillinase-producing but excluding
methicillin-resistant strains); Serratia sp.; and Enterobacter sp.
URINARY TRACT INFECTIONS caused by Escherichia coli; Staphylococcus epidermidis; Pseudomonas aeruginosa; Proteus mirabilis; Klebsiella sp.; Serratia
marcescens; and Enterobacter sp.
Due to the nature of the underlying conditions which usually predispose patients to
Pseudomonas infections of the urinary tract, a good clinical response accompanied
by bacterial eradication may not be achieved despite evidence of in vitro sensitivity.
INTRA-ABDOMINAL INFECTIONS caused by Escherichia coli; Staphylococcus
epidermidis; Streptococcus sp. (excluding enterococci); Klebsiella sp.; Bacteroides
sp. (including B. fragilis); Peptococcus sp.; and Peptostreptococcus sp.
SEPTICEMIA caused by Streptococcus sp. (excluding enterococci but including S.
pneumoniae)-, Staphylococcus aureus (excluding methicillin-resistant strains);
Escherichia coli; Bacteroides sp. (including B. fragilis); Klebsiella sp.; and Serratia
marcescens.
SKIN STRUCTURE INFECTIONS caused by Staphylococcus aureus (excluding
methicillin-resistant strains); Staphylococcus epidermidis; Escherichia coli;
Klebsiella sp., (including K. pneumoniae); Streptococcus sp. (excluding enterococci
but including Group A B-hemolytic Streptococcus pyogenes); Proteus mirabilis;
Serratia sp.; Enterobacter sp.; Bacteroides sp. (including B. fragilis); Peptococcus
sp., and Peptostreptococcus sp.
BONE AND JOINT INFECTIONS caused by Staphylococcus aureus (excluding
methicillin-resistant strains); Proteus mirabilis; Peptococcus sp.; and Pepto
streptococcus sp.
Specimens for bacteriologic culture should be obtained prior to therapy in order to
identify the causative organisms and to determine their susceptibilities to cefti
zoxime. Therapy with CefizoxTM may be initiated before results of the susceptibility
studies are known. However, modification of the treatment may be required once
these results become available.
CONTRAINDICATIONS
CefizoxTM (sterile ceftizoxime sodium), is contraindicated in persons who have
shown hypersensitivity to ceftizoxime or other members of the cephalosporin group
of antibiotics.
WARNINGS
Before therapy with CefizoxTM (sterile ceftizoxime sodium) is instituted, careful
inquiry should be made to determine whether the patient has had previous hyper
sensitivity reactions to cephalosporins, penicillins, or other drugs. CefizoxTM
should be given cautiously to penicillin-sensitive patients. Antibiotics, including
CefizoxTM, should be administered with caution to any patient who has demon
strated some form of allergy, particularly to drugs. If an allergic reaction to Cefi
zoxTM occurs, its administration should be discontinued. Serious acute hyper
sensitivity reactions may require epinephrine and other emergency measures.
Pseudomembranous colitis has been reported with the use of CefizoxTM (and other
antibiotics). Therefore, it is important to consider this diagnosis in patients adminis
tered CefizoxTM who develop diarrhea.
Treatment with broad-spectrum antibiotics alters normal flora of the colon and may
permit overgrowth of Clostridia. Studies indicate a toxin produced by Clostridium
difficile is one primary cause of antibiotic-associated colitis.
Mild cases of colitis may respond to drug discontinuance alone. Moderate to severe
cases should be managed with fluid, electrolyte and protein supplementation as
indicated. When the colitis is not relieved by drug discontinuance or when it is
severe, consideration may be given to the administration of oral vancomycin or
other suitable therapy. Other possible causes of colitis should also be considered.
PRECAUTIONS
General: Transient elevations of BUN and serum creatinine have been observed in
clinical studies. However, there is no other evidence that CefizoxTM (sterile cefti
zoxime sodium) has produced alterations in renal function. Renal status should be
periodically evaluated, especially in seriously ill patients.
Prolonged use of CefizoxTM may result in the overgrowth of nonsusceptible
organisms including species originally sensitive to the drug. Careful observation of
the patient is essential. If superinfection occurs during therapy, appropriate
measures should be taken.
CefizoxTM should be administered with caution to individuals with a history of
gastrointestinal disease, particularly colitis.
Impaired Renal Function: Since ceftizoxime is excreted primarily in the urine,
patients with impaired renal function (i.e., creatinine clearance S1.32 mL/s or
<79 mL/min) should be placed on a special dosage schedule recommended under
DOSAGE AND ADMINISTRATION. Normal dosages in these individuals are likely to
produce excessive serum concentrations of ceftizoxime.
Drug Interactions: The concomitant administration of some cephalosporins and
aminoglycosides has caused nephrotoxicity. The effect of administering CefizoxTM
concomitantly with aminoglycosides is not known.
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Pregnancy: The safety of CefizoxTM in pregnancy has not been established. The
use of CefizoxTM in pregnant women requires that the likely benefit from the drug
be weighed against the possible risk to the mother and fetus. The pharmacokinetics
of CefizoxTM in pregnant patients has not been investigated. Reproduction studies
performed in rats and rabbits have revealed no evidence of impaired fertility or harm
to the fetus caused by ceftizoxime. Animal reproduction studies, however, are not
always predictive of human response.
Labour and Delivery: The safety and efficacy of CefizoxTM use during labour and
delivery has not been investigated.
Nursing Mothers: Ceftizoxime is excreted in human milk in low concentrations
(less than 4% of serum concentrations at 1 hour after dosing). The clinical signifi
cance of this is unknown; therefore caution should be exercised if CefizoxTM is to
be administered to a nursing woman.
Infants and Children: The safety of CefizoxTM in infants less than 6 months of age
has not been established. In children six months of age and older, treatment with
CefizoxTM has been associated with transient elevated levels of eosinophils,
SGOT, SGPT and CPK (creatine phosphokinase). The CPK elevation may be related
to intramuscular administration.
Elderly Patients: The elimination of ceftizoxime may be reduced due to an agedependent reduction in renal function.
ADVERSE REACTIONS
CefizoxTM (sterile ceftizoxime sodium) is generally well tolerated.
Incidence
Incidence
Adverse
<1%
>1% but < 5 %
Reaction
Hypersensitivity:

Rash
Pruritus
Fever

Liver:

Transient elevation of SGOT,
SGPT and alkaline phosphatase
Transient eosinophilia
Thrombocytosis
Positive direct Coombs’ test

Blood:

Neutropenia
Leukopenia
Thrombocytopenia

Renal:

Transient elevation
of BUN and creatinine
Injection site: burning, cellulitis,
phlebitis (with IV administration),
pain, induration, tenderness,
parasthesia

Local:

Genitourinary:

Vaginitis

Gastro
intestinal:

Diarrhea, Nausea, Vomiting, Pseudomembranous colitis

No disulfiram-like reactions have been reported with CefizoxTM
TREATMENT OF OVERDOSAGE
No case of acute overdosage has been reported to date; consequently there is no
specific information available on symptoms or treatment. In cases of suspected
overdosage, supportive therapy should be instituted according to symptoms. Serum
ceftizoxime levels can be reduced by hemodialysis.
DOSAGE AND ADMINISTRATION
CefizoxTM (sterile ceftizoxime sodium) may be administered either intramuscularly
or intravenously after reconstitution.
Dosage and route of administration should be determined by the condition of the
patient, severity of the infection and susceptibility of the causative organism(s). The
intravenous route may be preferable for patients with bacterial septicemia, or other
severe or life threatening infections.
The usual course of treatment should be 7-14 days, and should normally continue at
least 48 hours after evidence of bacterial eradication has been obtained. For
B-hemolytic streptococcal infections, a minimum of 10 days of treatment is
recommended.
DOSAGE
Adults: The recommended daily dosage of CefizoxTM is 1 to 12 grams admin
istered in equally divided doses every 8 or 12 hours (see Table 1 below).
TABLE 1
Type of Infection

Daily Dose
(Grams)

Frequency and Route

Uncomplicated
Urinary Tract

1

500 mg q12h, IV or IM

Other Sites

2-3

1 g q8h or q12h, IV or IM

Severe or
Refractory

3-6

1 g q8h, IV or IM, to
2g q8h orq12h, IV or IM*

Life-Threatening

9-12

3 o r4 g q8h IV

•When administering 2 g intramuscularly, the dose should be divided and injected
into different large muscle masses.
Because of the serious nature of urinary tract infections due to Pseudomonas
aeruginosa and because many strains are only moderately susceptible to CefizoxTM,
higher dosage may be appropriate when urinary tract infections are caused by
these organisms. Other therapy should be instituted if the response is not prompt.

Adults with Impaired Renal Function: In p atien ts in w hom the creatinine clearance
is 1.32 mL/s (79 mL/min) or less, the d o sa g e of C efizoxTM m ust be reduced. Fo llo w 
ing an initial loading dose of 500 mg to 1.0 g IM or IV, the m aintenance dosing
schedule presented in Table 2 should be follow ed in pa tie n ts with reduced renal
function.

RECONSTITUTION
S T A N D A R D V IA L S (1 G R A M and 2 G RAM S)
For Intramuscular Injection: R econstitute with Ste rile W a te r fo r Injection o r B a c 
terio static W ater fo r Injection.
Reconstitution Table for Standard Vials - I.M. Injection

TA BLE2
Renal
Function
Mild
Impairment

Creatinine
Clearance
mL/s
mL/min

Less Severe
Infections

Life-Threatening
Infections

0.83-1.32

50-79

500 mg
q8h

750 mg to 1.5 g
q8h

0.08-0.82
M oderate to
severe impairment

5-49

250 or 500 mg
q12h

500 mg to 1.0 g
q12h

500 mg q48h or
250 mg q24h

500 mg to 1.0g
q48h or 500 mg
q24h

Hem odialysis
patients*

0-0.07

0-4

*ln patients undergoing he m o d ia ly sis no additional supplem ental d osing is
required. DOSING, HO W EV ER , S H O U L D B E S C H E D U L E D SO TH AT T H E PATIENT
R E C E IV E S TH E D O SE AT TH E EN D O F T H E DIALYSIS. W hen started 24 hours after
adm inistration of 1 g of CefizoxTM, h e m o d ia ly sis has been show n to reduce serum
levels by 50%.
When only the serum creatinine level is available, cre a tinin e clearance may be
calcu lated from the follow ing form ulae (for patients 18 years and over only). The
serum creatinine level should represent renal function at the steady state.
Males:
Creatinine C learan ce

Vial
Size

D iluent to be
A d d ed to V ia l

A pproxim ate
A vailab le
V olum e

A p p ro xim a te
A verag e
C o n c e n tra tio n

ig
2g

3.0 m L
6.0 m L

3.7 m L
7.4 m L

270 m g/m L
270 m g/m L

Shake well until disso lv e d .
For Intravenous Injection: R eco nstitute o nly w ith Ste rile W a te r for Injection.
Reconstitution Table for Standard Vials - I.V. Injection
Vial
Size

D iluent to be
A d d ed to Via l

A pproxim ate
A vailab le
Volum e

A p p ro xim a te
Average
C o n c e n tra tio n

ig
2g

10 m L
20 m L

10.7 m L
21.4 m L

95 m g/m L
95 m g/m L

Shake well until disso lve d.
For Intravenous Infusion: R econstitute a s for intraven ou s in je ctio n . Fu rther
d ilute the re co nstitu te d s o lu tio n to 50 to 100 m L w ith o n e of the “ S o lu tio n s for
Intravenous Infu sio n” (see below).
TABLE 4: Solutions for Intravenous infusion

W eight (kg) x (140 - age)

(mL/min)

72 x serum creatinine (mg/100 mL)
W eight (kg) x 140 - age)

Creatinine Clearance

49 x serum creatinine ( /xmol/L)

(mL/s)

Females: 0.85 of the above values
Infants and Children: The follow ing d o sa g e schedule is recomm ended:
TABLE 3
Age Group
Infants (6 mo-2 yrs.),
and
Children (2-12 yrs.)

Sodium C h lo rid e Injection
5% or 10% D extrose Injection
5% D extrose and 0.9%, 0.45% or 0.2% So d ium C h lo rid e Injection
Ringer’s Injection
Lactated R in g er’s Injection
10% Invert S u g a r in Ste rile W ater for Injection
5% Sodium B icarb o n a te in S te rile Water for Injection
5% D extrose in L acta ted Ringer’s Injection O N L Y w hen re co n stitu te d
4% Sodium B icarb o n a te Injection.

w ith

STABILITY OF SOLUTIONS

Unit D osag e

Frequency and Route

50 mg/kg IV or IM

q6h or q8h, IV o rIM

Storage: A ll re co n stitu te d so lu tio n s and tho se further d ilute d s h o u ld be used
w ithin 24 hours if stored at room tem perature or w ith in 48 hours if refrigerated.
These storage lim its are from the time of the initial reco nstitu tio n .
Incompatibility: CefizoxTM should not be added to b lood p ro d u cts, protein
hydrolysates o r am ino a cid s . CefizoxTM sho uld not be m ixed to g e th e r w ith an
am in og lyco sid e.

The pediatric d o sag e should not e xce e d the m axim um adult dosage for serious
infections.

DOSAGE FORMS

ADMINISTRATION

Availability: CefizoxTM is available a s a sterile pow der in S ta n d a rd V ia ls of
1 gram or 2 gram s, co n ta in in g ceftizoxim e a s sod ium salt.

Intramuscular: The reconstituted so lu tio n of C e fizo xT M sho uld be injected well
w ithin the body of a relatively large m u scle , such a s the gluteus. W hen adm inister
ing 2 g IM doses, the dose should be divided equally and then injected into different
large m uscle m asses.

Storage: CefizoxTM pow der for injection sho uld be sto re d at room tem p erature
(15°-30°C).

Intravenous: Injection (bolus): The reconstituted so lu tio n of CefizoxTM should be
injected slow ly over 3 to 5 m inutes, d ire ctly or through the tubing system by w hich
the patient is receiving another c o m p a tib le intravenous solution. During ad m inistra
tion of the so lution containing CefizoxTM, it is d e sirab le to tem porarily disco ntinue
adm inistration of the other solution.
Intermittent or con tinuo us infusion: The further dilute d reconstituted solution of
CefizoxTM should be adm inistered over a 20 to 30 m inute period.
NOTE: CefizoxTM solutio ns should not be p h y sic a lly m ixed with any other drug.
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Introduction (N.V. Christou)
Intra-abdominal sepsis accounts for
a large proportion of hospital
deaths in surgical patients. Much
progress has been made in under
standing the pathophysiology of the
host-bacterial interaction and the
contribution of new antibiotic regi
mens and surgical drainage modali
ties to the outcome of severe intra
abdominal sepsis. This symposium
addresses three main areas of lifethreatening surgical sepsis: compli
cated biliary tract sepsis, pancreatic
sepsis and colonic and rectal perfo
ration. The symposium is in a question-and-answer format, using actu
al surgical cases [small type] to
highlight the problems encountered
in these conditions. Each panelist
uses his own clinical and research
experience as well as the consensus

from the literature in responding to
these difficult questions. The panel
ists were chosen because of their
expertise in each problem area.

Complicated Biliary Tract
Sepsis (O.D. Rotstein*)
A 62-year-old man had a right inguinal
and umbilical hernia repair on Jan. 14,
1988. Postoperatively, his abdomen be
came distended and he had right upper
quadrant pain. Ultrasonography showed
a distended gallbladder with stones. A
HIDA scan was consistent with acute
cholecystitis. The patient was treated
conservatively because of the previous
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symposium.
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surgery. He was discharged home on
Jan. 27, 1988. Elective cholecystectomy
was scheduled 6 weeks later.

Dr. Christou: What is the value of
"urgent” cholecystectomy in acute
cholecystitis?
Dr. Rotstein: The relative benefit of
immediate versus delayed cholecys
tectomy for acute cholecystitis has
been addressed frequently in the
literature. One viewpoint1 holds
that initial conservative therapy fol
lowed by interval cholecystectomy 2
to 3 months later is optimal. The
advocates cite, as factors favouring
delayed intervention, the low mor
tality associated with interval chole
cystectomy and the diagnostic un
certainty and high risk associated
with operation in the acute situa
tion.
The advantages of early opera
tion were shown in a randomized
trial of 140 patients who received
either early or delayed operation for
acute cholecystitis.2 Although there
was no difference in the death rate,
total hospital stay was shortened
(10.1 days versus 18.9 days), dura
tion of fever was reduced and lost
work days were lowered by 50% as
a result of early intervention. One
minor drawback of early operation
in this and other studies2-4 is that
wound infection occurs more fre
quently. However, the overall mor
bidity is substantially lower in the

:
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group of patients having early oper
ation if one considers those in
whom conservative treatment fails
(13% to 20%) or those who refuse
operation once symptoms disap
pear. Patients in the latter group
risk serious complications with lifethreatening ones developing in 15%
to 28%.5
The technical difficulty of early
operation is also cited as further
justification for delay. However, ex
perienced surgeons have found no
difference in the level of difficulty
between the two operations; con
versely, junior surgeons have had
more difficulties with early interven
tion as measured by duration of
operation and the frequency of op
erations requiring “senior” assis
tance.2 In the series of Jarvinen and
Hastbacka,3 length of operation and
frequency of minor operative com
plications were equal in both
groups.
In summary, the benefits of early
cholecystectomy generally outweigh
the risks (Table I6' 9). Serious com
plications of conservative therapy
are avoided, there is no increase in
mortality or serious morbidity and
costs to both the system and the
patients are minimized because hos
pital stay and duration of incapaci
tation are shortened. Finally, there
is no risk of further complications
developing in the interim between
the acute attack and elective sur
gery.
He underwent a cholecystectomy 6
weeks later.

Dr. Christou: Should antibiotics be
used prophylactically for elective
cholecystectomy?
Dr. Rotstein: There are three major
questions regarding prophylactic
use of antibiotics for cholecystecto
my: who should get them?, what
drug should be used? and for how
long should it be administered? An
tibiotics should be administered

prophylactically to patients at high
risk for postoperative wound infec
tion. Chetlin and Elliott6 evaluated,
retrospectively, 1421 biliary opera
tions over a 5-year period. Onethird of bile cultures were positive
and septic complications were 40
times more frequent in those who
had positive cultures (infection rate
1.3% in negative cultures versus
46% in positive cultures). Certain
clinical features were associated
with a high degree of culture-posi
tive bile. Conversely, in patients at
low risk, the rate of culture-positive
bile was only 17%. Of particular
interest was the fact that infecting
organisms were identical to the bili
ary organisms in 37 of 39 cultures.
The high overall rate of septic com
plications in this series (16%) oc
curred almost entirely in those pa
tients with positive bile cultures.
The organisms recovered were
gram-negative in 69% (Escherichia
coli, Klebsiella, Aerobacter and
Pseudomonas) and gram-positive in
31% (Enterococcus, Streptococcus
and Staphylococcus).
Based on their ability to identify
patients at high risk for postopera
tive wound infection, Chetlin and
Elliott10 examined the efficacy of a
first generation cephalosporin as
antimicrobial prophylaxis in highrisk biliary tract surgery. Prophy
lactic antibiotics decreased the
wound infection rate from 27% to
4%.
Subsequent studies1112 have con
firmed these data, showing the effi
cacy of “selective” use of prophy
lactic antibiotics in cholecystecto
my. The high-risk patient can al
most always be identified preoperatively from clinical findings. Only
those with unsuspected commonbile-duct stones escape detection.
However, they are identified soon
after the beginning of the opera
tion, and antibiotics can be given
before the wound is closed. There
appears to be no role for the pro

phylactic use of antibiotics in the
low-risk group. Wound infection
rates are less than 4% and will not
be altered by antibiotics. Some au
thors13 have suggested the intra
operative use of Gram’s staining
of the gallbladder bile to identify
accurately those at high risk. While
this is conceptually attractive, the
practical aspects of this technique
make it unfeasible in most hospi
tals.
The common infecting organism
dictates the choice of antibiotic and
it should be borne in mind that high
tissue levels rather than steriliza
tion of the bile is the aim of prophy
laxis.14 Although gram-negative en
teric organisms, gram-positive
aerobes, anaerobes and Enterococ
cus are all frequently isolated, it
appears that prophylaxis need not
cover all possible microorganisms
recovered from the bile. The first
generation cephalosporin, cefazolin
is highly effective in prophylaxis of
the biliary tract.11 Moreover, it is
inexpensive and has few sideeffects. It should be administered
intravenously just before operation
when there is adequate time to
allow the development of appropri
ate tissue levels and yet prevent
significant clearance. Three doses
(one preoperatively and two postoperatively) have been considered opti
mal for prophylaxis, although some
studies suggest that a single periop
erative dose is sufficient.1112
On postoperative day 6, a wound infec
tion was diagnosed clinically. The
wound was opened and drained of pus,

Table I. Risk Factors for Patients Who
Undergo Cholecystectomy
Age > 70 yr6
Obstructive jaundice7
Common duct stones, with or without
jaundice7
Acute cholecystitis7
Previous biliary surgery8
Operation within 1 mo of acute
cholecystitis9
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which showed gram-negative organisms
on Gram’s staining.

Dr. Christou: Should antibiotics be
used to treat wound infections and,
if so, which ones?
Dr. Rotstein: As a general principle,
antibiotics are not required for a
wound infection. Complete open
drainage of the wound is adequate
unless the host is immunocompro
mised, such as a patient who has an
indwelling prosthetic device or
signs of systemic infection. In such
cases, drainage plus antibiotics is
appropriate.
Two days later Klebsiella and Bacteroides fragilis were cultured. The patient
was treated with Dakin’s packs and
cefazolin, 500 mg orally every 8 hours
for 10 days. The patient was discharged
home 2 days later, but was readmitted
after 7 days because of persistent fever.
Examination and abdominal ultrasonog
raphy demonstrated a subphrenic ab
scess. This was aspirated under com
puted tomographic guidance, and pus
was identified which showed gram
negative organisms and grew Klebsiella
oxytoca, B. fragilis and Streptococcus
group D. A pigtail catheter was placed
to drain the subhepatic space. He was
treated with netilmicin and met
ronidazole.

Dr. Christou: What is the appropri
ate antibiotic choice for empiric
therapy, or should one wait for
sensitivity results?
Dr. Rotstein: Empiric antibiotic
therapy for a subphrenic abscess
that develops after cholecystectomy
should include coverage of the com
mon biliary organisms already cited.
Ampicillin plus an aminoglycoside
plus an antianaerobe would be ap
T a b le II. Complications of Endoscopic

Sphincterotomy
C om plication

%

Hemorrhage
Acute pancreatitis
Cholangitis
Other

46
19
17
18
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propriate. In this case, culture of
the aspirated pus grew the microor
ganisms originally recovered from
the bile; therefore, the above regi
men would constitute definitive
therapy. The need to include antibi
otics directed against Enterococcus
has been hotly debated.15 Because
this microorganism is a well-defined
pathogen in the biliary tree, our
practice is to provide specific cover
age for it in infections related to the
biliary tract.
After 2 days, fever and rigors developed
and cholangitis was suspected. Endo
scopic retrograde cholangiopancreatog
raphy (ERCP) showed a dilated common
bile duct with debris in the base. A
papillotomy was carried out, releasing
pus under pressure.

Dr. Christou: What would consti
tute an appropriate drainage proce
dure — ERCP or operative drain
age?
Dr. Rotstein: Traditional manage
ment of cholangitis includes vigor
ous replacement of fluids, intrave
nous administration of antibiotics
and early operation. However, early
endoscopic drainage now represents
the initial treatment of choice when
medical therapy fails in centres
where the expertise is readily avail
able. Leese and associates16 showed
that endoscopic sphincterotomy in
cases of acute cholangitis resulted
in successful stone clearance in
90%. Both death and complication
rates were lower for endoscopic
sphincterotomy than for operative
drainage, even though patients who
underwent sphincterotomy were
significantly older and sicker than
those who underwent operation.
The complications of sphinc
terotomy include hemorrhage, pan
creatitis and cholangitis (Table II).17
As with any procedure, inexperi
ence is associated with lower suc
cess rates and more complications.18
Failure of endoscopic sphincteroto

my is usually due to the inability of
the endoscopist to clear the duct of
stones completely. The use of a
nasobiliary catheter or repeat at
tempts at stone removal may reduce
the incidence of recurrent cholangi
tis. However, even if sphincteroto
my fails, the option of surgical
decompression still remains.
The patient was stabilized and was
discharged from the intensive care unit
to the ward 4 days later. Repeat com
puted tomography showed a small subhepatic collection, in the same area as
previously, not drained because of a
blocked catheter. This collection, aspi
rated under tomographic guidance, pro
duced 6 ml of bloody, thick fluid.
Again, the aspirate grew K. oxytoca, B.
fragilis and Streptococcus group D.
Blood cultures were positive for the
same organisms. All organisms were
sensitive to the antibiotics used.

Dr. Christou: What are the possible
explanations for this failure? Which
is at fault, the antibiotics or the
surgery?
Dr. Rotstein: Although the organ
isms were the same and were sensi
tive to the antibiotics used, the
abscess persisted. Antibiotic treat
ment in the face of established
infection, specifically abscess, is
fraught with problems. Several
questions should be asked when
antibiotic therapy fails: (a) Is the
antibiotic the one of choice? (b) Are
the systemic levels adequate? (c) Do
the antibiotics penetrate the ab
scess? and (d) Is there adequate
activity of the antibiotic in the ab
scess.
Clearly, in this patient, the antibi
otics were appropriate for the in
fecting organisms. Drug levels of
aminoglycosides were not stated,
but there is a tendency to under
dose aminoglycosides rather than
overdose them. It is generally
thought that antibiotics do not pen
etrate well-established abscesses.
This thinking was challenged by
Wells and colleagues19 who demon-
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strated that antibiotics can pene
trate into abscesses, achieve ade
quate intra-abscess levels and cause
notable killing of bacteria within
the abscess. However, abscesses re
mained even though more than 99%
of the bacteria were killed. This
finding suggests that, with respect
to established abscesses, viable bac
teria represent only one factor con
tributing to the persistence of the
infection and that once an abscess
is mature, even small numbers of
bacteria may be sufficient to perpet
uate it. Other factors, such as the
presence of an abnormal microenvi
ronment, bacterial toxins and ne
crotic debris, may contribute to the
inability of host phagocytes to re
solve the infection. Surgical or per
cutaneous drainage not only re
duces the numbers of bacteria but
also reverses many of these factors.
Computed tomography showed an intrahepatic abscess, which was drained
under tomographic guidance and pro
duced thick pus, which, on Gram’s
staining, contained mixed gram-positive
cocci and gram-negative rods.

Dr. Christou: What would be ap
propriate empiric antibiotic therapy
at this time?
Dr. Rotstein: Intrahepatic abscess
is a well-recognized complication of
cholangitis. Table III shows the
common organisms involved and
the etiology of this disease.20 Em
piric antibiotic therapy should in
clude coverage of these microorga
nisms. Our choice is usually ampicillin, metronidazole and an ami
noglycoside.
Two days later K. oxytoca, Enterococ
cus, Streptococcus group D and B.
fragilis were reported to be growing
from the pus; Enterococcus was report
ed in both samples and Streptococcus
group D and K. oxytoca in the aerobic
blood culture taken previously. The
patient was treated with netilmicin, met
ronidazole and ampicillin. He was well

for 3 days, then his condition deterio
rated; at that time a repeat computed
tomogram showed reduction in the size
of the original abscess, but in two, new,
separate areas of the liver additional
abscesses were suspected. He was taken
to the operating room on Apr. 17, 1988
to drain and evacuate the subhepatic
abscess and to provide better drainage
of the new abscesses. The drainage was
not satisfactory and the patient deterio
rated. His body temperature increased
and multiple organ failure was progres
sive.

Dr. Christou: What would be the
appropriate antibiotic to use at this
point?
Dr. Rotstein: Antibiotic therapy
was probably adequate; there is
usually no need to switch antibiot
ics unless there is evidence that
resistance has developed or there
are specific complications due to
the antibiotic itself (e.g., a decline
in renal function because of amino
glycosides).
Because of increasing renal failure, anti
biotic therapy was changed. Imipenem
therapy, 500 mg every 12 hours, was
started and this was increased 5 days
later to 500 mg every 8 hours. The
patient suffered an upper gastrointesti
nal hemorrhage despite H2 blocker
therapy. Angiography showed that the
source of bleeding was the pan
creaticoduodenal artery at the level of
the ampulla in the area of the sphinc
terotomy. He underwent operation to
control the bleeding. Pus from the
subhepatic area was again cultured and
grew Klebsiella, B. fragilis, a-hemolytic
Streptococcus and Candida. Four days
later the patient suffered a respiratory
arrest and died. At autopsy, a persistent
right subphrenic abscess was identified
together with a large abscess in the
right lobe of the liver. On careful
postmortem cultures, both abscesses
were sterile.

nized complication of cholangitis
(Table IV), namely intrahepatic ab
scess, initiated a sequence that in
volved repeated attempts at abscess
drainage, multiple antibiotic regi
mens, progression of septic foci and
multiple system organ failure.
Patients with multisystem failure
represent an immunocompromised
host in whom there is usually glob
al failure of normal host-defence
mechanisms, both specific and non
specific.21 23 Furthermore, the sys
temic consequences of major sepsis
affect not only organ systems, but
probably act at the cellular level to
impair such basic processes as
phagocytosis, chemotaxis and cyto
kine secretion.7-21 Once the spiral of
sepsis and multiple system organ
failure has been entered, death usu
ally follows. Prevention lies in ag
gressive and timely drainage of sep
tic foci and at times nonseptic foci,
such as fracture hematomas,24 in
combination with the appropriate
antibiotics. It is hoped that future
research in this area will delineate
some of the mechanisms involved in
this process and allow us to manip
ulate the process more specifically
to control the sepsis.
Table III. Organisms Found in Liver
Abscesses
Gram-negative

Escherichia coli
Klebsiella sp
Enterococcus
Proteus sp
Gram-positive

Staphylococcus
Streptococcus
Anaerobes

Bacteroides
Streptococcus

Table IV. Common Causes of Hepatic
Abscess

Dr. Christou: If both cavities were
sterile, what went wrong?
Dr. Rotstein: The chain of events
that ultimately led to this patient’s
death is seen frequently in surgical
practice. In this case, a well-recog

Cause
Benign or malignant biliary tract
disease
Intra-abdominal infection
Direct extension trauma or
hematogenous dissemination

CJS, VOL. 32, NO. 4, J U L Y 1989

■>/o
50
15
15

253

CHR1ST0U, ET AL.

Pancreatic Sepsis (E. Bradley,
III)
A 78-year-old man was admitted to
hospital because of abdominal pain,
vomiting and a serum amylase value of
1122 U/L. The abdominal x-ray series
showed a colonic cut-off sign, and clini
cal and radiologic findings were com
patible with acute pancreatitis. Ul
trasonography was attempted, but was
limited due to gas in the overlying
colon. The patient was treated with
nasogastric suction and intravenous flu
ids. Two days later his temperature
increased to 39°C and his leukocyte
count increased to 18.6 X 109/L . The
chest x-ray film showed pneumonia of
the left lower lobe and culture of the
urine grew Enterococcus, more than 10
colonies per millilitre. Ampicillin, 1 g
every 6 hours, was started. Another
abdominal series demonstrated air-fluid
levels in the right upper abdomen and
questionable edema of the retroperitoneum. A blood sample was ob
tained for culture. On day 3, ul
trasonography of the upper abdomen
showed a small stone in the gallbladder,
whose wall was slightly thickened. A
HIDA scan gave equivocal findings. The
serum amylase level was now 127 U/L.
Computed tomography showed a thick
ened edematous pancreas but no retro
peritoneal abscess, and there was no
dilatation of the biliary system. On the
following day, the blood culture grew
Klebsiella pneumoniae. The patient was
given netilmicin, 100 mg intravenously
every 8 hours.
Over the next 7 days, the patient was
treated with nasogastric suction and
total parenteral nutrition. His condition
deteriorated on day 10; he was con
fused and his body temperature was
39°C. A computed tomogram of the
abdomen showed a large abscess in the
retroperitoneal area filling the lesser
sac. At operation, necrotic hemorrhagic
pancreatitis was noted with a large
abscess at the base of the mesocolon
extending from the head to the tail of
the pancreas with extensive phlegmon.
The pancreatic abscess was drained and
a cholecystectomy, cystic duct cholangi
ography, gastrostomy and feeding jejunostomy were carried out. There was no
choledocholithiasis, and bilateral axiom
sumps were inserted to drain the ab
scess as best possible. Cultures from
this area grew Klebsiella sp. The patient
did not improve and 5 days later he still
had signs of sepsis with a temperature
254
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of 39°C. A computed tomogram of the
abdomen revealed a reaccumulation of
the pancreatic collection extending to
ward the spleen and the left paracolic
gutter. He underwent surgery for fur
ther drainage of these abscess cavities.

Dr. Christou: Dr. Bradley, would
you comment on the management
of this patient.
Dr. Bradley: This case is typical of
the complicated clinical course ex
hibited by many patients with sec
ondary pancreatic infections. In sur
gical cases there is a wide range of
death rates (from 10% to 59%) and
an alarming frequency of major
morbidity (60% to 93%).25 While
some may view these results as
disturbing, medical treatment of pa
tients with secondary pancreatic in
fections results in a death rate
approaching 100%.
The pathophysiology of second
ary pancreatic infections begins
with thrombotic and cytolytic con
sequences of acute pancreatitis. It is
becoming clear that pancreatic ne
crosis precedes the secondary devel
opment of infections. Only 40% of a
group of 145 patients with severe
acute pancreatitis and pancreatic
necrosis who underwent pancreatic
resection were found to have tissue
cultures positive for bacteria.26
These observations have been inter
preted to mean that bacterial inva
sion of pancreatic necrosis is a
secondary phenomenon. The pan
creatic necrosis demonstrated in
each of these patients ranged from
gross to microscopic and from limit
ed to diffuse. Whether the extent of
parenchymal necrosis is also a de
terminant of the chances of suprainfection is not presently known.
The mechanism for suprainfection of the devitalized retroperitone
al tissue is not clear. Although it
has been proposed that regional
inflammation permits direct tran
scolonic migration of enteric bacte
ria through an otherwise intact in

testinal mucosa, little proof exists
for this hypothesis. Recently, Wells
and colleagues9 demonstrated that
suprainfection can follow the hema
togenous route as a result of defec
tive phagocytes. In the experimen
tal animal, they demonstrated that
viable bacteria can be transported to
necrotic tissue by phagocytes and
then released upon the death of the
carrier. Regardless of the mecha
nism of secondary infection, the
colon is likely the source of the
offending organisms. The bacteria
involved in secondary pancreatic in
fections are primarily enteric. The
most common organisms in de
scending order of frequency are: E.
coli, K. pneumoniae, Streptococcus
faecalis, Staphylococcus aureus,
Pseudomonas aeruginosa, Proteus
mirabilis, Streptococcus spp, Enterobacter aerogenes and B. fragilis.27 However, secondary infections
due to Candida albicans are being
reported with increasing frequency,
suggesting that fungal cultures
should be obtained in addition to
routine aerobic and anaerobic cul
tures.
The choice of a particular antibi
otic for the management of acute
pancreatitis and its complications is
a matter of concern. Little work has
been done in humans on specific
antibiotic penetrance into pancreat
ic tissue and the levels of various
antibiotics in pancreatic juice. As an
example, several studies purporting
to show “lack of effect of prophy
lactic antibiotics” in preventing sec
ondary infections in acute pan
creatitis have used ampicillin as the
study drug, yet ampicillin is known
not to appear in pancreatic tissue or
juice. The small volume of data on
antibiotic penetrance into pancreat
ic tissue that does exist suggests
that the following agents are ex
creted in human pancreatic juice in
clinically substantial concentra
tions: cefotaxime, ceftazidime, cip
rofloxacin, trimethoprim-sulfame-
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thoxazole, rifampin and Chloromy
cetin. In contrast, none of the ami
noglycosides tested (including ami
kacin, gentamicin, tobramycin or
netilmicin) reached therapeutic con
centrations in human pancreatic
juice. On the basis of current
knowledge of tissue penetrance and
the bacteria commonly responsible
for pancreatic infections, cef
tazidime is the best single agent for
prophylaxis in severe acute pan
creatitis. Established secondary
pancreatic infections, however,
should be treated according to dem
onstrated organisms and sensitivi
ties.
Terminology in secondary pan
creatic infections needs to be more
precise. Death rates range widely
between the various conditions —
from 10% with infected pseudocysts
to 25% with pancreatic abscesses,
all the way to 50% and more with
infected pancreatic necrosis.28 Fur
thermore, surgical management can
vary from simple external drainage
to extensive retroperitoneal debride
ment and open packing. Clearly,
these secondary infections must be
properly defined and characterized
to establish a meaningful prognosis
and direct appropriate therapy.
In reports of more than 1100
cases of secondary pancreatic infec
tions published between 1966 and
1987, only 11 authors attempted to
differentiate between infected pan
creatic necrosis, pancreatic abscess
and infected pseudocyst. Moreover,
no two authors proposed definitions
that were the same! This lack of
precise disease definitions necessi
tates re-evaluation of the natural
history of acute pancreatitis. In ad
dition, ritual acceptance of long
standing treatment regimens for
secondary pancreatic infections
should be questioned.
The following operational defini
tions are suggested for clinical dif
ferentiation of the different forms of
pancreatic “sepsis”.

• Pancreatic necrosis. Sterile
pancreatic or peripancreatic necro
sis, microscopic or macroscopic,
patchy or diffuse, limited or exten
sive.
• Infected pancreatic necrosis.
Necrosis positive for bacteria or
fungi on smear or culture.
• Pancreatic abscess. A collec
tion of purulent material in the
region of the pancreas which is
positive for bacteria and bounded by
adjacent tissues and organs.
• Infected pseudocyst. A local
ized collection of infected material
in the region of the pancreas, en
closed by well-developed fibrous
walls with or without communica
tion with the pancreatic ductal sys
tem.
Because of the demonstrated im
portance of necrosis in the patho
physiology of pancreatic infections,
initial diagnostic efforts should cen
tre on whether an episode of acute
pancreatitis has resulted in pancre
atic or peripancreatic necrosis.
Buchler and colleagues29 have
claimed that serum levels of C-reactive protein greater than 0.1 g /L
are highly accurate in distinguish
ing pancreatic necrosis from acute
interstitial (edematous) pancreatitis.
Since C-reactive protein is a general
“acute phase protein”, which is
elevated in many situations, confir
mation of these observations would
represent an important advance in
the diagnosis and management of
these cases.
It may also be possible to detect
pancreatic necrosis by large-bolus
contrast-enhancing computed to
mography. Although computed to
mography, in general, represents
the best method of evaluating sec
ondary pancreatic infections,26 rec
ognition of pancreatic necrosis in
the absence of a secondary collec
tion has not been possible until
now. Several groups have recently
reported impressive success in dem
onstrating pancreatic necrosis by

dynamic contrast pancreatography,
in which the progress of a 150 to
200-ml intravenous bolus of con
trast material is followed in the
pancreatic parenchyma by comput
ed tomography.30-21
Another important consideration
is the distinction between inflamma
tion and infection. It is often not
possible to distinguish the clinical
signs of sepsis (tachycardia, fever,
elevated leukocyte count and ab
dominal tenderness) due to pancre
atic inflammation from similar find
ings caused by secondary pancreatic
infections.32 Guided transcutaneous
needle aspiration of pancreatic col
lections noted on computed tomog
raphy has become a valuable ad
junct for this important distinction.
If bacteria are present on Gram’s
staining of aspirated material, the
diagnosis of secondary pancreatic
infection is established and surgical
drainage is indicated.33-34
Treatment of infected pancreatic
necrosis is primarily surgical. While
guided transcutaneous drainage of
infected pseudocysts can be effec
tively and safely performed by radi
ologic means, particulate necrotic
material present in other forms of
secondary pancreatic infection can
not be drained through smallcalibre Ring catheters. For this rea
son, guided transcutaneous drain
age of pancreatic necrosis is notori
ously unsuccessful35-36 and surgical
debridement and drainage are re
quired. Such observations under
score the necessity for precise defi
nitions which permit clear differen
tiation between the various causes
of pancreatic sepsis.
A number of controversies con
tinue to surround the surgical man
agement of pancreatic sepsis, prin
cipally whether surgery should be
early or delayed and whether drain
age should be closed or open. Re
cent clinical studies have demon
strated significantly lower operative
death rates when exploration is de-
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layed until after the second week of
illness.37 Unfortunately, randomized
studies comparing the risks of early
versus delayed surgery do not exist.
Several workers continue to ad
vocate debridement and closed
drainage employing multiple
sumps.38 Others, ourselves includ
ed, favour debridement and open
drainage for patients with infected
pancreatic necrosis.3940 Repeated
dressing changes associated with
open drainage have all but eliminat
ed persistent sepsis as the principal
cause of death in these patients.
However, if closed drainage is se
lected, an extremely low threshold
for re-exploration is required, since
approximately one-half of patients
treated thus will require reoperation
for persistent or recurrent sepsis.
Overall death rates for pancreatic
abscesses and infected pancreatic
necrosis have been reduced to 10%
to 20% by aggressive and en
thusiastic surgical management.
With particular regard to the
78-year-old patient in the case re
port, the initial conservative man
agement of his severe biliary pan
creatitis was quite appropriate. One
week later, sepsis became apparent
and a computed tomogram was pos
itive for “abscess” . Exploration was
correctly undertaken at about 2
weeks (delayed intervention). Chole
cystectomy, gastrostomy and jejunostomy were done along with
closed sump drainage. In the pres
ence of pancreatic and peripancreatic necrosis, we would have preferred
open drainage and would have
avoided cholecystectomy or gastros
tomy at that time. Unfortunately,
the approach chosen did not result
in improvement and re-exploration
was necessary. At that point, even
staunch advocates of closed drain
age would have changed to open
drainage.
The patient was treated with a “meshzipper” open drainage approach, which
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included laparotomy three times daily in
the surgical intensive care unit. Ten
days later he was still febrile, having a
body temperature of 38.5 °C. The retroperitoneum was not draining pus and
the mesh was removed after 12 days.
Thirty days later he was still febrile
(39.2°C). Computed tomography of the
abdomen showed no further collections.
He was discharged home 55 days later.

Dr. Christou: Why the persistent
fever? Does this indicate continued
infection?
Dr. Bradley: The persistently febrile
course of this patient after open
drainage is not characteristic of the
procedure. Usually, temperature
continues to decline and is general
ly normal by the third to fourth
dressing change. Two possibilities
exist for the persistent temperature
elevation: undrained purulence (re
peated computed tomograms are
useful) and Candida sepsis (fungal
cultures are part of our routine in
these cases). Almost all of our pa
tients with open drainage have been
healed within 3 months. Neither
abdominal flaps nor skin grafting
have been necessary.
In conclusion, recent advances in
diagnosis and management have
markedly improved the prognosis of
patients with pancreatic sepsis. To
day, timely and appropriate treat
ment will return most of these
patients to productive lives.

Colonic and Rectal Perforations
(P. Belliveau)
A 72-year-old man had a 1-day history
of lower abdominal pain spreading to
the right side of the abdomen as the
day progressed. He had a history of
rheumatoid arthritis for which he took
prednisone 5 m g/d as well as indomethacin 25 mg 3 times daily and 50 mg
at bedtime. He also had a heart pace
maker. There was no history of hematu
ria, no vomiting and he had had three
soft bowel movements without bleeding
earlier in the day. There was no previ
ous surgery to the abdomen. He had

mild cushingoid facies, a temperature of
38.5°C, pulse 100 beats/min and blood
pressure 120/70 mm Hg. The abdomen
was obese and mildly distended. Bowel
sounds were present, but rare, and
palpation elicited guarding in all quad
rants with marked tenderness in the
right lower quadrant. Testing for occult
blood in the stool was negative. The
leukocyte count was 20.0 X 109/L ,
hematocrit 0.37, plasma glucose level
6.88 mmol/L, serum urea nitrogen
level 1.04 mmol/L urea and serum
creatinine level 132.6 /xmol/L. Abdomi
nal films showed few air fluid levels and
free intraperitoneal air. He was given
ampicillin 1 g, netilmicin 80 mg and
clindamycin 600 mg intravenously as
well as hydrocortisone 100 mg intrave
nously, and taken to the operating
room, where a moderate amount of thin
turbid fluid without gross fecal contam
ination was found. The sigmoid colon
had a pinpoint perforation surrounded
by inflammatory tissue, suggesting a
ruptured abscess. The abdomen was
irrigated with a solution of cefazolin 1
g /L and a Hartmann resection of perfo
rated diverticulitis with end colostomy
using healthy sigmoid was fashioned.
The abdomen was irrigated again with
antibiotic solution and the fascia closed.
The subcutaneous tissue was packed
open. Cultures of the fluid grew E. coli
and Klebsiella sp. Apart from an attack
of syncope on day 6, he remained
afebrile and antibiotics were stopped
after 7 days. He was restarted on his
regular prednisone and the wound was
covered with Steri-strips on day 13. He
was transferred to a convalescent hospi
tal.

Dr. Christou: Dr. Belliveau, would
you comment on the surgical and
antibiotic management of this pa
tient.
Dr. Belliveau: The management of
acute colonic perforations has been
controversial for several decades.
Surgical judgement is often the
final recommendation, but there are
a few concepts that have become
more generally accepted in the last
10 years.
Important factors that influence
the outcome of colonic perforations
include host immunocompetence,
shock, steroid therapy, fecal con-
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tamination, ability to localize the
septic process and the type of anti
biotic therapy. Causes of perfora
tion are multiple; they include trau
ma, inflammatory bowel disease,
collagen abnormalities, steroid
usage and diverticulitis.
The case presented illustrates
two risk factors, diverticulitis and
steroid use; both may weaken the
wall of the colon and prevent local
ization of the sepsis by the host’s
natural defences. Diverticular perfo
ration must then be divided first
into localized or walled-off perfora
tion, where the patient has been
able to overcome the spread of pus
or stool and he may be constitution
ally well, and, second, into free
perforation with generalized perito
nitis, where the host’s ability to
localize has been overcome or sup
pressed as in cases of perforation in
patients with renal transplants. In
deed, in one study reporting perfo
rations of the colon in renal homo
graft recipients, only 6 of 27 pa
tients with free perforation survived
while in those with localized perfo
ration 12 of 17 survived.41 Factors
that contribute to morbidity and
mortality include delay in diagnosis
(mean 2 to 8 days depending on the
dosage of steroids [more or less
than 20 mg]), confusing the condi
tion with rejection, the degree of
spread of sepsis and reduction of
immunosuppression.
The diagnosis is not always sim
ple, and radiologic imaging studies
should utilize abdominal series and
soluble contrast studies. Computed
tomography and ultrasonography
may help in diagnosing abscess for
mation. Free intraperitoneal gas on
abdominal films warrants rapid fluid
resuscitation and antibiotic adminis
tration to cover both aerobes and
anaerobes. Generally, in the acute
setting, an aminoglycoside com
bined with clindamycin or met
ronidazole, or a single agent, such
as cefoxitin or more recently imipe-

nem, is efficacious in limiting mor
bidity in these abdominal catastro
phes.
The choice of surgical procedure
is wide, but certain approaches have
been shown to reduce mortality.
Classen and associates,42 in 1976,
reported on the use of staged proce
dures for perforated diverticulitis.
In 203 patients who underwent
transverse colostomy and drainage,
there was a 7.9% death rate. How
ever, second-stage resection had a
0.7% death rate and the colostomy
closure 3.9%. Himal and col
leagues,43 in 1977, proposed selec
tive management for perforated di
verticulitis. They reported a 25%
death rate in 47 patients with local
perforation who underwent a colos
tomy, whereas in a few patients
who had resection or exterioriza
tion there were no deaths. In 20
cases of free perforation, colostomy
was associated with a 30% death
rate and resection or exteriorization
with a 15% rate. Eng and col
leagues,44 also in 1977, reported on
46 patients with perforation of the
colon and found that in 8 patients
with generalized peritonitis treated
by resection and colostomy, and in
27 patients treated by resection and
anastomosis for localized abscess,
there were no deaths. In a large
collected series of 1300 patients
reported by Greif and associates45
there was a 2% death rate when
resection was done for localized
abscess compared with 12% for co
lostomy without resection; also, a
12% death rate in patients with
generalized peritonitis treated by
resection compared favourably with
a 29% rate when only a colostomy
was used.
These data support the current
trend toward resection and proxi
mal end colostomy in cases of free
perforation, whereas localized per
foration in patients without ob
struction who can undergo mechan
ical and antibiotic bowel preparation

may be treated, with good results,
by resection of the affected seg
ment, including the abscess and all
the distal diverticular disease down
to the rectosigmoid junction with
primary anastomosis.
An 88-year-old woman presented with a
2-week history of dark urine and pale
stools. She appeared jaundiced but oth
erwise well. The serum bilirubin level
was 156 /xmol/L, serum alkaline phos
phatase 1109 U/L, serum urea nitro
gen level 7.14 mmol/L urea and serum
creatinine 972.4 ^mol/L. Ultrasonogra
phy of the abdomen showed a dilated
common bile duct and choledocholithiasis. In preparation for surgery, her
hematocrit was found to be 0.26,
down from a level of 0.38 2 months
earlier. She had occult blood in the
stool. A barium enema was performed
and on the initial films the radiologist
commented on retroperitoneal barium
extravasation. She underwent colonos
copy. A mucosal defect was noted at the
11-cm level. Abdominal films showed
free air, but the patient remained
asymptomatic. Clindamycin, 600 mg in
travenously every 8 hours and gen
tamicin, 40 mg every 12 hours were
started. Her temperature 2 days later
was 38.6°C. She remained stable and
on hospital day 8 she was afebrile, her
leukocyte count was 15.4 X 109/L and
her hemoglobin was 100 g/L. She had
diarrhea but no pain. Antibiotics were
changed to cefoperazone, 1 g intrave
nously every 8 hours and metronidazole
500 mg orally three times a day. Com
puted tomography showed no pelvic
abscess but persistent dilatation of the
common bile duct. Two days later ce
foperazone was increased to 2 mg intra
venously every 8 hours and she under
went an uncomplicated common-bileduct exploration and choledochoduodenostomy. Follow-up rectal ex
amination showed no tenderness or per
sistent fistula.
Dr. Christou: Dr. Belliveau, is it
appropriate to treat rectal perfora
tions without surgical intervention?
Dr. Belliveau: Rectal injuries pres
ent a difficult problem for the treat
ing surgeon. The causes of these
lesions include various surgical pro
cedures, endoscopy, foreign bodies
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either ingested or inserted, blunt or
penetrating trauma and stercoral
perforation. Factors important in
determining outcome include extent
of soft-tissue trauma, presence of
associated injury, delay in the onset
of treatment, health and age of the
patient, amount of fecal contamina
tion and level of injury.
Barium enema complications are
numerous; they include rectal per
foration, rectal tear or extravasa
tion, colonic perforation, barium
peritonitis, barium submucosal gra
nulomas, toxic megacolon, septice
mia, venous barium embolism, ret
rograde filling with vomiting and
aspiration in infants. In this particu
lar case, a colostomy was consid
ered, but the surprising lack of
rectal and general symptoms al
lowed a more conservative approach
to be used successfully. Any deteri
oration would have necessitated a
colostomy with presacral drainage
from a posterior anal approach.
Management of rectal injuries in
cludes early administration of
broad-spectrum antibiotics, provid
ing aerobic and anaerobic coverage,
rectal examination, anoscopy and
sigmoidoscopy. Barium enema
should be avoided and, when in
doubt, soluble contrast material
should be used to demonstrate dis
ruption of the rectal mucosa. In the
management of important pelvic in
juries with blunt pelviperineal trau
ma, a colostomy with a distal wash
out of the rectum has been pro
posed by Kusminsky and col
leagues.41’ They had a 42% death
rate in 14 patients who had associ
ated extensive injuries.
In the treatment of rectal trauma,
classification according to the level
of the injury has proven to be
helpful. Injuries from penetrating
trauma below the levator ani are
treated by debridement, partial su
ture, drainage and antibiotics. Teta
nus prophylaxis is important in
these patients as well as elemental
2 58
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diet to reduce fecal output. In the
management of patients with inju
ries above the levator ani who are
more at risk for pelvic sepsis, the
use of a proximal sigmoid colosto
my should be considered with divi
sion of the bowel, dependent drain
age using a posterior perianal inci
sion, debridement and distal wash
out of the rectum.
Controversy exists regarding mo
bilization of the rectum and repair
of the injury from an abdominal
approach for high rectal injuries.
Burch and associates,47 in 1986,
reported on the treatment of 60
patients with extraperitoneal pene
trating injuries over a period of 6
years. Fifty percent had irrigation
of the distal rectal segment, 20%
mobilization of the rectum and re
pair of the extraperitoneal wound.
The use of these two adjuncts did
not appear to reduce the frequency
of abdominal abscess, rectal fistula
or pelvic cellulitis. For intraperitoneal injuries of the rectum,
the Hartmann procedure or sigmoid
colostomy with closure of the rectal
wound have been suggested, the
latter being the simpler and associ
ated with fewer complications. For
posterior rectal wounds above the
peritoneal reflection, the manage
ment should include mobilization of
the rectum with repair and proximal
colostomy.
Antibiotic management in this
patient was appropriate. Initially
she received empiric broad-spec
trum coverage with an aminoglyco
side for the gram-negative aerobes
plus clindamycin for the anaerobes
and gram-positive cocci. Enterococ
cus is not covered by this approach.
Alternatively, monotherapy with a
carbapenem or combination therapy
with a third generation cephalos
porin and metronidazole could have
been used. The rationale for switch
ing antibiotics to cefoperazone and
metronidazole some days later is
based on the need to cover possible

pathogens in the patient’s dilated
common bile duct and prevent the
development of ascending cholangi
tis in its most virulent form (i.e.,
fever, chills, jaundice, hypotension
and leukopenia). Cefoperazone is
primarily excreted in the bile and
can reach levels ranging from 50 to
6000 fig/m l in bile depending on
the degree of common-bile-duct ob
struction. Ceftriaxone which has a
dual route of excretion (i.e., kidney
and liver) could have been an alter
native third generation cephalos
porin. Orally administered met
ronidazole is appropriate for anaer
obic coverage since this agent is
absorbed from the gastrointestinal
tract and is actively secreted in the
large bowel; thus, it would have
both local and systemic effects.
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Spontaneous Abortion
M.E. Boyd, MD, FRCSC
As a result of improved investigation and treatment techniques, understanding of all
aspects of spontaneous abortion has improved. The term “threatened abortion” is
often a misnomer, for the fate of the pregnancy is decided when bleeding occurs. A
dilated cervix indicates that abortion is inevitable. If the cervix is not dilated, pelvic
ultrasonography will usually show the following: a live fetus, an anembryonic
pregnancy, incomplete abortion or missed abortion. If fetal heart movement is seen,
no further treatment is needed and the prognosis is excellent (98% fetal survival). In
other cases, the uterus must be evacuated, with a Karman catheter if the uterus is
small, with a suction curette if the uterus is large. Forceful dilatation of the cervix is
avoided through the use of Laminaria.

Comme consequence de l’amelioration des techniques d’examen et de traitement, nos
connaissances de tous les aspects de l’avortement spontane se sont ameliorees.
L’appellation “menace d’avortement” est souvent mal appropriee car le sort de la
grossesse est deja decide quand l’hemorragie survient. Un col dilate signifie que
1’avortement est inevitable. Quand le col n’est pas dilate, 1’echographie pelvienne
revele habituellement les observations suivantes: un foetus vivant, une grossesse
anembryonnaire, un avortement incomplet ou une retention foetale. Quand les
mouvements du coeur foetal sont presents, aucun traitement n’est requis et le
pronostic est excellent (98% de survie foetale). Autrement, l’uterus doit etre evacue
avec un catheter Karman si l’uterus est petit, ou par curetage par aspiration si
l’uterus est large. L’emploi de Laminaria evitera une dilatation vigoureuse.

n 20% of all pregnancies the first
trimester will be complicated by
vaginal bleeding, and in half of
these the fetus will spontaneously
abort. The management of sponta
neous abortion is therefore a com
mon problem. It is important that
the clinician have a clear idea of the
nature of this condition and its
treatment. The introduction of pel
vic ultrasonography has given us
new understanding of this process.
The most important consequence of
this is our ability now to forecast

I

outcome, which has eliminated the
use of a variety of unnecessary,
possibly dangerous, empiric reme
dies for threatened abortion. The
use of Laminaria to dilate the cervix
and of suction curettage to empty
the uterus have been notable ad
vances. They have reduced need for
mechanical dilatation of the cervix
and sharp curettage of the uterus.
A number of patients abort with
in a few days of conception,1 with
few or no symptoms, so that the
patient is usually unaware of the
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pregnancy’s existence. In this paper
I shall consider only the loss of a
clinically apparent pregnancy.

Natural History

Fetal development is best under
stood by relating it to ultrasono
graphic findings. Pregnancy before
5 to 6 weeks of amenorrhea does
not have a unique ultrasonographic
appearance, but at 5 to 6 weeks a
small eccentrically located gesta
tional sac is seen. At 6 to 7 weeks,
the sac has enlarged and a fetal
pole and active fetal heart are seen.
Most pregnancies that abort have
not completed fetal development.
The cause of the failure is common
ly assumed to be a chromosomal
anomaly, most often trisomy,2 but
this is difficult to confirm because
necrosis of the placental tissue
often prevents karyotyping.3 If the
insult causing abortion is both early
and severe, there is no fetal devel
opment, and ultrasonography will
show an empty gestational sac, the
so-called blighted ovum or anemb
ryonic pregnancy. If the initial inju
ry is less serious or occurs later,
fetal development will proceed to a
certain point and stop. In this in
stance disorganized fetal parts will
be seen within the gestational sac,
with no fetal heart activity; this is
called a missed abortion.
The initial failure of fetal devel
opment or of continued fetal
growth are asymptomatic and pass
unnoticed. The clinical manifesta
tions of this are seen, usually after
7 to 10 weeks of amenorrhea, when
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painless vaginal bleeding occurs.
Although the clinician will call this
a threatened abortion, the fate of
the pregnancy has been already
decided. Painful uterine contrac
tions ensue and cause the cervix to
dilate (inevitable abortion); finally
the placenta is expelled, either to
tally (complete abortion) or partly
(incomplete abortion).
The prognosis is completely dif
ferent if ultrasonography demon
strates fetal heart activity. Al
though the vaginal bleeding is the
same as that seen in patients with
an anembryonic pregnancy or
missed abortion, in this case 97.4%
of pregnancies will continue with
normal fetal development.4 The ori
gin of the bleeding usually is not
established, but in a few cases a
second, empty gestational sac or an
intrauterine hematoma are seen to
explain the bleeding. The empty sac
will gradually absorb, as will the
hematoma, and the pregnancy con
tinues without ill effect on the
fetus.5

Diagnosis
The patient’s initial complaint is
vaginal bleeding, the volume and
nature of which are variable and
cannot be used to predict the final
outcome.6 If, on vaginal examina
tion, the cervix is dilated, abortion
is inevitable and the only decision
to be made is the means of comple
tion. If products of conception are
found, the physician merely decides
on the completeness of the process
and the need for any surgery.
If the cervix is closed, the diag
nosis is threatened abortion. Refine
ments of this diagnosis require pel
vic ultrasonography. The outcome
and findings in patients who have
ultrasonography at this stage have
been reported:5 51% have a normal
outcome, 15% an anembryonic
pregnancy, 13% an ectopic preg

nancy, 9% an incomplete abortion
and 7% a missed abortion.
The ultrasonographer will have
little difficulty in confirming that
the fetus is alive or that the abor
tion is missed or incomplete. In
most instances anembryonic preg
nancy is easily diagnosed (i.e., if the
volume of the gestational sac is
over 2.5 ml and no fetal parts are
seen7). If a diagnosis of anembryon
ic pregnancy is uncertain, ul
trasonography should be repeated 1
week later. In the series of Stabile
and colleagues,5 this was necessary
in 15% of referred cases.
The diagnosis of early intrauter
ine pregnancy or ectopic pregnancy
must be made if the urinary preg
nancy test is positive but ul
trasonography does not show an
intrauterine pregnancy. The differ
ential diagnosis will depend on the
correlation of ultrasonographic
findings with the quantitative levels
of human chorionic gonadotropin
(/3-HCG) and the selective use of
culdocentesis. An intrauterine ges
tational sac should be visible if the
/3-HCG is over 6500 IU/L.8 If the
diagnosis remains uncertain (/3-HCG
less than 6500 IU/L), the /3-HCG is
measured 2 days later. If a rise of at
least 66% is not seen, the diagnosis
is an abnormal intrauterine preg
nancy or an ectopic pregnancy.9 A
normal rise in /3-HCG level strongly
suggests that the pregnancy is in
trauterine and normal. Ultrasonog
raphy should be repeated in 1
week’s time, however, to identify
the small percentage of ectopic
pregnancies associated with a nor
mal rise in quantitative /3-HCG.

blood transfusion will rarely be re
quired. If patients are found to have
low blood pressure, the cause is
likely to be dilatation of the cervix
by retained placental tissue. Blood
pressure will quickly be restored to
normal by lifting the placental tis
sue from the cervix with sponge
forceps. Despite the infrequent need
for transfusion, the patient’s blood
group should be determined be
cause Rh0 immunoglobulin D (50
Mg) must be given to Rh-negative
patients after abortion. An intrave
nous line should be established and
20 IU of oxytocin added to 1 L of
solute.
Surgery is unnecessary if the
abortion is complete, but the diag
nosis should be confirmed by ul
trasonography.10 Complete sponta
neous evacuation of the uterus is
less likely if the uterine size is that
of 8 or more weeks’ gestation.
Patient and physician preference
can be used with respect to the
choice of anesthetic. General anes
thesia is preferable if the uterus is
large or the patient is anxious. On
the other hand, local anesthesia
with supplementary intravenous se
dation, is safe and inexpensive. Lidocaine 1% with 1:200 000 epi
nephrine is the drug of choice and a
maximum of 20 ml should be used.
The recommended sites are 12, 4
and 8 o’clock at the cervical vaginal
junction. The injection should be
made just beneath the mucosa and
cause the skin to “pop”.
Treatment varies between pa
tients with a dilated cervix and
those with a closed cervix, being
further subdivided into those with
early and those with late abortion.

T reatment

Dilated Cervix

The typical patient with a sponta
neous abortion is in good condition
when first examined. It is unusual
for such patients to bleed so much
that hemorrhagic shock develops;

Early abortion (less than 8
weeks). The standard surgical man
agement today is suction curettage
using the Karman suction cathe
ter.11 The device consists of a 50-ml
CJS, VOL. 32, NO. 4, JULY 1989
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disposable syringe with a self-lock
ing seal and attached cannula. Near
the end of the cannula there is a
side opening, which is used to
scrape the uterine wall and take up
the placental tissue.
Evacuation of the uterus with the
Karman cannula is not painful but
is unpleasant. The patient should be
given intravenous sedation (Deme
rol 50 mg and Valium 5.0 mg); no
other anesthesia is needed. Follow
ing bimanual examination, a bivalve
vaginal speculum is inserted. The
anterior lip of the cervix is grasped
with a single-toothed tenaculum in
the anterior-posterior direction and
downward tension is applied to the
cervix. The largest Karman cannula
that can be easily inserted into the
uterine cavity should be used (usu
ally 5 to 6 mm diameter). After
insertion of the cannula, the handle
of the syringe is retracted, thereby
giving negative suction to the appa
ratus. The cannula is used in the
same way as a uterine curet but is
not removed from the uterus be
tween strokes. The motion is longi
tudinal and the uterine walls are
systematically curetted. Completion
is signalled by sensing the uterus
clamp down on the cannula and
feeling a gritty sensation on curet
tage. The cannula is then removed
from the uterus, cleared and rein
serted for a final brief curettage.
A serious error is to curet the
uterus of a patient with an ectopic
pregnancy and then to discharge
her with a diagnosis of an incom
plete abortion. To prevent this, the
physician must examine the tissue
in the syringe and confirm that
placental tissue has been aspirated.
The diagnosis is straightforward if
there is abundant placental tissue,
but special measures must be taken
if the curettings are scanty. In such
cases the curetted material should
be washed in water and the blood
stained fluid decanted repeatedly
until the water is clear. The sample
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should then be examined under a
good light. Chorionic villi of the
placenta will be seen to have a light
feathery border; their appearance is
that of seaweed floating freely in
water. In contrast, decidua is heavy
and its edges are rough and shag
gy. Diagnosis from gross examina
tion as to the presence of chorionic
villi is remarkably effective.12 If this
differentiation is uncertain a frozen
section of the curettings can be
done. If chorionic villi are not seen,
the diagnosis of an ectopic pregnan
cy is likely but not certain. An
intrauterine pregnancy may be pres
ent despite the inability to identify
chorionic villi on histologic exami
nation.13 The clinician may try to
confirm the diagnosis of an ectopic
pregnancy by laparoscopy or decide
to monitor the patient by quantita
tive measurement of /3-HCG levels.
Late abortion (more than 8
weeks). In these cases the surgeon
can evacuate the uterus with the
traditional sharp curet or a suction
curet, but all evidence shows that
evacuation is faster, with less blood
loss and less need for further dila
tion of the cervix if the suction
curet is used.
The suction curet makes use of
high negative pressures (600 mm
Hg); for that reason, the tubing and
the attached cannula are rigid. The
rigidity makes the apparatus some
what cumbersome and the operator
will lose some of the “feel” of the
traditional curet.
Bimanual examination is done to
confirm the size and position of the
uterus. If local anesthesia is chosen,
a bivalve speculum is used and the
cervix is grasped with a single
toothed vulsellum or a sponge for
ceps. The largest cannula that can
comfortably pass the dilated cervix
is inserted just beyond the internal
os. The suction is then turned on
and the opening on the cuff is
occluded. The cannula need not be
moved if evacuation of placental

tissue continues. If flow decreases,
a rotary motion of the cannula is
utilized. (The movement is rotary
rather than longitudinal in these
cases because the aperture of the
suction cannula is at the distal end.)
If flow stops, the vacuum seal
should be broken and the cannula
taken outside the uterus. The
blocked aperture on the cannula
should be cleared of placental tissue
and the evacuation continued. Com
pletion of the process is signalled
by feeling the uterus clamp down
on the cannula and seeing the aspi
rate become frothy. A sharp curet is
then used to confirm that the uter
us is indeed empty, after which a
second brief suction curettage is
done.
If a general anesthetic has been
given, much of the evacuation can
be done at the time of the prelimi
nary examination under anesthesia.
At that time, the second finger of
the examiner’s right hand should be
inserted through the internal os
into the uterine cavity. Exploration
of the uterus with a digit is possible
only if the second finger is used and
if the left hand firmly pushes the
uterus against the finger through
the abdominal wall. The finger in
the uterine cavity sweeps the pla
cental fragments from the uterine
wall with a rotary motion. This
mobilization of the placenta is com
pleted in a few moments and is
completely atraumatic.
An Auvard speculum is next ins
erted into the vagina. In most in
stances, large amounts of placental
tissue will be found there. The
anterior lip of the cervix is then
grasped with a sponge forceps. A
second sponge forceps is inserted
into the uterine cavity; the forceps
are opened widely and then closed.
The forceps will grasp the loosened
placental tissue. This procedure is
repeated a few times, but after
reinsertion and before opening, the
forceps are turned 90°. The largest
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sharp curet that can be easily ins
erted through the cervix is then
used to curet the uterus. It is
important to use a large curet since
this is much less likely to perforate
the uterus and is more efficient in
removing placental tissue. The need
for a large curet is critical if the
uterus is more than 12 weeks in
size. Sharp curettage is done by
gently inserting the curet to the
uterine wall on the outstroke; the
amount of force used is a matter of
experience and the neophyte will
use less than is necessary. The
curettage should be systematic. The
completion of curettage is indicated
by the surgeon feeling the gritty,
rather firm uterine wall and hear
ing a different sound on curettage.
In contrast, remaining placental
tissue will give a “doughy” feel.
Warnings of the danger of overcu
rettage are traditionally given. The
fear is of Asherman’s syndrome,
which is a massive scarring of the
endometrial cavity resulting from
curettage that removes all of the
lining of the uterine cavity. This is
an unusual complication; it is more
likely to occur when curettage is
done on a recently pregnant patient.
After curettage is completed, the
sponge forceps are removed from
the cervix and the Auvard speculum
from the vagina. The uterine cavity
is again explored with the second
finger. The uterine walls should feel
remarkably smooth, save for the
placental site which is roughened.
Occasionally, placental tissue is pal
pated and if so the curetting proc
ess is repeated.

Closed Cervix

In the past, patients who present
ed with vaginal bleeding but who
were found to have a closed cervix
were diagnosed as having a threat
ened abortion. They were advised to
“rest in bed and avoid intercourse” ,

and await the final outcome. The
bleeding, pain and uncertainty as to
the final result would persist, some
times for weeks. The use of ul
trasonography allows us to give
more studied advice. If the fetus is
shown to be alive, the prognosis for
continuation of the pregnancy is
excellent. The patient should be
reassured and resumption of normal
life encouraged. If diagnosis of a
missed abortion or anembryonic
pregnancy is made, treatment op
tions are discussed. There is little
risk that a missed abortion in the
first trimester will cause either dis
seminated intravascular coagulation
or intrauterine infection. There is a
small but significant risk associated
with surgical evacuation of the
uterus.14 Weighed against this is
the psychological burden of contin
uing to carry a pregnancy which
will abort at some time in the
future. After weighing treatment
options, the majority of patients
will opt for surgical evacuation of
the uterus.
Complications of uterine evacua
tion mostly relate to forceful dilata
tion of the cervix. The use of
excessive mechanical force to dilate
the cervix is not only unacceptable
but unnecessary. If the cervix is
both undilated and uneffaced, eva
cuation should not be attempted
without the preoperative use of
Laminaria. The means by which
Laminaria causes dilatation of the
cervix is unsettled. It is more com
plex than the slow mechanical dila
tation of the cervix as a result of
Laminaria’s enlargement. Apparent
ly Laminaria causes the cervical
ground substance to change and
the secretion of endogenous prosta
glandins to increase. Laminaria use
reduces cervical lacerations five
fold15 and perforation of the uterus
threefold.16 A recent variant is the
substitution of the synthetic Lamicel (Cooper Medical Devices Corp.,
Philadelphia, Pa) for the traditional

It acts more quickly, it
can be inserted 1 hour before dilata
tion and is less expensive.17
There is an intermediate group of
patients who are seen early in the
process of abortion, in whom the
cervix may be effaced but incom
pletely dilated. It is a matter of
judgement as to whether immediate
surgery is necessary or whether the
patient’s condition should be moni
tored. The physician should err on
the side of conservatism and await
cervical dilatation.
Bimanual examination confirms
the size and position of the uterus.
Hegar dilators should be inserted
only to a depth of 5 cm. It is
emphasized that dilatation must be
easy and should be discontinued if
more than minimal resistance is
met. The aim is to dilate the cervix
to a diameter slightly above that of
the cannula chosen. Cannula size
should approximate the size of the
uterus in weeks. For example, a
uterus 8 weeks in size should be
evacuated with an 8-mm cannula,
and will, therefore, require dilata
tion of the cervix to a number 10
Hegar.
Laminaria.

Complications
Infection

The diagnosis of septic abortion
is made when a patient who is
aborting is found to be febrile. For
the most part, septic abortion is
caused by interference with the
pregnancy. Treatment depends on
evacuation of infected uterine con
tents and the use of intravenous
antibiotics. Evacuation should be
prompt. It is not necessary to delay
the evacuation while a prolonged
course of antibiotics is given. The
fear of septicemia at the time of
curettage is unfounded. Clin
damycin and gentamicin are chosen
because of the polymicrobic nature
CIS, VOL. 32, NO. 4, JU LY 1989
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of the infection. The response will
be rewarding. Septic shock is an
uncommon but possible complica
tion. The patient’s pulse, blood
pressure and urine output must be
monitored.
Serious clostridial infections are
rarely seen. At one time, hysterecto
my was frequently advised as part
of the treatment for this infection.
This is no longer necessary, and
finding Clostridium sp on Gram’s
staining of the cervix or even seeing
gas patterns in the uterine muscle
on the pelvic x-ray film should not
be taken as an indication for hyster
ectomy. A satisfactory response to
antibiotics (penicillin) should be an
ticipated with most clostridial infec
tions. Hysterectomy in this case is
only indicated when there is evi
dence of intravenous hemolysis.

intestine or fatty tissue in the aspi
rate. In all such circumstances lapa
rotomy must be done to confirm the
extent of the injury. Perforation of
the uterus by a sound or a dilator is
not so serious. The abortion can be
completed under laparoscopic guid
ance.18

6. Duff GB, E vans JJ, L ecge M: A study of
investigations used to predict outcom e
of pregnancy after threatened abortion.

7.

8.

Follow-up
9.

Spontaneous abortion is an inci
dent in a woman’s life that will
invariably be remembered. Patients
often lay the blame for the abortion
on chance happenings. They should
be reassured that they are not re
sponsible and that recurrent abor
tion is most unlikely. Should re
peated abortion occur (habitual
abortion), specialist investigation
will be required.

13.

References

14.

10.

11.

12.

Hemorrhage
Continuing vaginal hemorrhage
after curettage usually relates to an
incomplete evacuation of the uter
us. In most instances the uterus
should be recuretted. The possibili
ty that the previous dilatation and
curettage has injured the uterus or
that a coagulation disorder has de
veloped must be kept in mind.

Perforation
Perforation of the uterus with
the suction curet may result in
catastrophic injury to the intestine
or its mesentery. The perforation is
usually diagnosed by seeing the
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Is Neomycin Necessary for Bowel
Preparation in Surgery of the Colon? Oral
Neomycin Plus Erythromycin Versus
Erythromycin-Metronidazole
R.T. Lewis, MB, FRCSC, FACS;* R.G. Goodall, MD, FRCSC, FACS;t B. Marien, MD, FRCSC;$
W. Lloyd-Smith, MD, FRCSC, FACS;t M. Park, MD, FRCSC, FACS;$
F.M. Wiegand, MD, FRCSC, FACS$
In 132 patients who underwent elective surgery of the colon, the value of bowel
preparation with a conventional oral antibiotic preparation of neomycinerythromycin (N-E) was compared with erythromycin-metronidazole (E-M).
Of 125 patients who were available for assessment, 61 received N-E and 64 E-M.
The two groups were evenly matched. Two wound infections occurred in patients
receiving E-M, neither due to anaerobic bacteria, but seven wound infections
developed in patients given N-E (p = 0.057), five of them caused by anaerobic
bacteria. Anaerobic bacteria of the colon are the dominant cause of postoperative
wound infection in elective surgery of the colon. Adequate antibiotic preparation
directed against these bacteria makes the use of neomycin unnecessary.

On a compare, chez 132 patients qui ont subi une chirurgie non urgente du colon,
l’efficacite de deux regimes prophylactiques: la preparation antibiotique orale
classique constitute de neomycine et d’erythromycine (N-E) et une association
erythromycine et metronidazole (E-M). Des 125 patients evaluables, 61 re?urent la
N-E et 64 l’E-M. Les deux groupes etaient comparables. Deux infections de plaies
sont survenues chez les patients qui avaient re?u l’E-M, ni une ni l’autre
n’impliquant des bacteries anaerobies, alors qu’on compta sept infections de plaies
chez les patients qui avaient eu la N-E (p = 0.057), dont cinq a bacteries anaerobies.
Les bacteries anaerobies sont la cause predom inate des infections de plaies
postoperatoires lors des operations non urgentes du colon. Une antibiotherapie
specifique adequate contre ces bacteries rend superflu l’usage de la neomycine.

eomycin has long been the
mainstay of oral antimicrobial
prophylaxis for surgery of the colon
because of its influence on coliform

N

organisms in the bowel lumen.1 Its
efficacy was questioned as early as
1953,2 and by 1974 it was clear
that neomycin alone did not prevent

wound infection after bowel sur
gery.34 Since the importance of
anaerobic bacteria was recognized
in the pathogenesis of infection
after surgery of the large bowel,5
neomycin has been used successful
ly in combination with such agents
as tetracycline, erythromycin and
metronidazole.46-7
Some surgeons have suggested
that drugs such as metronidazole
and lincomycin aimed at anaerobic
bacteria provide effective bowel
preparation on their own and there
fore oral neomycin is unneces
sary.8-9 Others claim that orally ad
ministered metronidazole alone has
no influence on microflora10 and is
ineffective in preventing wound in
fections after elective resection of
the colon.11 The aim of this study
was to assess whether oral neomy
cin needs to be added to erythromy
cin or to combinations of antibiotics
aimed at anaerobic bacteria to pre
vent sepsis after elective colonic
resection.

Methods
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Patients admitted into the study
were scheduled for elective colorec
tal operations at the Queen Eliza
beth Hospital, Montreal. Patients
were excluded if they had received
antimicrobial therapy during the
week before surgery or had a histo
ry of allergy to any of the study
antibiotics. Written informed conCJS, VOL. 32, NO. 4, JU L Y 1989
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sent was obtained from 132 pa
tients. All had mechanical bowel
preparation, consisting of dietary
restriction, laxatives and enemas.12
They were then randomized by hos
pital pharmacists to receive one of
two prophylactic antimicrobial regi
mens. The “standard neomycin-ery
thromycin regimen” (N-E) consisted
of erythromycin base and neomycin
sulfate, 1 g each by mouth at 1300
hours, 1400 hours and 2200 hours
on the day preceding operation.6 In
the “ erythromycin-metronidazole
regimen” (E-M), erythromycin base
was given as above, but neomycin
sulfate was replaced by met
ronidazole orally, 750 mg three
times daily for 2 days before opera
tion. The pharmacist responsible for
randomizing the patients and dis
pensing the drugs did not partici
pate further in assessment of the
patients.
The age, sex, height and weight
of each patient were recorded. At
operation, the diagnosis, operative
procedure and degree of wound
contamination13 were noted. Speci
mens were obtained for culture
from the colon and subcutaneous
fat of the wound before skin clo
sure. Infection control personnel

examined the wound on days 5 and
7 after operation, and thereafter as
necessary for up to 1 month. A
wound infection was diagnosed
when pus drained from the
wound;14 a sample of the discharge
was then obtained for culture.
Wounds that were red or tender
were followed without antibiotic
treatment until the problem re
solved or the wound drained pus.
An anastomotic leak was diagnosed
when a fistula developed postoperatively or at operation for postopera
tive peritonitis. An intra-abdominal
abscess was diagnosed by the usual
clinical and radiologic criteria15 and
confirmed by drainage. A blood
stream infection was diagnosed
when a blood culture, done because
of a postoperative temperature of
39°C or higher, was positive.
For each patient, a risk index of
wound infection was calculated
from the age, degree of wound
contamination, duration of opera
tion and results of subcutaneous fat
cultures, as recommended by David
son and associates.16 The preopera
tive total leukocyte and differential
counts, serum albumin and serum
iron concentrations and iron-bind
ing capacity (TIBC) were measured

T a b le 1. R e a so n s f o r E x c lu d in g P a tie n ts fro m Final A s s e s s m e n t
N e o m y c in -e ry th ro m y c in

E ry th ro m ycin -m etro n id azo le

R e tro p e rito n e a l a bscess
S y s te m ic a n tib io tic s f o r m itra l s te n o s is
P o rta l v e in th ro m b o s is (d ied p o s to p d a y 2)
P e lv ic a b s c e s s

In tra -a b d o m in a l a b sc e s s
D elayed w o u n d clo s u re
A b d o m in a l w a ll a b sc e s s

by standard methods. The blood
lymphocyte count was calculated as
the product of the leukocyte count
and percent lymphocytes, and the
serum transferrin value was calcu
lated from the TIBC.17
Statistical analysis was performed
where necessary by Student’s t-test,
Fisher’s exact test, and x2 analysis
with Yates modification.

Results
Sixty-five patients were random
ized to receive the N-E regimen and
67 the E-M regimen. Four N-E and
three E-M patients were excluded
from further analysis because of the
presence of overt infection at opera
tion or for violation of the protocol
(Table I). Thus, 125 patients
formed the study group; 61 re
ceived N-E and 64 E-M.
The two groups were evenly
matched with respect to age, sex
and percent actual of ideal weight
for height. The mean risk index of
wound infection was higher in the
E-M group, but the groups were
similar in wound class, preoperative
blood lymphocyte count, and serum
albumin and transferrin concentra
tions (Table II). Table III compares
the treatment groups with respect
to the operative diagnosis and site
in the large bowel. No differences
were observed.
A wound infection was diagnosed
in two patients receiving E-M, corn-

T a b le II. C o m p a riso n o f P a tie n ts R e ce iv in g P re o p e ra tiv e B ow el P re p a ra tio n W ith N e o m y c in -E ry th ro m y c in (N -E ) o r E ry th ro m y c in -M e tro n id a z o le (E -M ).
V a lu e s A re M ean ± SEM
Group
F a c to r
A ge, yr
S e x , M /F
W e ig h t, % a c tu a l/id e a l
R is k in d e x , %
W o u n d c o n ta m in a tio n
(c o n ta m in a te d /c le a n -c o n ta m in a te d )
B lo o d ly m p h o c y te s , X 10 9/ L
S e ru m a lb u m in , g /L
S e ru m tra n s fe rrin , g / L
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N-E

E -M

S ig n ifican ce
(t v a lu e )

68 ± 2
3 1 /3 0
116 ± 3
31 ± 2 .6

67 ± 2
3 2 /3 2
115 ± 3
4 2 ± 2 .5

NS (0 .5 9 )
NS
NS (0 .2 4 )
p < 0.01 (3 .0 6 )

1 1 /5 0
1 .5 49 ± 0 . 0 9 2
3 6 .8 ± 0 .0 7
1.63 ± 0 . 0 6 3

1 0 /5 4
1 .4 4 4 ± 0 .0 7 8
3 6 .8 ± 0 .7
1 .7 5 ± 0 . 0 7 1

NS
NS (0 .8 7 )
NS (0 .0 7 )
NS (1 .2 5 )
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pared with seven patients receiving
N-E (p = 0.057, Fisher’s exact
test). Other postoperative complica

tions were similar in the two groups
(Table IV). Table V lists the bacteria
causing wound infection. Anaerobic

T a b le III. C o m p a ris o n o f T re a tm e n t G ro u p s - O p e ra tive D ia g n o s is and S ite
G roup
D ia g n o s is /S ite
D ia g n o s is
Tum our
In fla m m a tio n
O th e r
O p e ra tiv e site
L e ft c o lo n o r re c tu m
R ig h t o r tra n s v e rs e c o lo n

N -E

E -M

S ig n ific a n c e

45
14
2

41
19
4

NS

48
13

48
16

NS

Discussion

T a b le IV. C o m p a riso n o f P o s to p e ra tiv e C o m p lic a tio n s
Group
C o m p licatio n

N -E

E -M

W o u n d in fe c tio n
A n a s to m o tic leak
In tra -a b d o m in a l a b sc e s s
B lo o d s tre a m in fe c tio n

7 (1 1 .5 % )
1
0
1

2 (3 .1 % )
2
1
0

T o ta l se p s is

7 (1 1 .5 % )

3 (4 .7 % )

T a b le V. B a c te ria C a u sin g In fe c tio n
G roup N-E

G roup E-M
No. of
patien ts

B a c te ria

Escherichia coli +
Bacteroides fragilis
Clostridium s p /Peptococcus

N o. O f
p a tie n ts

B a c te ria

Escherichia coli +
Streptococcus G ro u p D
Enterococcus

3
1

1
1

A n a e ro b ic d ip th e ro id s /

Staphylococcus epidermidis
Staphylococcus aureus
Staphylococcus aureus +
Escherichia coli

1
1
1

N-E

P

Anaerobes

30

Coliform s
Candida
No growth

25

16

10

E-M

? 001

0 .0 0 1 3

jij:

50

0 .0 0 8

: 6

0 .0 7 5

5

bacteria were found in five o f the
seven wound infections in the N-E
group, but were absent from in
fected wounds o f both E-M patients.
Figure 1 shows the results o f in
traoperative stool culture from the
bowel lumen. Anaerobic bacteria
were still present in significant
numbers of patients who received
N-E, whereas coliforms were domi
nant in the E-M group.

No. of patients
FIG. 1. Results of cultures taken intraoperatively from bowel lumen. N-E =
neomycin-erythromycin, E-M = erythromycin-metronidazole.

Although the neom ycin-ery
thromycin preparation has been the
“ gold standard” o f antibiotic prepa
rations for elective colonic sur
gery,18 there is still controversy
about how it works and the reasons
for its success in preventing postop
erative infection.19 The current con
sensus is that aerobic and anaerobic
bacteria are both important in the
pathogenesis o f infection after elec
tive colonic surgery and that antibi
otics used for prophylaxis should be
effective against both groups of
bacteria.20 In the N-E preparation,
neomycin is given to reduce the
number of coliform bacteria in the
large bowel and erythromycin is
used to reduce the number o f an
aerobic bacteria. However, several
questions arise.
First, is it necessary to reduce the
number of coliform organisms in
the bowel lumen by giving neomy
cin orally? This question arises be
cause neomycin fails to prevent
wound infection when used alone,
but it works well when combined
with antibiotics that kill intestinal
anaerobic bacteria (Table VI3'4'6-7'2124). We have shown that neomycin
is not necessary. Indeed, the regi
men that excluded neomycin was
marginally more successful, and
most failures o f N-E were caused by
intestinal anaerobes, not coliforms;
E-M prevented these infections de
spite persistence o f coliforms in the
CJS, V O L. 32, N O . 4, J U L Y 1989
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colon. Arabi and associates10 and
Vallance and colleagues11 found a
neomycin-metronidazole prepara
tion more effective than met
ronidazole alone, but they gave
only a small dose of metronidazole.
Our findings agree with those of
most other workers.8'9 25-28 Neomy
cin is not necessary for bowel prep
aration; and, when given alone, neo
mycin fails because it is ineffective
against the dominant anaerobic bac
teria of the colon.
Second, does neomycin also fail
because it is not absorbed from the
bowel? This raises the larger ques
tion of whether the dominant effect
of oral antibiotic prophylaxis in
colonic surgery is systemic (destroy
ing bacteria in blood and con
taminated tissues) or luminal (re
ducing the number of bacteria in
the colon). Our study did not exam
ine this question, but others sug
gest a primary systemic29-30 and sec
ondary luminal effect.101131
Keighley and colleagues29 com
pared oral with intravenous kanamycin and metronidazole in pa
tients having colonic operations.
The oral preparations did not pro
duce substantial blood levels of the
antibiotics, but did reduce the num
ber of bacteria in the bowel. Wound
sepsis was high (36%). On the other
hand, the intravenous agents did
not change the fecal microflora but
produced high blood levels of anti
biotics and a low rate of wound
infection (6.5%). Using a higher
dose of oral metronidazole, Dion
and coworkers30 compared oral with
intravenous neomycin and met
ronidazole. Bacterial counts in the
colon were low and blood levels of
metronidazole were high with both
regimens, and in both the rate of
wound sepsis was low. Taken in
conjunction, these studies show
that the main effect of the oral
antibiotics is systemic: when blood
concentrations of appropriate anti
biotics are high, the wound infec
268
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tion rate is low, even in the pres
ence of normal colonic microflora;
when blood concentrations of the
antibiotics are low, the wound infec
tion rate is high, despite effective
reduction of bacterial counts in the
colon.
Other studies suggest a lesser
luminal effect for oral antimicrobi
als in bowel preparation. Thus,
Arabi and colleagues10 and Vallance
and colleagues11 found that lowdose metronidazole alone had no
effect on colonic microflora, and
allowed wound infections to develop
in 51% of patients having elective
colonic surgery. Neomycin alone
reduced the number of coliform
bacteria in the bowel but had no
effect on colonic anaerobes. When
given together, neomycin and met
ronidazole profoundly reduced both
aerobic and anaerobic bacteria in
the colon, and reduced the inci
dence of wound infection to 22%.
Similarly, Finegold31 has suggested
that in the N-E preparation, eryth
romycin acts to prevent the over
growth of anaerobic bacteria that
occurs when neomycin alone is
used.
Third, are agents that are effec
tive only against anaerobic bacteria
adequate for oral antibiotic prepara
tion of the colon? Our study shows
that erythromycin-metronidazole is
effective; and Keighley and associ
ates32 found lincomycin, a macrolide
antibiotic related to erythromycin,
effective when given intravenously.

Most workers9-26-28-33 report that
metronidazole alone provides good
prophylaxis, but, as noted above,
Vallance and associates11 found lowdose oral metronidazole ineffective.
Would erythromycin alone be
sufficient? This question has not
been studied. However, we can spe
culate that it would be no better
than low-dose metronidazole, since
oral erythromycin in the N-E prepa
ration has only a marginal systemic
effect against intestinal anaerobes.
Approximately 50% of the oral dose
is absorbed,34 but wide variations
occur.35 So although the mean peak
blood concentration of erythromy
cin, 3.4 to 6.5 Atg/ml,35-40 is suffi
cient to inhibit many anaerobic bac
teria, including 60% to 90% of
isolates of Bacteroides fragilis,3B
blood concentrations vary widely in
individual patients. Therefore oral
erythromycin alone probably has an
unreliable systemic effect against
anaerobic bacteria of the colon; and
this may explain some of the report
ed failures of the N-E prepara
tion.40-41 Certainly, in the present
study, the failure of the N-E prepa
ration was a failure of erythromy
cin, since anaerobic bacteria were
dominant in most infections in the
N-E group. Unfortunately, blood
concentrations of erythromycin
were not measured. We have report
ed similar findings before.42
We can also speculate that neo
mycin contributes to the usual suc
cess of the N-E preparation by

T a b le V I. R e p orted R e su lts U s in g N e o m y c in O ra lly in B ow e l P re pa ratio n
W ou nd infection, no. (% )

S e rie s
R u b b o and co lle a g u e s, 1 9 6 5 3
H u g h e s , 1 9 6 7 22
W a s h in g to n and co lle a g u e s, 1 9 7 4 4
C la rk e and c o lle a g u e s, 1 9 7 7 6
K han and N ixo n, 1 9 7 8 23
M a th e s o n and c o lle a g u e s , 1 9 7 8 7
M o lin and R ieger, 1 9 7 9 21
J a g e lm a n and c o lle a g u e s , 1 9 8 5 24

N e o m y c in
11 (2 8 )
3 5 (3 7 )
2 8 (4 1 )

Controls
1 9 (4 8 )
3 8 (4 8 )
27 (4 3 )
21 (3 5 )

9 (6 0 )
2 5 (4 2 .3 )
41 (6 2 )
8 (2 2 )

N eom ycin +
antib io tic a g a in s t
a n a ero b ic b a c te ria

3 ( 4 .6 )
5 (8 .9 )
3 (2 0 )
9 ( 1 7 .6 )
9 (1 2 )
0 (0 )
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synergy with erythromycin. This ef
fect may be similar to that observed
with low-dose metronidazole.1011 In
the present study, we chose instead
to augment the power of antimicro
bial preparation against anaerobes
by giving metronidazole orally in a
dose sufficient to inhibit and de
stroy intestinal anaerobic bacte
ria. 12-30'43 Our study confirms the
efficacy of this regimen directed
only against the anaerobic bacteria
of the colon.
Finally, is oral neomycin poten
tially harmful when used for antibi
otic preparation of the colon? The
main risk is from the emergence of
resistant organisms. As early as
1953, Poth2 noted overgrowth of
Candida in patients on a 3-day
neomycin preparation. Nichols and
colleagues1 found no evidence of
Candida overgrowth when a short
(19-hour) neomycin-erythromycin
preparation was used, but Weaver
recently questioned this finding.37
We observed some overgrowth of
Candida in the N-E group, but no
clinical problem resulted from this.
It appears, then, that oral neomy
cin is not necessary for antibiotic
preparation of the colon when ade
quate prophylaxis against anaerobic
bacteria is provided. It remains to
be seen whether systemic antibiot
ics effective against coliforms can
produce a further reduction in post
operative wound infection.
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SESAP VI Critique
Item 300
Prolonged total parenteral nutrition (TPN) can produce significant liver
abnormalities, including fatty infiltration of the liver, particularly when
the glucose to nitrogen calorie ratio is high. The resultant hepatocellu
lar damage occurs to the various enzyme systems in the hepatocytes,
and these changes occur long before the hepatocyte damage leads to a
bile leak into the vascular spaces. Liver enzymes should be monitored in
any patient receiving TPN. Monitoring reveals abnormalities in the
various transaminases, the alkaline phosphatase, and gammaglutamyl
transferase long before hyperbilirubinemia occurs. If one waits until the
patient becomes clinically jaundiced or simply follows the bilirubin as an
indicator of liver damage, hepatic damage would be much greater than
if enzymes are used for monitoring.

cu
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University of Toronto —
Continuing Education
A symposium on ischemia/reperfusion
injury in skeletal muscle will be held
Sept. 10, 1989 in Toronto. For further
information contact: Continuing Educa
tion, Faculty of Medicine, University of
Toronto, Medical Sciences Building, To
ronto, Ont. M5S 1A8; (416) 978-2718.

American Association for Hand
Surgery
The 19th annual meeting of the Ameri
can Association for Hand Surgery will
be held in San Francisco, Calif., Oct.
26-29, 1989. The program’s goal is to
provide those attending with state-ofthe-art information on hand surgery
through panel discussions, mini-courses
and “ask-the-expert” sessions. Write to
Myra Josephson, Central Office Manag
er, American Association for Hand Sur
gery, Ste. 210, 2934 Fish Hatchery
Rd., Madison, WI, 53713 for informa
tion or call (608) 273-8940.

Bone and Soft-Tissue Tumours
A conference on the diagnostic modali
ties, pathologic features and treatment
of bone and soft-tissue tumours will be
held Nov. 3-5, 1989 in Sacramento,
Calif., which will also be the setting for
a symposium on anesthesiology Nov.
17-19. Information on both of these
events can be obtained from the Office
of Continuing Medical Education, UC
Davis School of Medicine, 2701 Stockton Blvd., Sacramento, CA 95817;
(916) 453-5390.

American Back Society
The American Back Society Fall Sym
posium on Back Pain will be held from
Nov. 30 to Dec. 3, 1989 in Las Vegas.
The course chairman is Dr. Vert Moo
ney. The course provides 18 hours of
CME credit. For further information
contact: American Back Society, 2647
East 14th Street, Ste. 401, Oakland,
CA 94601, or phone (415) 536-9929.
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Patent Ductus Venosus: Problems in
Assessment and Management
M.F. Barsky, MD, FRCPC;* R.N. Rankin, MB, ChB, FRCPC;* W.J. Wall, MD, FRCSC;t
C.N. Ghent, MD, FRCPC;* B. Garcia, MD, FRCPC§
A congenitally patent ductus venosus is the rarest form of portosystemic shunt.
Although it occurs in the absence of serious parenchymal liver disease, it may be
associated with hepatic encephalopathy. This case report describes a 49-year-old
man with a patent ductus venosus who presented with recurrent bouts of
encephalopathy but few other features of chronic liver disease. Ligation of the shunt
was followed by life-threatening complications. The portal venous system must be
carefully assessed before closure of a patent ductus venosus is attempted.

La persistance du canal veineux represente la forme la plus rare d’anastomose
congenitale systemo-porte. Bien qu’elle survienne en l’absence d’atteinte grave du
parenchyme hepatique, elle peut etre associee a une encephalopathie hepatique. On
fait la description du cas d’un homme de 49 ans presentant une persistance du canal
veineux et qui a ete vu souffrant d’acces d’encephalopathie a repetition, en l’absence
d’autres signes d’hepatite chronique. La ligature de l’anastomose fut suivie de
complications qui mirent en peril la vie du patient. Le systeme veineux porte doit
etre soigneusement evalue avant de tenter la fermeture du canal veineux.

ortosystemic encephalopathy is
a well-recognized complication
of surgically created portosystemic
shunts, performed to relieve portal
hypertension. Bypassing blood from
the normal detoxification processes
within the liver can result in neuro
logic disturbances manifested in
many ways.1 Congenital portosys
temic shunts are rare, but have also
been associated with encephalopa
thy.1-6 We recently treated a man
suffering from recurrent episodes of
encephalopathy, in whom a diagno
sis of hepatoportal sclerosis had
been made by liver biopsy. A patent
ductus venosus was demonstrated

P

by ultrasonography and angiogra
phy. There have been a few in
stances in which surgical ligation or
resection of a portosystemic shunt
has led to clinical improvement and
correction of encephalopathy.2-5
This report describes a serious com
plication resulting from attempted
closure of the shunt and reviews
the literature relating to congenital
portosystemic shunts.

Case R eport

A 49-year-old man was admitted
to the University Hospital in Lon
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don, Ont., for assessment for a liver
transplant. In 1979, recurrent he
patic encephalopathy secondary to
portal vein occlusion had been diag
nosed. The patient was born prema
turely, his intelligence quotient was
borderline and milestones of devel
opment were delayed; he required
special education classes. He was,
however, functional, was married
and held several jobs. He was first
seen after repeated episodes of con
fusion, inappropriate behaviour and
tremulousness that began around
1974. There was no history of drug
or alcohol abuse or hepatitis. In
1979, abdominal angiography, in
cluding selective celiac and superior
mesenteric artery injection, demon
strated tortuous hepatic arteries.
The venous phase demonstrated a
markedly dilated portal vein (5 cm).
Splenoportography showed an ap
parent portal vein obstruction at the
porta hepatis, but no collaterals
were seen. No esophageal varices
were seen on endoscopy. A percuta
neous liver needle biopsy showed
changes of hepatoportal sclerosis
with a striking absence of visible
venules in the portal areas.
Over the next few years, the
patient was admitted to hospital on
numerous occasions with recurrent
episodes of hepatic encephalopathy.
Serum ammonia levels were variably
elevated, as high as 176 /umol/L
(normal 11 to 35 /umol/L), with
normal liver enzymes, slightly de
creased albumin and mildly elevated
serum bilirubin levels. He initially
responded well to therapy, which
CJS, VOL. 32, NO. 4, JULY 1989
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included lactulose, neomycin and a
low protein diet. However, progres
sive physical and mental deteriora
tion led to his admission to a nurs
ing home in 1986.
At that time he was inattentive,
agitated and had a resting tremor
and athetosis. There was one spider
nevus and testicular atrophy, but
no other signs of chronic liver dis
ease. Results of cerebellar function
tests were abnormal, reflexes were
brisk and Babinski’s reflex was pos
itive. There were no KayserFleischer rings. Laboratory tests
showed mildly abnormal liver en
zyme levels and tests of synthetic
function gave the following results:
serum alanine aminotransferase 43
U /L (normal 5 to 30 U/L), aspar
tate aminotransferase 36 U/L (nor
mal 10 to 30 U/L), 7-glutamyl
transferase 40 U /L (normal 0 to 30
U/L), alkaline phosphatase 135
U /L (normal 18 to 113 U/L), pro
tein 54.3 g /L (normal 60 to 80
g/L), albumin 26.4 g /L (normal
29 to 49 g/L), total bilirubin 22.8
/umol/L (normal 3.4 to 17.1
^mol/L). The serum ammonia level
was 39 ij. mol/L (normal 11 to 35
jumol/L) and the serum copper was
10.7 junol/L (normal 11 to 22
jiimol/L).
Ultrasonography demonstrated a
large tortuous vessel originating
from the portal vein and communi
cating with the inferior vena cava
(Fig. 1). Celiac angiography con
firmed the abnormal communication
between the inferior vena cava and
the proximal left branch of the
portal vein. This was catheterized
through the inferior vena cava, and
retrograde injection demonstrated
patent portal, splenic and superior
mesenteric veins (Fig. 2). Small,
tortuous portal branches to the
right lobe, with a deficient branch
ing pattern, were also seen (Fig. 3).
The patient was operated on to
close the patent ductus venosus in
the expectation that the portosys
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temic encephalopathy would be
cured by redirecting portal flow to
the liver. Division and closure of the
patent ductus as it entered the
retrohepatic cava was performed
without difficulty, but following clo
sure of the shunt, the bowel became
edematous and engorged. Portal
vein pressure changed from 18 cm
H20 before ligation to 31 cm H20
after. Postoperatively, there was an
increase in abdominal girth, oliguria
and acidosis and a rise in the serum
inorganic phosphate level. Because
of the clinical findings, laparotomy
was carried out 12 hours later,
revealing dusky, engorged, edema
tous intestine, ascites and clot with
in the portal vein. An end-to-side
portacaval shunt was performed.
Bowel colour immediately improved
and adequate urine output was re
stored. The patient required a third
operation 2 days later to ligate a
bleeding artery adjacent to the por
tal vein dissection. At that time, the
intestine was normal.
The patient recovered from the
surgery but his mental status re
mained poor. While awaiting place
ment in a nursing home 7 months
later, pneumonia developed and he
died.
At autopsy, the liver appeared
small; it weighed 650 g. There was
micronodular scarring, particularly
in the periportal regions, but with
out regenerative nodules. Within

FIG. 1. Portal region demonstrates
large communication (arrow) between
portal vein and inferior vena cava.

the periportal hepatocytes there
were a -1-antitrypsin globules.

\

Discussion
Previous reports of congenital
portosystemic anastomoses have de
scribed a variety of connections.
Raskin and associates2 described a
patient with multiple connections

FIG. 2. Anteroposterior (top) and lat
eral (bottom) views showing catheter
ization of shunt vessel via inferior
vena cava. Patent splenic vein and
proximal left portal vein are seen with
antegrade flow of contrast up inferior
vena cava.

\

PATENT DUCTUS VENOSUS

between portal and hepatic veins.
Kerlan and colleagues3 reported a
patient who had an extrahepatic
communication between portal vein
and inferior vena cava. Ohtomo and
colleagues4 found multiple intrahepatic channels between
branches of the portal and hepatic
veins in their patient. Chagnon’s
group5 reported on two patients,
one with an aneurysmal communi
cation between left portal and left
hepatic veins and another with mul
tiple connections between right por
tal vein and an accessory right
hepatic vein. Mori and associates6
presented a patient who had multi
ple peripheral portohepatic shunts
through the liver. All these patients
had encephalopathy.
Wittich and associates7 described
a shunt between a right portal vein
branch and the middle hepatic vein,
in a patient who was asymptomatic.
A right portal vein to right hepatic
vein shunt was observed also in an
asymptomatic patient by Charnsangavej and colleagues.8 Mori and
associates9 had two patients with
membranous obstruction of the in
ferior vena cava; one had a connec
tion between the left portal vein and

FIG. 3. Selective catheterization of
right portal vein by way of shunt
vessel demonstrates small but patent
right portal vein with incomplete,
slightly bizarre branching pattern.

the inferior vena cava and the other
was between the right portal vein
and right hepatic vein. A patent
ductus venosus was reported by
Ohnishi and colleagues10 in a pa
tient with alcohol-induced cirrhosis
and encephalopathy. To the best of
our knowledge, this is the first
report of a patent ductus venosus in
a patient who had minimal signs of
liver disease.
Surgical intervention, carried out
in three of the symptomatic cases,
included resection of the involved
area of liver or ligation of the shunt
vessel.235 In another case,4 several
channels were closed by coil emboli
zation. The encephalopathy was im
proved in all patients, apart from
Raskin’s, who died 2 days postoperatively of prolonged hypotension,
renal failure and pneumonia. Our
case is unique in that ligation of the
shunt resulted in acute portal ve
nous congestion and bowel isch
emia requiring decompression of
the portal vein by an emergency
portacaval shunt.
Our patient was reported previ
ously11 as a case of occult portal
vein occlusion, neuropsychiatric
disturbances being the presenting
feature. At that time, the nature of
the portosystemic shunt was not
appreciated. This may be because of
the limited injection of contrast
material used in performing spleno
portography and superimposition of
the dilated portal vein over the
ductus. Clearly, the shunt must
have been present in view of the
apparent portal vein occlusion with
out variceal collaterals.
Pathologically, a diagnosis of hepatoportal sclerosis was made. The
pathogenesis of this condition is
uncertain. Phlebosclerosis may be
secondary to thrombosis within the
portal venous system, but a primary
phlebosclerosis or congenital failure
of normal development of the portal
venous system are possible
causes.12 The extent of liver in

volvement may vary and liver biopsy
may not reflect the degree of portal
venous obstruction.13 We believe
that our patient’s hepatoportal scle
rosis reflects congenital failure of
the ductus venosus to close togeth
er with hypoplasia of intrahepatic
portal venous radicals. No precipi
tating events could be established.
The onset of neurologic symptoms
in late adulthood is consistent with
previously reported cases;1"5 en
cephalopathy may be due to in
creasing sensitivity of an aging
brain to toxic materials. The patient
was determined to be heterozygous
for a-l-antitrypsin deficiency;
whether this condition played an
additive or separate role is unclear.
However, the portal venous branch
ing pattern was not typical of that
seen in cirrhosis.14
Although previous reports have
shown good results after interrup
tion of portosystemic connections
in noncirrhotic patients, in our case
the result was life-threatening be
cause the intrahepatic portal venous
system could not accommodate sud
den restoration of the normal portal
blood flow. Detailed angiography of
the portal system, including visual
ization of intrahepatic portal radi
cals, is suggested as a prerequisite
to operation on these patients. The
integrity of the portal system must
be established if ligation of a por
tosystemic collateral is planned. Ap
preciation of the venous intrahepat
ic anatomy in our case could have
warned of this problem and deter
mined the need for an alternative
surgical strategy.
We thank Dr. S.N. Sullivan for allowing
us to review his files on this patient.
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ORAL ANTIBIOTIC
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THE FREEDOM OF TABLETS.
"CIPRO"
Ciprofloxacin Hydrochloride
THERAPEUTIC CLASSIFICATION
Antibacterial Agent
PRESCRIBING INFORMATION
ACTIONS
Ciprofloxacin, a synthetic fluoroquinolone, has a bactericidal mode of action. This actli
achieved through inhibition of DNA gyrase, an essential component of the bacterial DNA
_ .
replication system, inhibition of the alpha subunit of the DNA gyrase Mocks the reseating of
the nicks on the DNA strands induced oy this alpha subunit, leading to the degradation ofthe
DNA by exonucleases. This bactericidal activity persists not only during the multiplication
phase, but also during the resting phase of the Bacterium.
Ciprofloxacin retained some of its bactericidal activity after inttibitfoh of RNA and protein
synthesis by rifamycin and chloramphenicol, respectively. These observations suggest
ciprofloxacin may possess two bactericidal mechanisms, one mechanism resulting from
the inhibition of DNA gyfase and a second mechanism which may be independent on RNA
and protein synthesis,
INDICATIONS AND CLINICAL USES
CIPRO* (CtoroflQxacm Hydrochloride Monohydratei may be indicated tot the treatment of patients
with the following infections caused by susceptible strains of the indicated microorganisms'
RESPIRATORY TRACT INFECTIONS:
Acute bronchitis and acute pneumonia caused by
'
....

Enterobacter cloacae mmgumtgmmmm/fc’ Proteus mirabilis
Escherichia cnii
Pseudomonas aeruginosa
Haemophilus in f i m m
Staphylococcus aureus
Klebsiella pneumoniae
Streptococcus pneumoniae
Due to the nature of the undeflying conditions which usually predispose patients to
Pseudomonas infections of the respiratory tract, bacterial eradications may not be achieved
in patients who display clinical improvement despite evidence of in vitro sensitivity. In
patients requiring subsequent courses of therapy, CIPRO* should be used alternately with
other anti; pseudomonal agents. Some strains of Pseudomonas aeruginosa may develop
"uring treatment. Therefore, susceptibility testing should be performed period
therapy to detect the
o f bacterial resistance.
CT INFECTIONS:
Upper and lower urinary
ary tract infections, such as complicated and uncomplicated cystitis,
pyelonephritis, and pyefitis, caused by:

Citrobacter diversus
Citrobacter treundn
Enterobacter cloacae
Escherichia coli
Klebsiella pneumoniae
Klebsiella oxytoca
Morganeiia morganii

Moieus
Pseudomonas aeruginos.
Serntia marcescens
Staphylococcus aureus
Staphylococcus epidermidis
Streptococcus taecalis * j

SKIN AND SOFT TISSUE INFECTIONS:
caused by:

Enterobacter cloacae
Escherichia coli
Klebsiella pneumoniae
Proteus vulgaris
Proteus mirabilis

Pseudomonas aeruginosa
Streptococcus pyogenes
Staphylococcus aureus
Staphylococcus epidermidis

BONE AND JOINT INFECTIONS:
caused by:

Enterobacter cloacae
Pseudomonas aeruginosa

Serntia marcescens
Staphylococcus aureus

INFECTIOUS DIARRHEA: (When antibacterial therapy is indicated)
caused by:

Escherichia coli (enterotoxigenic strains)
Campylobacterjejuni

Shigella flexneri
Shigella sonnei

. . . Therapy with CIPRO* may L . ______________________
these tests are known. However, modification of this treatment may be required once results
become available or if there is no clinical improvement. Culture and susceptibility testing
performed periodically during therapy will provide information on the possible emergence or
bacterial resistance.
CONTRAINDICATIONS
CIPRO* (Ciprofloxacin Hydrochloride Monohydrate) is contraindicated in patients who have
shown hypersensitivity to ciprofloxacin or other quinolone antibacterial agents.
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WARNINGS
Children
The safety of CIPRO* (Ciprofloxacin Hydrochloride Monohydrate) in children has not yet
been established. Damage to juvenile weight-bearing joints and lameness were observed
both in rat and dog studies but not in weaned piglets (see Product Monograph: TOXI
COLOGY). Histopatnological examination ot the weight-bearing jo in ts of immature dogs
revealed permanent lesions of the cartilage. Consequently, CIPRO* should not be used in
prepubertal patients.
Pregnancy
The safety of CIPRO* in the treatment of infections in pregnant women has not yet been
established (see PRECAUTIONS).
PRECAUTIONS
General
Anaphylactic reactions including cardiovascular collapse have occurred rarely in patients
receiving therapy with CIPRO* (Ciprofloxacin Hydrochloride Monohydrate). These reactions
have occurred within the first 30 minutes following the first dose and may require epineph
rine and other emergency measures.
CIPRO* may cause central nervous system (CNS) stimulation which may lead to tremor,
restlessness, light-headedness, confusion, and very rarely to hallucinations or convulsive
seizures. Therefore, CIPRO® should be used with caution in patients with CNS disorders,
such as severe cerebral arteriosclerosis or epilepsy. Patients with known convulsive seizure
disorders should only be treated with CIPRO* if anticonvulsive therapy has been initiated.
Crystalluria related to ciprofloxacin has been reported only rarely in man because human
urine is usually acidic. Patients receiving ciprofloxacin should be well hydrated and alkalinity
of the urine should be avoided. The recommended daily dose should not be exceeded.
Crystals of ciprofloxacin have been observed rarely in the urine of human subjects but more
frequently in the urine of laboratory animals.
Prolonged use of CIPRO" may result in the overgrowth of nonsusceptible organisms. Careful
observation of the patient is therefore essential, and if superinfection should occur during
therapy, appropriate measures should be taken.
Pregnancy
The safety of CIPRO * in pregnancy has not yet been established. CIPRO* should not be used
by pregnant women unless tne likely benefits outweigh the possible risk to the fetus. CIPRO"
has been shown to be non-embryotoxic and non-teratogemc in animal studies.
Nursing Mothers
It is not known whether ciprofloxacin is excreted in human milk. However, it is known that
cipiQtlgxacin is. excreted in the m ilk of lactating rats and that other drugs ot this class are
excreted in human milk. A decision should be made to discontinue nursing or to discontinue
the administration of CIPRO* , taking into account the importance of the drug to the mother
and the possible risk to the infant.
Drug Interactions
Concurrent administration of ciprofloxacin with theophylline may lead to an elevated plasma
concentration and prolongation ot elimination
a lf-ti'---------1
..... _ h.....
ife of theophylline.
This may result in
increased risk of fheophyll, .
ted adverse reactions. It concomitant use cannot be
avoided, plasma concentrations
theophylline should be monitored and dosage adjustments made as appropriate
Ciprofloxacin has been shown to interfere with the metabolism and pharmacokinetics of
caffeine. Excessive caffeine intake should be avoided.
Probenecid blocks renal tubular secretion of ciprofloxacin and has been shown to produce an
increase in the level of ciprofloxacin in the serum.
Concomitant administration of a nonsteroidal anti-inflammatory drug with ciprofloxacin has
been reported to increase the risk of CNS stimulation and convulsive seizures.
Antacids containing aluminum or magnesium hydroxide have been shown to reduce the
absorption of ciprofloxacin. Concurrent administration with these agents should be avoided.
Renal Impairment
Since ciprofloxacin is eliminated primarily by the kidney, CIPRO* should be used with
caution an d^aredu ced dosage in patients with impaired renal function (see DOSAGE AND
ADVERSE REACTIONS
CIPRO" (Ciprofloxacin Hydrochloride Monohydratei is generally well tolerated. During worldwide
clinical investigation, 8,861 courses of ciprofloxacin treatment were evaluated for drug
safety. (Included in this evaluation were data from 283 patients who received ciprofloxacin
only intravenously and 169 patients who received sequential intravenous/oral ciprofloxacin
therapy.)
Adverse events, whether drug-related or not. occurred in 10.2% of patients These adverse
events occurred in the following frequencies: Gastrointestinal System (5.0%). Central
Nervous System f t .6%). Skirr/Hypersensitivity (1.4%), and Adverse Laboratory Changes
(5.6%).
JM
The most frequently reported events, drug-related ofjnot, were nauseajl ,6%) and diarrhea
Additional events that occurred in less than 1% of ciprofloxacin courses are listed below:
Gastrointestinal vomiting, dyspepsia, abdominal pain, anorexia
Central Nervous System: dizziness, light-headedness, headabhe, nervousness, anxiety,
agitation, restlessness, tremor, lethargy, drowsiness, somnolence
Skin/Hypersensitivity: rash, pruritus, local edema, urticaria, increased perspiration,
photosensitivity
Most of the adverse events were described as only mild or moderate in severity.
There have been 9 reports of arthropathy associated with CIPRO®. Three of these reports
involved children. Arthralgia was usually the first symptom which led to rapid assessment
and withdrawal of the drug. No irreversible arthropathies have been observed.
Adverse Laboratory Changes
Changes in laboratory parameters listed as adverse events without regard to drug relationship (5.6%):
Hepatic:
Elevations of: SGPT (1.3%), SGOT (1.4%),

^kHal(iSe3^ferStma^,Sr°u^|b^,amyl tranSpep,idaSe

Hematologic: Eosinophilia (0.6%), leukopenia (0.2%)
Renal:
Elevations of: Serum creatinine (0.3%), BUN (0.3%)
Other changes occurring in less than 0.1% of courses were: elevated uric acid elevated
cholesterol, increase in Blood platelets, monocytes, and leukocytes
SYMPTOMS AND TREATMENT OF OVERDOSE
Overdose has not yet been reported with CIPRO® (Ciprofloxacin Hydrochloride Mono
hydrate). In the event of acute overdosage, the stomach should be emptied by inducing
vomiting or by gastric lavage. The patient should be carefully observed and aiven sup
portive treatment.
DOSAGE AND ADMINISTRATION
The determination of dosage for any particular patient must take into consideration the
severity and nature of the infection, the susceptibility of the causative organism and the
status of renal (unction.
CIPRO® (Ciprofloxacin Hydrochloride Monohydrate) may be taken before or after meals
Absorption is faster on an empty stomach. Patients should be advised to drink fluids liberally
and not take antacids containing magnesium or aluminum.

Adult
The recommended dosages of CIPRO~· are:

DOSAGE FORMS

Location of
Infection

Type/Severity

Unll
Dose

Frequency

Dally
Dose

Urinary Tract

Mild/Moderate
Severe/Complicated

250 mg
500mg

q 12h
q 12h

500 mg
1000 mg

Lower Respiratory
Tract
Bone & Joint
Skin & Soft Tissue

Mild/Moderate
Severe/Complicated*

500mg
750 mg

q 12h
q 12h

1000mg
1500 mg

Infectious Diarrhea
Mild/Moderate/Severe
500 mg
q 12h
1000 mg
* e.g. hospital-acquired pneumonia, osteomyelitis.
Depending on the severity of the infections, as well as the clinical and bacteriological
responses, the average treatment period should be approximately 7 to 14 days. Generally,
treatment should last 3 days beyond the disappearance ol clinical symptoms or until
cultures are sterile. Patients with osteomyelitis may require treatment for a minimum of 6
to 8 weeks and up to 3 months. With acute cystitis, a live-day treatment may be sufficient.
Impaired Renal Function
Ciprofloxacin is eliminated primarily by renal excretion. However, the drug is also metabolized and partially cleared through the biliary system of the liver and through the intestine
(see Product Monograph: HUMAN PHARMACOLOGY). This alternate pathway of drug
elimination appears lo compensate for the reduced renal excretion of patients with renal
impairment. Nonetheless some modification of dosage is recommended, particularly for
patients with severe renal dysfunction. The following fable provides dosage guidelines for
use in patients with renal impairment. However, monitoring of serum drug levels provides
the most reliable basis for dosage adjustment. Only asmall amount of ciprofloxacin (<10%)
is removed from the body after ~emotlialysis or peritoneal dialysis.
Dose

> 3010.5/
< 30 0.5
and patients on hemodialysis
or peritoneal dialysis

No dosage adjustment
Use recommended dose
once daily or hall
the dose twice daily

72 xserum creatinine(mg/1 OOmL)
Females:
0.85 x the above value
To convert to international units, multiply result by 0.01667
CHILDREN
The safety and efficacy of CIPRO® in children have not been established. CIPR0'1o should not
be used in prepubertal patients (see WARNINGS).

3.

4.

5.

shunt. Neurology 1984; 34: 666-669
RASKIN NH, PRICE JB, FISHMAN RA:
Portal-systemic encephalopathy due to
congenital intrahepatic shunts. N Engl J
Med 1964; 270: 225-229
KERLAN RK JR, SOLLENBERGER RD, PALU·
BINSKAS AJ, et al: Portal-systemic encephalopathy due to a congenital portocaval shunt. AJR 1982; 139: 10131015
OttTOMO K, FURUI s, SAITO M, et al:
Enormous intrahepatic communication
between the portal vein and the hepatic
vein. Clin Radiol 1986; 37: 513-514
CHAGNON SF, VALLEE CA, BARGE J, et al:

7.

8.

9.

Aneurysmal portahepatic venous fistula:

report of two cases. Radiology 1986;
159: 693-695
6. MORI H, HAYASIII K, FUKUIJA T, et al:
"lntrahepatic portosystemic venous
shunt: occurrence in patients with and

Bottles of 50
Unit Dose Package of 100

Str11ngth

Tablet
Jdenllflcatlon

250mg
500mg
750mg
500mg
750mg

Miles 512
Miles513
Miles 514
Miles 513
Miles 514

References:

1. Editorial, The Lancet 1984; 1:24-25.
2. Product monoaraph.

3. Ball AP, Eur JC/in Mic,obio/ 1986; 5(2):214-19.

A

MILES r.ANADA INC.

MILES

PHARMACEUTICAL DMSfON
77 BELFIELD ROAD, ETOBICOKE, ONTARIO M9W 1G6

© MILES CANAOA INC., 1989

Creatinlne Clearance
ml/min (mL/s)

When only the serum creatinine concentration is available, the following formula (based on
sex, weight and age of the patient) may be used to convert this value into creatinine
clearance. The serum creatinlne should represent asteady state or renal function:
Males:
Weight (kg) x1140- age)

2.

Avallablltty
CIPRO® 250-each tablet contains ciprofloxacin hydrochloride monohydrate
equivalent to 250 mg c1pro1Joxacin.
CIPRO® 500-each tablet contains ciprofloxacin hydrochloride monohydrate
equivalent to 500 mg c1profloxacin.
CIPRO® 750-each tablet contains ciprofloxacin hydrochloride monohydrate
equivalent to 750 mg c1profloxacin.
STORE BELOW 30° C(B6° F).

10.

Registered Trademark
MILES CANADA INC. is the Registered User of the
Trademark CIPRO~. the original brand of clprofloxacin hydrochloride.
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Importance of Magnetic Resonance
Imaging in Osteoid Osteoma: a Case
Report
R.S. Bell, MD, FRCSC; G.D. O'Connor, MD; J.P. Waddell, MD, FRCSC
A 23-year-old man presented with a femoral osteoid osteoma, which, because of its
small calcified nidus and extensive osteoblastic response, could not be localized on
bone scanning, computed tomography or angiography. Magnetic resonance imaging
clearly defined the nidus and permitted excision with minimal morbidity.
Un homrne de 23 ans a ete recu souffrant d'un osteDide-osteome qui, a cause d'un
foyer calcifie de petite taille et d'une osteol>lastose reactionnelle importante, n'a pu
etre localise par scintigraphie osseuse, par tomodensitometrie ou par angiographie.
La resonance magnetique nuclfaire definit clairement le foyer et en permit ]'excision
avec un minimum de rnorbidite.

he surgical treatment of osteT
oid osteoma depends on the
localization and excision of the osteoid nidus that is characteristic of
this benign bone tumour.1. 2 We
present a case of osteoid osteoma
with an extensive osteoblastic response and emphasize the difficulty
in identifying the nidus within this
marked sclerotic reaction. Magnetic
resonance imaging (MRI) proved to
be the only imaging technique capable of demonstrating the osteoid
nidus.

Case Report
~-·'

A 23-year-old man was admitted
for investigation of pain in the
distal, medial left thigh. The pain,

present for several months, was
continuous, not activity related,
worse at night and partially relieved
by acetylsalicylic acid. There was
no history of trauma or infection.
Physical examination revealed a diffuse, firm expansion of the left
femur, limited to the distal portion
of the thigh and accompanied by
moderate muscle wasting. Laboratory investigations, including complete blood count, determination of
the erythrocyte sedimentation rate,
serum calcium, phosphorus and alkaline phosphatase levels gave normal results. X-ray films and computed tomography showed an extensive osteoblastic lesion involving
12.5 cm of the distal diaphysis of
the femur (Fig. 1). A technetium-99m bone scan demonstrated

marked, diffuse, increased uptake
of tracer throughout the sclerotic
process (Fig. 2). Computed tomography showed that the lesion was
circumferential, not involving the
medullary canal and with no evidence of a soft-tissue mass (Fig. 3).
No nidus was identified. The differential diagnosis included parosteal
osteosarcoma, so the patient underwent incisional biopsy through the
vastus medialis• muscle. Extensive
sampling of the sclerotic process
demonstrated organized, lamellar
periosteal new bone formation overlying normal cortex. Based on the
investigations, we thought the patient had a healing stress fracture
and advised him to limit his activity.

From the Division of Orthopaedic Surgery, St. Michael's Hospital and the University of Toronto,
Toronto, Ont.
Accepted for publication Sept. 28, 1988
Reprint requests to: Dr. Robert S. Bell, Ste. 476, Mount Sinai Hospital, 600 University Ave.,
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FIG. 1. Anteroposterior view of sclerotic femoral lesion.

MRI IN OSTEOID OSTEOMA

;

Six months later, he was referred
to the Orthopaedic Oncology Ser
vice at St. Michael’s Hospital in
Toronto with increasing pain in the
distal, medial left thigh. Results of
roentgenography, conventional to
mography and technetium bone
scanning, undertaken with collimation over the distal femur, were

unchanged from the previous re
sults. Angiography, concentrating
on the late arterial phase to evalu
ate the possible presence of a vascu
lar nidus within the sclerotic bone,
showed no abnormality. A contrastenhanced computed tomogram
showed the previous biopsy site but
was otherwise unchanged. Magnetic

FIG. 2. Technetium-99m scan, anterior and left-lateral views. There was diffuse,
intense uptake of technetium on delayed bone scan. No nidus was seen on early or
late phases.

resonance imaging, using a repeti
tion time of 1800 ms and an echo
time of 30 ms finally identified a
small intracortical nidus in the mid
dle portion of the sclerotic reaction
within the lateral femoral cortex
(Fig. 4). Excision of the nidus was
accomplished by removing overly
ing periosteal new bone until a
6-mm lesion Filled with calcified,
reddish brown tissue was encoun
tered within the femoral cortex.
The affected site was curetted and
filled with bone graft, using the
surrounding reactive new bone. Mi
croscopic review of the specimen
showed osteoid and fibrovascular
granulation tissue, typical of oste
oid osteoma. Cultures taken intraoperatively showed no evidence
of infection. Postoperatively, the
pain resolved and the patient was
free of symptoms at 18-month fol
low-up.

Discussion
This case is remarkable for the
extent of reactive bone formation in
response to a single nidus of oste
oid osteoma and for the difficulty
experienced in localizing this nidus.
Since Jaffe’s original description3 of
osteoid osteoma, there have been
many reports on its clinical presen-

FIG. 3. Computed tomogram shows circumferential cortical thickening throughout
lesion but no nidus.

FIG. 4. Magnetic resonance imaging
clearly shows small intracortical nidus
on proton density image.
CJS, VOL. 32. NO. 4. JULY 1989
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tation and pathophysiology,1'2-4"20
but little has been written about the
extent of the periosteal reaction
that may be produced by the tu
mour. In reviewing the radiologic
features of osteoid osteoma, Karlsberg and Kittleson13 and Wilner21
commented that the sclerotic reac
tion may extend for several cen
timetres from the central nidus;
however, both the extent (12.5 cm)
and the circumferential nature of
the periosteal reaction in our case
are unusual. The location of the
nidus and the age of the patient
may be important in determining
the subsequent osteoblastic re
sponse. Wilner21 suggested that the
intracortical nidus elicits a greater
local blastic response than one aris
ing in cancellous bone and that the
sclerotic reaction is greater in pa
tients younger than 5 years. The
blastic reaction may also be en
hanced in the unusual case with
more than one nidus.10
Localization of the nidus may be
difficult if the lesion is surrounded
by extensive new bone formation;
the nidus is generally recognized by
its uptake of tracer on the technetium-99m bone scan and, indeed,
intraoperative scanning has been
used to identify occult lesions.22
The increased uptake associated
with the reactive bone in our case
presumably masked the uptake in
the nidus, the small size and calcific
density of which prevented detec
tion on either angiography or com
puted tomography. Magnetic reso
nance imaging, however, provided
excellent resolution of the interface
between the abnormal osteoid of
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review of the literature. Semin A rthritis
Rheum 1983; 12: 265-281
F irooznia H, Rakii M, Golimbij C: Com
puted tomography of osteoid osteoma. J
Comput Tomogr 1985; 9: 265-268
Glynn JJ, L ichtenstein L: Osteoidosteoma with multicentric nidus. A re
port of two cases. J Bone Joint Surg
IAm ] 1973: 55: 855-858
H abermann ET, Stern RE: Osteoidosteoma of the tibia in an eight-monthold boy. A case report. J Bone Joint
Surg lA m j 1974; 56: 633-636
H eiman ML, Cooley CJ, Bradford DS:
Osteoid osteoma of a vertebral body:
report of a case with extension across
the intervertebral disk. Clin Orthop
1976: 118: 159-163
K ari.siserc RC, K ittelson AC: Osteoid
osteoma. Radiol Clin North Am 1964; 2:
337-345

the nidus and the reactive bone,
thus permitting excision of the le
sion with minimal disruption of the
surrounding bony architecture.
Demonstration of the nidus on
computed tomography depends on
finding osteoid within the lesion
that is more or less calcified than
surrounding bone.23 Magnetic reso
nance imaging may be more sensi
tive since it may detect the vascular,
abnormal tissue within the nidus,
even when it has a radiologic densi
ty similar to the surrounding
bone.23

11.

We thank Mrs. Krista Sereno for her
help in preparing and editing this
manuscript.

14. L awrib TR, Aterman K, Sinclair AM:
Painless osteoid osteoma. A report of
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Immunohistologic Diagnosis of Multiple
Carcinomas. The Role of Monoclonal
Antibodies Against Carcinoembryonic
Antigen
Marie-Christine Guiot, MD;*J Robert Sawka, BSc;* Jonathan L. Meakins, MD, DSc, FRCSC;t
Serge Jothy, MD, PhD, FRCPC*
The occurrence of multiple malignant lesions in the same patient requires that
management decisions be made from an accurate pathological identification of the
tumours. The authors describe five patients who had colorectal adenocarcinoma
preceded or followed by adenocarcinomas in other organs. Definitive identification
could not be established from routine histopathologic findings. The use of
immunohistochemistry helped to clarify the relationship between the various
tumours; in particular, a monoclonal antibody (D14) directed against
carcinoembryonic antigen (CEA) made a notable contribution. Because of the
increasing number of monoclonal antibodies with well-defined tumour specificities,
their use in the documentation of multiple malignant tumours has great clinical
potential.

Une identification anatomo-pathologique precise est necessaire dans les cas de
tumeurs malignes multiples a cause de l’impact sur le traitement. Les auteurs
decrivent cinq patients atteints d’adenocarcinomes colorectaux, precedes ou suivis
d’adenocarcinomes dans d’autres organes. L’histopathologie de routine n’a pas
permis d’etablir de diagnostic definitif. L’emploi de l’immunohistochimie a aide a
clarifier la relation entre les differentes tumeurs. Un anticorps monoclonal (D14)
dirige contre l’antigene carcinoembryonnaire (ACE) a apporte en particulier une
contribution significative. Etant donne que l’on peut obtenir un nombre croissant
d’anticorps monoclonaux dont la specificite tumorale est bien definie, il apparait
judicieux de les utiliser dans l’identification de tumeurs malignes multiples.

he occurrence of synchronous
or metachronous carcinomas in
the same patient is uncommon.

T

These patients present serious man
agement problems, such as deter
mining whether a second tumour

From the *Department o f Pathology and fDepartment o f Surgery, McGill University and Royal
Victoria Hospital. Montreal. PQ

represents a new and different pri
mary malignant lesion or metastatic
spread, or whether one of the multi
ple tumours can be treated by adju
vant methods. Routine histopa
thologic examination of the tumour
tissues is often inconclusive when
the second tumour involves a differ
ent organ, especially the lung. How
ever, the demonstration of tumour
markers might help to clarify these
diagnostic problems. We1’2 and oth
ers3 have shown that some poly
clonal and monoclonal antibodies
possess enough tissue specificity to
distinguish different types of solid
tumours. We report here on five
patients who had carcinoma of the
colon and a synchronous or meta
chronous malignant tumour at a
distant site and in whom the use of
monoclonal antibodies to carcino
embryonic antigen (CEA) helped to
identify the relation between the
two tumours.

Material and Methods
Immunohistochemical Studies

$Recipient o f a France-Quebec research scholarship. Present address: Ludwig Institute fo r
Cancer Research. Montreal Branch, 687 Pine Ave. W. M ontreal PQ
This work was supported by grant MA-10315 from the Medical Research Council o f Canada
Accepted for publication Nov. 15, 1988
Reprint requests to: Dr. Serge Jothy, Department o f Pathology. McGill University, Lyman D u ff
Medical Sciences Building. 3775 University St.. Montreal. PQ H3A 2B4

Tissue was obtained from each
patient and fixed in formalin. In
addition to routine histopathologic
examination of the tissue, each pa
tient was tested for the presence of
CEA using polyclonal and monoCJS, VOL. 32, NO. 4. JU L Y 1989
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clonal antibodies. Rabbit anti-CEA
(Dakopatts, Glostrup, Denmark)
was used as a source of polyclonal
antibody. Like most polyclonal antiCEA reagents, it reacts not only
with colonic adenocarcinomas but
also with many extracolonic car
cinomas. The monoclonal antibody
used was the mouse D14 (E-Z-EM
Co., Westbury, NY), known to be
more specific for colonic carcinoma
than polyclonal anti-CEA reagents.
The D14 is one of the monoclonal
antibodies to CEA that have been
produced and fully characterized
previously.4 Its tumour specificity
has been extensively documented.2
Paraffin sections of the tumours
were immunostained with the poly
clonal antibody using a peroxidaseantiperoxidase technique.5 D14 an
ti-CEA monoclonal antibody immunostaining was performed using
a three-layer double peroxidase
technique.6
The immunohistochemical reac
tions were reported positive when
5% or more of the tumour cells
were immunostained. Normal rabbit
serum and mouse myeloma super

natant were used as negative con
trols.
In addition to staining for the
presence of CEA, the tumour tis
sues were tested for the presence of
one or more of the following mark
ers, depending on the case: pros
tate-specific antigen (PSA), cytokeratin, tissue polypeptide antigen
(TPA), protein S-100 and pancreatic
cancer-associated antigen (Bl).

Case Reports
Case 1

A 76-year-old man presented with
signs and symptoms of carcinoma
of the ascending colon, confirmed
by biopsy. He had a history of stage
I prostatic adenocarcinoma, which
had been treated by transurethral
prostatic resection 9 years earlier.
He underwent a right hemicolecto
my which revealed a Dukes’ class C
tumour.
Eleven months later, the patient
was readmitted with a history of
bilateral leg swelling and heavy pro

teinuria. A kidney biopsy showed
membranous nephropathy. A liver
scan showed a single filling defect
in the liver. The serum CEA level
was 38 ng/ml. A right hemihepatectomy was performed. It showed a
metastatic adenocarcinoma with
histologic features consistent with a
colonic origin, although a metasta
sis from the prostatic carcinoma
could not be ruled out. Postoperatively, a right hemothorax devel
oped, accompanied by respiratory
failure, septicemia and renal failure.
Autopsy showed that the patient
had residual adenocarcinoma of the
prostate. The pelvic and periaortic
lymph nodes were enlarged. The
partial hepatectomy specimen and
the lymph nodes were examined by
immunohistochemistry. The results
showed that the liver contained metastases from the colonic carcinoma
and the periaortic lymph nodes con
tained metastases from the prostatic
cancer (Table I).
Case 2

A 64-year-old woman was admit-

Table I. Results of Immunohistochemistry in Subsequent Malignant Tumours
Immunohistochemical findings
Patient
no.
1

First tumour
Prostatic AD

Sites of
subsequent
tumours
Ascending colon
Liver
LN

Histopathology
of second
tumour
AD (liver)

Carcinoembryonic antigen
Polyclonal
D14 monoclonal
antibody
antibody
Liver +

Liver +

Aortic
LN -

Aortic
LN -

Breast carcinoma,
Dukes' stage I

Sigmoid colon
Liver

AD (colon)
AD (liver)

Liver +

Liver +

3

Transverse colonic
AD

Lung

AD

Lung +

Lung +

4

Rectal AD

Lung

AD

Lung +

Lung +

5

Sigmoid colon AD

Lung

AD

Lung -

Lung -

2

Other markers
Liver
Cytokeratin +
PSA Aortic LN PSA +

Diagnosis of
second tumour
Liver metastasis from
colonic carcinoma
Periaortic LN
metastasis from
prostatic carcinoma
Liver metastasis from
colonic carcinoma

Cytokeratin +
TPA B1 Cytokeratin +
TPA +
Lung
Cytokeratin +
Protein S-100 —
'PSA -

Lung metastasis from
colonic carcinoma
Lung metastasis from
colonic AD
Primary lung AD

AD = adenocarcinoma, LN = lymph nodes, + = reactive, - = nonreactive, PSA = prostate-specific antigen, TPA = tissue polypeptide antigen, B1 =
pancreatic cancer-associated antigen.
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DIAGNOSIS OF MULTIPLE CARCINOMAS

ted because she had signs and
symptoms of cancer of the sigmoid
colon. She had undergone a mastec
tomy for a right breast carcinoma
25 years previously. At that time,
the axillary lymph nodes were free
of metastases. A segmental resec
tion of the sigmoid colon was per
formed and two lymph nodes were
found to contain metastatic foci. In
addition, a single, large, hepatic
tumour nodule was discovered and
a biopsy was done. The serum CEA
level was greater than 50 ng/ml.
The histopathologic changes in the
liver tumour were compatible with
either a colonic or a breast origin.
When immunohistochemical studies
were performed, the hepatic lesion
was found to be of colonic origin.
Two months later she underwent a
right hemihepatectomy which

FIG. 1. Case 3. Tissue section of lung
tumour immunostained with D14 antiCEA monoclonal antibody. There is
evidence of dark CEA-staining of lumi
nal border of neoplastic glands (arrow
heads) and moderate staining of cyto
plasm. Positively stained single cells
are also present scattered through
stroma (arrows). This staining pattern
indicates that this lung tumour is
metastasis from colonic carcinoma (immunoperoxidase stain for CEA, origi
nal magnification X 330).

showed histopathologic changes si
milar to the previous liver biopsy.
After 1 year, follow-up studies doc
umented the presence of tumour in
the pelvis. She died 2 years after
hepatectomy of widespread colonic
carcinoma.
Case 3

This 67-year-old woman, a nonsmoker, first presented with signs
of rectal bleeding. Colonoscopy
demonstrated an adenocarcinoma of
the colon at the splenic flexure. The
tumour was resected. It involved
only the superficial layers of the
muscularis propria; the mesenteric
lymph nodes were free of disease.
Six years later a routine chest x-ray
film showed a nodular opacity in
the left upper lobe, with hilar
lymph-node involvement. A trans
thoracic needle aspirate showed an
adenocarcinoma. The serum CEA
level was within the normal range.
A lobectomy was performed. The
histopathologic findings suggested
a metastasis from the colon, al
though a primary lung adenocarci
noma could not be ruled out. The
patient received radiation therapy
to the chest. Immunohistochemical
studies performed later on the lung
tumour demonstrated that it was a
metastasis from the colonic carcino
ma. During the following year, liver
and cerebellar metastases devel
oped. The patient’s condition deteri
orated progressively and she died of
widely disseminated carcinomatosis.
Case 4

This 61-year-old man was found
to have a Dukes’ class C adenocar
cinoma of the rectum. It was treat
ed by abdominoperineal resection.
Radiotherapy was given postoperatively. Three years later, he was
found to have an opacity in the left
lower lung lobe. The serum CEA
level was not elevated. A clinical

diagnosis of a primary lung tumour
was made and a lobectomy was
performed. An adenocarcinoma was
documented on histologic examina
tion of the specimen, and had some
features of the previously resected
rectal tumour. The lung tumour
was tested immunohistochemically
and found to be a metastasis from
colorectal carcinoma. The patient
died 1 year later of disseminated
carcinomatosis.
Case 5

A 71-year-old alcoholic was ad
mitted because of neurologic symp
toms after a fall. While in hospital
he was found to have a Dukes’ class
B adenocarcinoma of the sigmoid
colon, which was resected. His post
operative course was complicated
by sepsis and he died 2 weeks after
surgery. At autopsy, an adenocarci
noma was found in the right upper
pulmonary lobe, without metastasis
to the hilar lymph nodes. Im
munohistochemical studies showed
an immunophenotype consistent
with a primary adenocarcinoma of
the lung.

Results and Discussion
The results are summarized in
Table I and one case is illustrated in
Fig. 1.
In each of our patients there was
a problem identifying the second
tumour. Specifically, a search was
made to determine if the second
tumour was a separate malignant
lesion requiring a specific treatment
or a metastasis from the colonic
carcinoma. In each case immunohis
tochemical testing of the tumour
specimens contributed diagnostic
information which, when combined
with clinical data, helped in estab
lishing the relation between the two
tumours. Although it is not always
difficult to establish metastatic or
CJS, VOL. 32, NO. 4, JU L Y 1989
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nonmetastatic relationships between
two asynchronous malignant tu
mours, the first four cases present
ed here illustrate that problems do
arise. For instance, patient 1 had
residual prostatic carcinoma at the
time of autopsy and, thus, shortly
before when his liver tumour was
discovered. Prostatic carcinoma can
metastasize to the liver and, fur
thermore, even when disseminated
it is known to respond to medical
treatment. Therefore, it was impor
tant to document whether the liver
tumour was a metastasis from the
prostatic or the colonic carcinoma.
With respect to patient 2, it was
important to determine whether the
hepatic tumour was a metastasis
from the breast or from the colonic
carcinoma, the former being more
likely to respond to chemotherapy
and the latter to resection.
The second malignant tumour in
the two last cases presented as a
lung parenchymal mass with evi
dence of involved mediastinal and
hilar lymph nodes. These findings
were interpreted as indicating that
the lung tumours were new primary
carcinomas and with this rationale
patient 3 was treated with radio
therapy to the chest.
In patient 5, the second tumour,
which was a primary lung carcino
ma, was discovered only at autopsy;
if it had been discovered earlier, the
patient’s management might have
been different. In all cases, the
regular histopathologic features of
the subsequent tumours showed ad
enocarcinoma. Although some fea
tures were typical of a colonic pri
mary, the pathologists did not be
lieve it was reliable or appropriate
to make a final diagnosis without
the help of immunohistochemical
studies.
When the second tumours were
tested, most were shown to react
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positively with a polyclonal anti
body to CEA. This finding by itself
is not specific of colonic origin
because polyclonal antibodies to
CEA react with most carcinomas
regardless of origin.2 By contrast,
the reactivity of tumours with the
D14 anti-CEA monoclonal antibody
is highly suggestive of a colonic
origin because this reagent is high
ly specific for colonic cancer.2 Our
patients had a history of carcinoma
of the prostate or breast in addition
to the colonic cancer, and subse
quently had liver or lung tumours.
The rate of positive staining with a
polyclonal anti-CEA antibody is
close to 100% for breast, liver or
lung cancers. By contrast, D14
staining is positive in primary
breast, liver or lung carcinoma in
only 9%, 20% and 8% of cases
respectively. Therefore, the high se
lectivity of D14 for colonic cancer
indicates that this monoclonal anti
body helps substantially in deter
mining tumour origin.
It should be noted, however, that
the specificity of D14 for colonic
cancer, although much higher than
that of polyclonal antibodies, is not
100%. This lack of absolute speci
ficity is found with all the mono
clonal antibodies that have been
generated so far against CEA or
other tumour markers. From the
various monoclonal antibodies di
rected against markers of colonic
cancer, those against CEA are still
the most specific.3 Consequently,
the immunohistopathologic diagno
sis of tumours depends not only on
the use of the most specific marker
but also on other markers that
complement the pattern of reactivi
ty. For instance, the association of
a negative staining of PSA and
positive staining of D14, as was
found in patient 1, was a clear
indication that a tumour originated

from colonic epithelium and exclud
ed a prostatic origin.
In conclusion, the immunohisto
chemical testing of tumours with
nonoclonal antibodies greatly facili
tates the identification of multiple
malignant tumours occurring in the
same patient. The use of monoclon
al antibodies in these tests has
significantly increased the value of
this approach. When combined with
operative findings, regular patho
logic changes and electron micros
copy, the use of monoclonal anti
bodies in immunohistochemistry
has the potential of diagnosing cor
rectly a large number of these tu
mours with a high degree of accu
racy, thereby facilitating appropri
ate multimodal therapy.
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Cecal Diverticulitis
Andrew Luoma, MD, FRCSC; Alex G. Nagy, MD, FRCSC
Cecal diverticulitis is an uncommon entity. Its operative treatment represents 0.2%
of procedures performed for an acute abdomen. The clinical presentation is often
indistinguishable from acute appendicitis. At operation, it may be confused with
cecal carcinoma. The surgeon must be aware of this condition and be prepared to
choose the most appropriate treatment. Local excision has been advocated as the
treatment of choice. The authors review 18 cases seen over a 10-year period. In no
case was the correct diagnosis made preoperatively. Intraoperatively, a correct
diagnosis was made in 12 of the 18. Carcinoma was the next most frequent
intraoperative diagnosis (four cases). Twelve of the 18 patients were treated by
standard or limited right hemicolectomy. One patient died early in the series of
sepsis caused by a perforated diverticulum and one patient had a life-threatening
complication. Right hemicolectomy appears to be a safe and effective treatment
option for cecal diverticulitis.

La diverticulite caecale est une affection rare. Son traitement chirurgical represente
0.2% de toutes les operations pratiquees pour abdomen aigu. II est parfois
impossible de distinguer son tableau clinique de celui d’une appendicite aigue. A
l’operation, elle peut etre prise pour un carcinome du caecum. Le chirurgien doit
tenir compte de cette affection et etre pret a choisir le traitement approprie.
L’excision locale a ete proposee comme traitement de premier choix. Les auteurs
passent en revue 18 cas qu’ils ont vu au cours d’une periode de 10 ans. Jamais, le
bon diagnostic n’avait ete pose en preoperatoire. A i’operation, le diagnostic
approprie fut pose 12 fois sur 18. Le second diagnostic le plus frequemment evoque,
fut celui de carcinome (quatre fois). Douze des 18 patients furent traites par une
hemicolectomie droite conventionnelle ou limitee. Un patient est decede tot dans
cette serie d’une sepsie consecutive a une perforation du diverticule, alors qu’un
autre patient subissait une complication qui mit sa vie en danger. L’hemicolectomie
droite paralt etre un traitement sur et efficace de la diverticulite caecale.

principles of emergency surgery in
volving the right colon have evolved
considerably in recent decades. Our
experience and the controversies
surrounding cecal diverticulitis
prompted this review.

Clinical Material
The records of the Vancouver
General Hospital, a major teaching
institution affiliated with the Uni
versity of British Columbia, provid
ed material for this study. The
charts of 18 consecutive patients
(13 men, 5 women) assigned a
diagnosis of cecal diverticulitis over
10 years were reviewed. The salient
features of clinical presentation,
laboratory data, preoperative, in
traoperative and postoperative
course, outcome and histologic
findings, where available, were re
corded for each patient.

Findings
cute cecal diverticulitis is an
uncommon condition. Since
Potier1 reported the first case in
1912, just over 500 cases have
been reported in the literature. The
largest modern series from a single
institution totals only 33 cases,2 so
an individual surgeon is unlikely to

A

have much experience with this
condition. Cecal diverticulitis pres
ents problems both in diagnosis and
management. Since it is often an
unexpected finding at laparotomy,
every surgeon must be prepared to
make decisions intraoperatively to
treat this disease effectively. The

From the Department o f Surgery, Division o f General Surgery . University o f British Columbia
and Vancouver General Hospital. Vancouver, BC
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The mean age of the 18 patients
was 44 years (range from 23 to 70
years). Eleven patients were Cauca
sian, 6 oriental and 1 was of Philip
pine extraction.
The chief complaints on admis
sion included right lower quadrant
pain in 17 patients, anorexia in 17
and nausea in 13. Central abdomi
nal pain, vomiting, diarrhea and
fever were less frequent. The aver
age duration of symptoms was 53
hours (range from 12 to 168
hours). On physical examination at
the time of admission, abdominal
CJS, VOL. 32, NO. 4, JU L Y 1989
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tenderness was present in all pa
tients and was characteristic of ap
pendicitis in 14. A lower abdominal
mass was palpable in four patients.
Two patients had previously under
gone appendectomy.
Investigation revealed an average
leukocyte count of 12.3 X 109/ L
(range from 6.7 to 18.0 X 109/L).
Plain x-ray films of the abdomen
were obtained in 14 patients. One
showed free intraperitoneal air, two
a mass effect and two showed loc
alized air fluid levels in the lower
abdomen. Other investigations in
cluded barium enema in one and
abdominal ultrasonography in
three. No other useful diagnostic
information was obtained from
these tests. Two patients, both men,
underwent laparoscopy before lapa
rotomy, but no useful diagnostic
information was obtained aside
from confirmation of an inflamma
tory process in the region of the
cecum.
The preoperative diagnosis was
acute appendicitis in 15 patients
and perforated appendicitis in 1; 4
of them were noted to have “atypi
cal” presentations. Ovarian tumour
was suspected in one patient as was
acute sigmoid diverticulitis. Both
these patients had previously under
gone appendectomy.
Fifteen patients underwent emer
gency laparotomy. Operation was
delayed for several days in three
patients; two of these underwent
mechanical bowel preparation be
fore laparotomy. The incisions used
were grid iron in seven patients,
muscle-cutting in six and paramedi
an in seven patients (two patients
had more than one incision). The
operative procedures varied (Table
I), but 11 patients had a standard or
limited right hemicolectomy. All but
one of these had a primary anasto
mosis.
One elderly patient with a free
perforation died of complications of
sepsis. One patient had bleeding at
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the anastomosis and required reop
eration, which led to a prolonged
stay in the intensive care unit and
delayed recovery. Three had wound
infections. The average hospital
stay was 16 days (range from 6 to
70 days).
Examination of the operative
specimens showed inflammation in
only eight, localized perforation in
seven and free perforation in one.
Two patients had no resection of
the diverticulum. Pathologic exami
nation combined with operative
findings revealed that the diverticuli
were nearly equally distributed
around the circumference of the
cecum. In one case the diverticulum
arose from the mesenteric aspect of
the terminal ileum. No comment
regarding the presence of muscularis in the wall of the diverticulum
was made in any case. The inflamed
diverticula were solitary in seven
cases and made up one of multiple
cecal diverticula in five cases. This
information could not be ascer
tained from the charts in six cases.

Discussion
Cecal diverticula are classified as
true or false. True cecal diverticula
are usually solitary, involve all lay
ers of the colon and are thought to
be congenital.3
In contrast, false cecal diverticula
are multiple, most often associated
in continuity with left-sided diverticulosis, do not contain muscle and
are typical, acquired, pulsion diver
ticula.4 In studies of cecal diverticu
litis, it is often difficult to document
the true pathologic appearance of a
pre-existing diverticulum, possibly
because of the inflammatory re
sponse,5 and controversy persists
concerning the origins of cecal di
verticula. Cecal diverticulitis does
tend to affect younger patients than
typical sigmoid diverticulitis.46
These diverticula are not particu

larly rare. Hughes,7 in a study of
200 cadavers, found diverticula of
the cecum in 24. In 10 of these, the
cecum was involved alone or discontinuously with left-sided diverticulosis. Williams8 identified cecal
diverticulosis in 5% of patients who
had barium enema examination.
Cecal diverticula usually cause
disease through inflammation.
Much more rarely they may bleed910
or undergo torsion.11 Greaney and
Snyder12 reported 14 cases of cecal
diverticulitis among 6781 emergen
cy laparotomies performed over 8
years. We found 18 cases over 10
years. Over the same period, ap
proximately 400 cases of appendici
tis have been diagnosed annually in
our hospital for a ratio of cecal
diverticulitis to acute appendicitis of
1:220. The condition may be more
common in orientals.2
Lauridsen and Ross4 emphasized
that most cases of acute cecal diver
ticulitis are misdiagnosed at presen
tation as acute appendicitis or ap
pendiceal abscess. Anderson,13 in a
review of the world literature, re
ported that the correct diagnosis
was made in only 6% of cases. In
each of these cases, appendectomy
had been carried out previously.
Appendicitis was the preoperative
diagnosis in 84%.13 In our series,
appendicitis was the tentative diag
nosis at presentation in all but two
patients and both of these had
already undergone appendectomy.
T a b le 1.

Operative Procedures Performed
for Cecal Diverticulitis

O peratio n

Right hemicolectomy
Limited right hemicolectomy
Right hemicolectomy, ileostomy
Diverticulectomy,
appendectomy
Appendectomy, cecostomy
Appendectomy, drainage
Laparotomy and closure.
Reoperation with right
hemicolectomy after bowel
preparation.

No. ol
p a tie n ts

5
5
1

3
1

2

1

CECAL DIVERTICULITIS

Of the alternative diagnoses, diver
ticulitis, carcinoma of the cecum,
bowel obstruction and cholecystitis
are assigned much less frequently
at presentation.13
Recently, Crist and colleagues14
reported the use of computed to
mography in seven patients with
cecal diverticulitis. Three had un
dergone appendectomy earlier. At
present we do not recommend com
puted tomography as a method of
diagnosing cecal diverticulitis, be
cause other pathologic processes —
perforated neoplasms, Crohn’s dis
ease and other inflammatory cecal
changes — may mimic the findings
of acute cecal diverticulitis. Lapa
roscopy also is sometimes per
formed in an attempt to find the
cause of atypical right lower quad
rant abdominal pain. It is of little
help in diagnosing cecal diverticuli
tis since the gross findings may be
nonspecific for a number of cecal
inflammatory conditions, including
perforated neoplasms of the cecum.
Accepting that the diagnosis will
rarely be correctly made preoperatively, the surgeon must consider
the diagnosis at the time of laparot
omy if a normal appendix is found.
Greaney and Snyder,12 in their re
view, found that it was possible in
over half the cases to identify an
obvious diverticulum at laparotomy.
Less commonly, it was possible only
to identify a mass within the bowel
wall. They referred to this as the
hidden diverticulum.
Several maneuvers have been ad
vocated to help make a correct
diagnosis intraoperatively. Trans
mural palpation of the ostium of
the diverticulum for a possible fecalith has been suggested.4 However,
this is not reliable because a malig
nant ulcer can feel quite similar.15
Similarly, colotomy with visualiza
tion of the lesion16 is unreliable and
exposes the patient to the unneces
sary risk of spillage of bowel con
tent. Biopsy of the lesion is associ

ated with a risk of false-negative
results due to sampling error and is
associated with a risk of spillage of
malignant cells.17 Lymph-node biop
sy has similar limitations. The re
sults of these maneuvers ultimately
will not affect operative decisions in
most instances and, since they are
unreliable, they are contraindicated.
Recommended treatment varies
widely. Anderson13 and Cutajar18
have advocated appendectomy with
drainage and administration of anti
biotics. Based on the death rates
reported by Lauridsen and Ross,4
the most commonly recommended
treatment is diverticulectomy. The
death rate associated with diver
ticulectomy was 1.4% versus 7.3%
for right hemicolectomy.4 Cecostomy drainage as an adjunct in diffi
cult cases has been recommended;5
however, rarely does cecostomy re
sult in adequate decompression of
the cecum. More recently, a review
of several series collected from the
literature since 1958 by Schuler
and Bayley5 reported a 1.4% cumu
lative death rate for right hemico
lectomy and no deaths with diver
ticulectomy. In the single largest
series in the modern literature, Ar
rington and Judd2 reported no
deaths among 31 patients treated
by right hemicolectomy or cecectomy out of a total of 33 patients
treated for cecal diverticulitis.
Resection and primary anastomo
sis of the right colon with unpre
pared bowel is now recognized to be
safe in the emergency situation.19
Primary anastomosis may be per
formed if no contraindications, such
as gross peritonitis,20 free perfora
tion or gross spillage of bowel con
tent preclude it. Resection with
ileostomy and staged anastomosis is
preferred in this instance.21 Modern
operative technique and periopera
tive antibiotic prophylaxis have
made this approach safe. The single
death in our series occurred after
resection and ileostomy of a free

perforation of a cecal diverticulum.
The possibility of complications
such as this preclude conservative
treatment of cecal diverticulitis.
We believe that the treatment of
cecal diverticulitis should be individ
ualized, but basic surgical princi
ples should be followed. If the in
traoperative diagnosis is certain, the
diverticulum is small and excision
will not compromise bowel function
or blood supply or expose purulence, then simple excision is ade
quate. More commonly in our expe
rience, however, these conditions
are not satisfied. In this case, right
hemicolectomy or limited right he
micolectomy with primary anasto
mosis is safe and effective for both
diagnosis and treatment. Where
conditions preclude primary anasto
mosis, resection with staged anasto
mosis is preferable.

Conclusions
Cecal diverticulitis is an uncom
mon condition which is usually mis
diagnosed as appendicitis at presen
tation. At laparotomy it must be
treated as an unexpected finding.
Free perforation is uncommon but
occurs with sufficient frequency to
preclude treatment by drainage and
administration of antibiotics. When
the diagnosis is uncertain at lapa
rotomy, right hemicolectomy or
limited right hemicolectomy is pre
ferred. Primary anastomosis may be
performed if no contraindications
exist.
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BO O K R E V IE W S
continued from page 237

Mohs micrographic surgery, 4 on der
matologic laser surgery and 21 chapters
on cosmetic and reconstructive derma
tologic surgery.
The text is indexed, and, although
many of the clinical photographs are
overexposed, in general the photo
graphs are adequate. The line drawings
of surgical techniques seem to be quite
good.
The chapters on surgical treatment
of skin disease, such as those on premalignant lesions and basal cell carcinoma,
are merely brief reviews of standard
dermatologic knowledge. All of this
material is more completely covered in
any standard dermatologic text.
To whom is the book addressed and
to whom might it be useful? Most
surgeons learn by doing, not by study
ing how-to-do-it sketches, and any der
matologist worth his salt will know all
the nonsurgical material in this book.
As a general overall review of the
surgical procedures that are performed
on the skin, it is satisfactory.
In the preface the authors state “our
goal is to help define dermatologic
surgery” , but, unfortunately, no defini
tions are given. There are some com
ments on the fluid dermatologic surgery
situation in the United States. The
difficulty that dermatology is having
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competing with plastic surgery and oto
laryngology is outlined. The question is
asked, should dermatologists be per
forming liposuction and lipoaugmentation? I admit to the rather old-fashioned
bias that dermatologists should diag
nose and surgeons do surgery. If der
matologists wish to do extensive sur
gery, they should become surgeons.
There is no way that in a 3-year period
a resident can learn to be both a
dermatologist and a surgeon. One diffi
culty I have with mixed training pro
grams is that the diagnostic acumen of
dermatologists will be lost. No one else
has this knowledge — but there are
many others who can do dermatologic
surgery!
Nowhere in this book is there men
tion of the financial aspect of dermato
logic surgery. Apparently, surveys in
the United States show that there is a
virtually unlimited demand for cosmetic
dermatologic surgical procedures. To
fill this demand, dermatology and other
surgical specialties are obviously ex
panding.
Robert Jackson, MD
Ste. 508,
1081 Carling Ave.,
Ottawa, Ont.
K1Y 4G2

DECISION MAKING IN SURGERY
OF THE CHEST. Edited by Laurens R.
Pickard. 168 pp. Iliust. W .B. Saunders
Company Canada Limited. Toronto,
1 9 8 9 . $ 1 0 7 .9 5 . ISBN 0 -7 2 1 6 -1 1 6 8 -0 .

This excellent text, containing the con
tributions of 70 recognized authorities
in the field, uses a new, effective ap
proach to promote logical thinking and
accurate problem-solving in cardiothoracic surgery. More than 80 specific
problems are presented in easy-tounderstand algorithms, each giving a
logical, systemic, step by step overview
of patient management for each condi
tion.
On the page facing each “decision
making tree” is an up-to-date explana
tion of the thinking behind the algo
rithm; this explanation expresses the
diagnosis and principles of treatment,
which justify the algorithm.
The book is not meant to encompass
every area of cardiothoracic surgery,
but all of the common conditions a
cardiothoracic surgeon would see are
covered. It includes the important top
ics of congenital and acquired diseases
of the heart and great vessels, the
pericardium and cardiac rhythm disturcontinued on page 289
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Transrectal Fine-Needle Aspiration and
Truecut Needle Biopsy of the Prostate: a
Blinded Comparison of Accuracy
L.H. Klotz, MD, FRCSC;* P.A. Shaw, MD, FRCPC;t J.R. Srigley, MD, FRCPCf
Transrectal needle aspiration biopsy and core biopsy of the prostate were performed
simultaneously on 88 men with prostatic nodules. Cytologic and histologic
assessments were made in a blinded, independent fashion, and the results were
compared. All patients with positive findings on aspiration also had positive
findings on core biopsy, for a positive predictive value for aspiration of 100%.
However, five negative and six “insufficient” results obtained by aspiration were
positive on core biopsy, for a negative predictive value for aspiration of 88%. This
experience supports the use of needle aspiration as an initial diagnostic maneuver in
the assessment of prostatic nodules.

Une ponction-biopsie transrectale a l’aiguille et une biopsie du centre de la prostate
ont ete pratiquees simultanement chez 88 hommes souffrant de nodules prostatiques. Les examens cytologiques et histologiques ont ete faits a l’aveugle et les
resultats ont ete compares. Tous les patients qui ont presente une ponction-biopsie
positive avaient aussi une biopsie centrale positive, ce qui donne une valeur
previsionnelle positive de 100% pour la technique par aspiration. Neanmoins, cinq
resultats negatifs et six resultats “insatisfaisants” obtenus par aspiration etaient
positifs a la biopsie reguliere, ce qui donne une valeur previsionnelle negative de
88% pour la ponction-biopsie. Cette experience valide l’utilisation de la ponctionbiopsie comme technique diagnostique initiale dans 1’evaluation des nodules
prostatiques.

ocalized carcinoma of the pros
tate is suspected by the family
practitioner when a prostatic nodule
or induration is palpated on digital
rectal examination. The ability to
screen such patients by a simple
diagnostic procedure is desirable.
As early as 1930, Ferguson1 at
tempted to perform cytologic exam
ination of transrectally aspirated
prostatic tissue. The specimens
were not satisfactory. In 1960,
Franzen and colleagues2 introduced
a technically simple procedure for
cytologic diagnosis of prostatic can

L

cer. This technique has been used
extensively in Europe,34 but until
recently it had few adherents in
North America.5
The advantages of fine-needle as
piration (FNA) are as follows:
• The intervention can be per
formed quickly, without anesthesia,
on out-patients.
• The needle guide permits pre
cise positioning and biopsy of ex
tremely small nodules.
• Fan-like aspiration captures
cells from different areas of the
prostate for analysis.

From the *Department o f Urology and f Department o f Pathology, Sunnybrook Medical Centre,
University o f Toronto, Toronto, Ont.
Accepted for publication Nov. 17, 1988
Reprint requests to: Dr. L. Klotz, Department o f Urology, Sunnybrook Medical Centre, 2075
Bay view Ave., Toronto, Ont. M 4N 3M 5

• The complication rate is ex
tremely low.
• The procedure may be repeat
ed at short intervals when the index
of suspicion is high, without caus
ing the patient undue discomfort.
• The low morbidity of the pro
cedure makes it applicable to other
clinical scenarios, including obtain
ing culture material in patients with
resistant prostatitis.
The accuracy of the procedure is
variable. In general, it can be com
pared to core biopsy as the “ gold
standard” . Because of its ability to
sample multiple sites, FNA may be
more accurate than core biopsy.

Patients and Methods
Between 1985 and 1988, simul
taneous FNA and transrectal core
biopsy (TCB) were performed on 88
patients at Sunnybrook Medical
Centre, Toronto. All procedures
were performed on out-patients
using urethral xylocaine anesthesia
only. In all patients prostatic cancer
was suspected because the gland
was abnormal to palpation. All pa
tients received antibiotic prophylax
is — Flagyl orally and tobramycin
intramuscularly — and a Fleet
enema the night before the proce
dure. Aspiration biopsy was per
formed according to the technique
of Franzen and colleagues,2 using a
0.6-mm aspiration needle. Tissue
was aspirated from one to three
sites, smeared on slides, fixed with
cytostat and stained according to
Papanicolaou’s technique. When no
fluid was obtained, the technique
CJS, VOL. 32, NO. 4, JULY 1989
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was performed a second time. Pa
tients continued to receive Flagyl
for 5 days postoperatively. The cy
tologic and core biopsy specimens
were reviewed by independent pa
thologists with no knowledge of the
results of the corresponding speci
men.

urosepsis requiring hospitalization
and intravenous administration of
aminoglycosides. All four responded
promptly to therapy; there was no
long-term morbidity. This frequency
of urosepsis undoubtedly reflects
the impact of two simultaneous
procedures, and would be lower
with FNA alone.

Comment
Fine-needle aspiration is easily
performed in an out-patient setting;
the procedure is well tolerated and
associated morbidity and discomfort
are minimal.
A positive FNA indicates carcino
ma of prostate with a high degree

Criteria for Cytologic
Evaluation
The criteria used for assessment
of FNA are well described in the
literature.5 Specimens were reported
as negative, positive or insufficient.
Benign prostatic epithelium ap
peared in cohesive uniform groups,
often with a honeycomb arrange
ment (Fig. 1). In addition to benign
prostatic epithelium, mesenchymal
elements were noted, and squamous
metaplasia was seen in association
with prostatitis. Seminal vesicle epi
thelium and colonic mucosa not
infrequently accompanied the pros
tatic elements. Malignant aspirates
were more cellular, with dissolution
and disarray of the epithelial groups
(Fig. 2). The usual cytologic criteria
for malignancy were applied.

FIG. 1. Benign prostatic epithelium appears in cohesive uniform groups, often with
honeycomb arrangement (Papanicolaou stain, original magnification X 400).

Results
The accuracy of aspiration biopsy
relative to core biopsy was high
when no carcinoma was identified
by core biopsy (Tables I and II). All
positive FNAs had a positive TCB
(specificity 100%). Twenty-four per
cent of the FNAs contained insuffi
cient cells for analysis.
Excluding the insufficient sam
ples from the calculations, the sen
sitivity of aspiration was 83%. Neg
ative and positive predictive values
were 88% and 100% respectively.
Morbidity

Four (5%) of 88 patients had
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FIG. 2. Malignant aspirates are more cellular than benign ones. They show
dissolution and disarray of epithelial groups, and nuclear pleomorphism (Papanico
laou stain, original magnification X 400).

PROSTATIC BIOPSY VERSUS ASPIRATION

of reliability (100% in our experi
ence). However, even with experi
ence, 24% of FNAs have given
insufficient material for examina
tion. This rate is higher than that
reported elsewhere.4 It likely re
flects a more conservative approach
to obtaining an excellent aspirate
because of the planned core biopsy
performed immediately afterwards
Table 1. Yields From the Two Biopsy
Techniques
FNA

TCB

Insufficient material
Positive
Negative

21
24
44

0
35
51

Totals

89

86

Result

FNA = fine-needle aspiration biopsy, TCB
= transrectal core biopsy.

in this cohort. Generally, we made
only a single pass of the aspirate
needle and did not attempt to sweep
the needle through the prostate. If
aspiration is being performed as a
sole maneuver (i.e., without a core
biopsy), a more aggressive ap
proach, including two or more pass
es and a sweeping technique, would
undoubtedly improve the number of
adequate samples and this might
also reduce the false-negative rate.
From a negative FNA one cannot
conclude unequivocally that carci
noma is not present (p = 92% ±
9%). Accordingly, FNA cannot re
place conventional biopsy complete
ly, even though it is associated with
less discomfort and morbidity.
Transrectal needle aspiration bi

Table II. Agreement Between TCB and FNA
TCB positive

TCB negative

Totals

FNA positive
FNA negative
FNA "insufficient” *

24
5
6

0
36
15

24
41
21

Totals

35

51

86

*lt is a clinical issue whether “ insufficient” FNAs should be included in the calculation of test
characteristics (e.g., as assumed negatives). If not, then the test characteristics are as follows:
sensitivity = 83% (24/29), specificity = 100% (36/36), positive predictive value = 100%
(24/24), negative predictive value = 88% (36/41).

opsy is a reasonable initial approach
to prostatic nodules. If the cytolog
ic interpretation is “negative” , “in
sufficient material” , “atypia” or
“suggestive” , aspiration should be
repeated or a core needle biopsy
performed. This is particularly im
portant in the “learning phase” of
the technique.
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BOOK REVIEWS
c o n tin u e d fro m page 28 6

bances; in the area of thoracic surgery,
important subjects concerning the
lungs and major airways, mediastinum,
pleura, chest wall, diaphragm and
esophagus are discussed. It also looks
at practical problems in trauma of the
chest and in pre- and postoperative
care.
This text, therefore, is an important
acquisition for the library of cardiothoracic surgeons and residents, who
would enjoy and benefit from browsing
through the text. It is an important
reference and guide to decision-making
for any problem with which a patient

presents. It has the additional excellent
feature of being an ideal reference for
preparing clinical problem-solving ses
sions for residents and students, a pre
sentation on an individual patient prob
lem, and even lectures. As a text for the
medical student, it is too overwhelming.
In summary, this book is highly
recommended. It has an excellent prob
lem-solving format, showing and ex
plaining practical steps for approaching
patient problems in cardiothoracic sur
gery. The algorithm (deductive) format
makes it a most valuable and practical
adjunct to the library of every cardio

thoracic surgeon and resident. It does
not replace the usual formal text which
includes extensive references. Rather, it
is a practical “how-to” book for day-today use in the management of patients
and the preparation of teaching ses
sions.
Edward J.P. Charrette, FRCSC
P rofessor o f S urgery,
Q ueen's U niversity.
R ichardson House.
102 S tu a rt St.
K in g s to n . O nt.
K 7 L 2V6
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^PRIMAXIN®
(imipenem and cilastatin sodium
for injection)
Antibiotic

•
•
•
•
•
•

Morganella morganii
Neisseria
Proteus (indole positive and indole negative
strains)
Providencia
Pseudomonas aeruginosa
Serratia marcescens

Gram-positive Anaerobes

CNS adverse experiences such as myoclonic
activity, confusional states, or seizures have
been reported with PRIMAXIN® especially when
recommended dosages based on renal function
and body weight were exceeded. These expe
riences have occurred most commonly in patients
with CNS disorders (e.g., brain lesions or
history of seizures) and/or who have compro
mised renal function. However, there were rare
reports in which there was no recognized or
documented underlying CNS disorder. Close
adherence to recommended dosage schedules
is urged, especially in patients with known
factors that predispose to seizures.

•
•
•

Clostridium (excluding C. difficile)
Peptococcus
Peptostreptoccus

Gram-negative Anaerobes

•
•

Bacteroides fragilis
Bacteroides (non-fragilis)

CONTRAINDICATIONS
PRIMAXIN® (imipenem and cilastatin sodium for
injection) is contraindicated in patients who have
shown hypersensitivity to either component of this
product.

ACTION

WARNINGS

Imipenem exerts a bactericidal action by inhibiting
cell wall synthesis in aerobic and anaerobic gram
positive and gram-negative bacteria.

PRIMAXIN® (imipenem and cilastatin sodium for
in je c tio n ) SHOULD BE ADMINISTERED WITH
CAUTION TO ANY PATIENT WHO HAS DEMONS
TRATED SOME FORM OF ALLERGY, PARTICULARLY
TO STRUCTURALLY-RELATED DRUGS. IF AN
ALLERGIC REACTION TO PRIMAXIN® OCCURS,
DISCONTINUE THE DRUG. SERIOUS HYPER
S E N S IT IV IT Y R EACTIONS MAY REQUIRE
E PIN E P H R IN E AND OTHER EMERGENCY
MEASURES.

P R IM A X IN ® c o n s is ts o f tw o c o m p o n e n ts :
(1) im ipenem , a derivative of thienam ycin, a
carbapenem antibiotic; and (2) cilastatin sodium, a
specific inhibitor of dehydropeptidase-l a renal
enzym e w h ic h m etabolizes and in a ctiva te s
imipenem. Cilastatin blocks the metabolism of
imipenem in the kidney, so that concom itant
administration of imipenem and cilastatin allows
antibacterial levels of imipenem to be attained in the
urine.
Inhibition of cell-wall synthesis is achieved in gram
negative bacteria by the binding of imipenem to
penicillin binding proteins (PBPs). In the case of
E s c h e r ic h ia c o li and s e le c te d s tra in s o f
Pseudomonas aeruginosa, imipenem has been
shown to have highest affinity for PBP-2, PBP-1a
and PBP-1 b, with lower activity against PBP-3. The
preferential binding of imipenem on PBP-2 and
PBP-1 b leads to direct conversion of the individual
cell to a spheroplast resulting in rapid lysis and cell
death without filament formation. When imipenem
is removed prio r to complete killing of gram
negative species, the remaining viable cells show a
measurable lag, termed a "post-antibiotic effect”
(PAE), prior to resumption of new growth.

INDICATIONS AND CLINICAL USE
PRIMAXIN® (imipenem and cilastatin sodium for
injection) may be indicated in the treatment of
serious infections when caused by sensitive strains
of bacteria Where considered necessary, therapy
may be initiated on the basis of clinical judgment
before results of sensitivity testings are available.
Continuation of therapy should be reevaluated on
the basis of bacteriological findings and of the
patient's clinical condition.
Imipenem is active in vitro against a wide range of
gram -positive and gram-negative aerobic and
anaerobic bacteria, including most strains which
are beta-lactam ase producing. Patients have
responded while under treatment with PRIMAXIN®
for single or mixed infections of the following body
systems, when they were associated with a number
of pathogenic species and strains of the genera
listed:
1.
2.
3.
4.
5.
6.
7.
8.

Lower Respiratory Tract Infections
Urinary Tract Infections
Intra-Abdominal Infections
Gynecological Infections
Septicemia
Endocarditis caused by Staphylococcus
aureus
Bone and Joint Infections
Skin Structure Infections

Gram-positive Aerobes

•
•
•
•

Listeria monocytogenes
Nocardia asteroides
Staphylococcus (excluding many strains
which are methicillin resistant)
Streptococcus (excluding S. taecium)

Gram-negative Aerobes

•
•
•
•
•
•
•

Acinetobacter
Citrobacter
Enterobacter
Escherichia coli
Haemophilus influenzae
Haemophilus parainfluenzae
Klebsiella

emesis, inappetence, body weight loss, diarrhea
and death) at doses equivalent to the average
human dose in pregnant rabbits and cynomolgus
monkeys that is not seen in non-pregnant animals in
these or other species. In other studies, PRIMAXIN®
was well tolerated in equivalent or higher doses (up
to 11 times the average human dose) in pregnant
rats and mice (see REPRODUCTION STUDIES
under TOXICOLOGY in the complete monograph).
Nursing Mothers

It is not known whether PRIMAXIN® is excreted in
milk. If the use of PRIMAXIN® is deemed essential,
the patient should stop nursing.
Pediatric Use

Efficacy and tolerability in infants under the age of
3 months have not yet been established; therefore,
PRIMAXIN® is not recommended in the pediatric
age group below the age of 3 months.
Drug Interactions

Concomitant administration of PRIMAXIN® and
probenecid results in only minimal increases in
plasma levels of imipenem and plasma half-life. It is
not recommended that probenecid be given with
PRIMAXIN®.
PRIMAXIN® should not be mixed with or physically
added to other antibiotics. PRIMAXIN® has been
administered concomitantly with some antibiotics,
such as aminoglycosides.
There is no evidence to suggest that association of
PRIMAXIN® with any other beta-lactam antibiotics
has any therapeutic advantage.

Pseudomembranous colitis

ADVERSE REACTIONS

Pseudomembranous colitis has been reported with
the use of PRIMAXIN®. Therefore it is important to
consider this diagnosis in patients who develop
diarrhea during or after therapy. This colitis may
range from mild to life threatening in severity.

PRIMAXIN® (imipenem and cilastatin sodium for
injection) is generally well tolerated. The following
adverse reactions were reported on 1,723 patients
treated in clinical trials. Many of these patients were
severely ill and had multiple background diseases
and physiological impairments, making it difficult to
determ ine causal relationship of adverse ex
periences to therapy with PRIMAXIN®.

Mild cases of pseudomembranous colitis may
respond to drug discontinuance alone. In more
s e v e re cases, m a n a g e m e n t m ay in c lu d e
sig m o id o sco p y, ap p ro p ria te b a c te rio lo g ic a l
studies, fluid, electrolyte and protein supple
mentation, and the use of a drug such as oral
vancomycin, as indicated. Other causes of colitis
should also be considered.

Local Adverse Reactions

Adverse local clinical reactions that were reported
as possibly, probably or definitely related to therapy
with PRIMAXIN® were:

PRECAUTIONS
General

Prolonged use of PRIMAXIN® (imipenem and
cilastatin sodium for injection) may result in
overgrowth of resistant organisms. Repeated
evaluation of the patient’s condition is essential. If
superinfection occurs during therapy, appropriate
measures should be taken.
CNS adverse experiences such as m yoclonic
activity, confusional states, or seizures have been
reported with PRIMAXIN® especially when recom
mended dosages based on renal function and body
weight were exceeded. These experiences have
occurred most commonly in patients with CNS
disorders (e.g., brain lesions or history of seizures)
and/or who have compromised renal function.
However, there were rare reports in which there was
no recognized or documented underlying CNS
disorder. Close adherence to recommended dosage
schedules is urged especially in patients with
known factors that predispose to seizures (see
D OSAG E A N D A D M IN IS T R A T IO N ). A n ti
convulsant therapy should be continued in patients
with a known seizure disorder If focal tremors,
myoclonus, or seizures occur, patients should be
evaluated neurologically and placed on an ti
convulsant therapy if not already instituted. If CNS
symptoms continue, the dosage of PRIMAXIN®
should be decreased or discontinued.
Use in Patients with Impaired Renal Function

Dosage in patients with impaired renal function is
based on the severity of infection but the maximum
daily dose varies with the degree of renal functional
im p a irm e n t (see DOSAGE AND A D M IN IS 
TRATION - Dosage in P atients w ith Renal
Insufficiency),
Use in Pregnancy

The use of PRIMAXIN® in pregnant women has not
been studied, therefore, PRIMAXIN® should be
used during pregnancy only if clearly needed. Use
of this drug in women of childbearing potential
requires that the anticipated benefits be weighed
against possible hazards.
Reproduction studies with bolus I.V. doses suggest
an apparent intolerance to PRIMAXIN® (including

Incidence (%)

Phlebitis/thrombophlebitis
Infused vein pain
Vein induration
Infused vein infection

1.7
0.6
0.2
0.1

Systemic Adverse Reactions

Adverse clinical reactions that were reported as
p o ssib ly, probab ly, or d e fin ite ly related to
PRIMAXIN® were:
Incidence (%)
Gastrointestinal

nausea
diarrhea
vomiting
tongue papillar hypertrophy
pseudomembranous colitis
(see WARNINGS)
hemorrhagic colitis
gastroenteritis
abdominal pain
glossitis
heartburn
pharyngeal pain
increased salivation

2.0
1.7
1.6
0.2
0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1

CNS

fever
dizziness
seizures
(see PRECAUTIONS)
somnolence
confusion
myoclonus
vertigo
headache
encephalopathy
paresthesia

0.4
0.3
0.2
0.2
0.2
0.1
0.1
0.1
<0.1
<0.1

Special Senses

transient hearing loss in
patients with impaired hearing
tinnitus

<0.1
<0.1

Respiratory

dyspnea
hyperventilation
thoracic spine pain

0.1
<0.1
<0.1

The maximum daily dose should not exceed 4 g or
50 mg/kg, which ever is less.

Cardiovascular
hypotension
palpitations
tachycardia

0.4
0.1
<0.1

Dosage In Elderly Patients

<0.1
<0.1

The recommended dosage of PRIMAXIN® in elderly
patients with normal renal function is the same as
given for adults above. Renal status o f elderly
patients may not be accurately portrayed by
measurement of BUN or creatinine alone. Deter
mination of creatinine clearance is suggested to
provide guidance for dosing in such patients.

Renal
oliguria/anuria
polyuria
Skin
rash
pruritus
urticaria
skin texture changes
candidiasis
erythema multiforme
facial edema
flushing
cyanosis
hyperhidrosis
pruritus vulvae

0.9
0.3
0.2
0.1
0.1
<0.1
<0.1
<0.1
<0.1
<0.1
<0.1

Dosage in Patients with Renal Insufficiency

Body as a whole
polyarthralgia
asthenia/weakness

<0.1
<0.1

Adverse Laboratory Changes
Adverse laboratory changes, without regard to drug
relationship, that were reported during clinical trials
were:
Hepatic: Increased SGPT, SGOT, alkaline phospha
tase, bilirubin and LDH.
Hemic: Increased eosinophils, positive Coombs
test, decreased WBC and neutrophils, increased
WBC, increased platelets, decreased platelets,
decreased hemoglobin and hematocrit, increased
monocytes, abnormal prothrombin time, increased
lymphocytes, increased basophils.
Electrolytes: Decreased serum sodium, indreased
potassium, increased chloride.
Renal: Increased BUN, creatinine.
Urinalysis: Presence of urine protein, urine red
blood cells, urine white blood cells, urine casts,
urine bilirubin, and urine urobilinogen.

TREATMENT OF OVERDOSAGE
There are no data available on overdosage.
PRIMAXIN® (imipenem and cilastatin sodium for
injection) is cleared by hemodialysis.

DOSAGE AND ADMINISTRATION
The dosage recommendations for PRIMAXIN®
(imipenem and cilastatin sodium fo r injection)
represent the quantity of imipenem to be ad
ministered by I.V. infusion only. An equivalent
amount of cilastatin is also present in the solution.
The dosage of PRIMAXIN® should be determined
by the severity of the infection, renal function, body
weight, the antibiotic susceptibility of the causative
organism(s) and the condition of the patient. Doses
cited are based on body weight of 70 kilos.
The median duration of treatment with PRIMAXIN®
in clinical trials for infections of the various body
systems ranged from 6 to 10 days except for
endocarditis and bone and joint infections for which
the median duration of treatment was 4 weeks.
Dosage in Adults

TABLE 2
MAXIMUM DOSAGE OF PRIMAXIN®
IN RELATION TO RENAL FUNCTION

RENAL
F U N C T IO N

Mild
impairment
Moderate
impairment

DOSE
(9)

DOSAGE
INTERVAL
(h)

M A X IM U M
T O TA L
DAILY
D O SA G E
(9)

31-70
(0.52-1.17)

0.5

6-8

1.5-2

21-30
(0.35 - 0.50)

0.5

8-12

1-1.5

C R EA TIN IN E
CLEARANCE
m L /m ln/1.73 m2
(m L/»/1.73 m2)

TABLE 1

Severe*
impairment

0-20
(0-0.33)

0.25 - 0.5

12

0.5-1.0**

* P a tie nts w ith c re a tin in e clea ra n ce o f 6 to
20 mL/min/1.73 m2 (0.1 -0 .3 mL/s/1.73 m2) should
be treated with 250 mg (or 3.5 mg/kg whichever is
lower) every 12 hours for most pathogens. When
the 500 mg dose is used in these patients, there may
be an increased risk of seizures.
* * The highest dose is only recom m ended fo r
infectio n s due to less susceptible organism s
primarily some strains of Ps. aeruginosa.

When only the serum creatinine level is available,
the following formula (based on sex, weight, and
age of the patient) may be used to convert this value
into creatinine clearance (mL/min). The serum
creatinine should represent a steady state of renal
function.
Males:

Weight (kg) x (140 - age)
72 x serum creatinine (mg/100 mL)

Females:

0.85 x above value.

When using the International System of units (SI),
the estimated creatinine clearance (mL/s) in males
can be calculated as follows:
(lean body weight, kg) x (140 - age, years) x 1.4736

I .V . A d m in is t r a t io n
Dose
( m g o f im ip e n e m )

and in females the estimated creatinine clearance
(mL/s) is:
(lean body weight, kg) x (140 - age, years) x 1.2526
(72) x (serum creatinine concentration, ^imol/L)

ADULT DOSAGE OF PRIMAXIN®

D osage
In t e r v a l

D a ily
Dose

6h

1.0 g

PRIMAXIN® is cleared by hemodialysis. After each
dialysis session the dosage schedule should be
restarted.
Dosage In Infants and Children

Mild

250 mg

Moderate

500 mg

8h

1.5 g

Severe (fully
susceptible)

500 mg

6h

2.0 g

1000 mg
1000 mg

8h
6h

3.0 g
4.0 g

Severe* infections
due to less
susceptible
organisms
or life threatening
conditions

x Primarily some strains of Ps. aeruginosa.

RECONSTITUTION
Contents of the vials must be suspended and
transferred to 100 mL of an appropriate infusion
solution.
A suggested procedure is to transfer approximately
10 mL from the 100 mL of the appropriate infusion
solution to the vial (see list of diluents under
COMPATIBILITY AND STABILITY). Shake well.
Return the resulting 10 mL of suspension to the
remaining 90 mL of the infusion solution.
Repeat, using 10 mL of the diluted suspension, to
ensure complete transfer of the contents of the vial
to the infusion solution.
CAUTION: CONTENTS OF VIALS NOT FOR
DIRECT INFUSION.

COMPATIBILITY AND STABILITY
List of diluents
0.9% Sodium Chloride Injection
5% or 10% Dextrose Injection
5% Dextrose Injection w ith 0.02% sodium
bicarbonate solution
5% Dextrose and 0.9% S odium C h lo rid e
Injection
5% Dextrose Injection with 0.225% or 0.45%
saline solution
NORMOSOL-M in D5-W
5% Dextrose Injection with 0.15% potassium
chloride solution
Mannitol 2.5%, 5% and 10%
Reconstituted solutions

(72) x (serum creatinine concentration, //mol/L)

The recommended daily dose is 1 to 2 g adminis
tered in equally divided doses every 6 to 8 hours
(see Table 1).

S e v e r ity
o f in f e c t io n

P a tie n ts w ith c r e a tin in e c le a r a n c e s o f
< 5 mL/m in/1.73m 2 « 0 .0 8 mL/s/1.73m2) should
not receive PRIMAXIN® unless hemodialysis is
instituted w ithin 48 hours. Both imipenem and
cilastatin are cleared from the circulation during
h e m o d ia ly s is . The p a tie n t s h o u ld re ce ive
PRIMAXIN® after hemodialysis and at 12 hour
intervals timed from the end of that hemodialysis
session. Dialysis patients, especially those with
background CNS disease, should be carefully
m o n ito re d ; fo r p a tie n ts on h e m o d ia ly s is ,
PRIMAXIN® is recommended only when the benefit
outweighs the potential risk of seizures (see
PRECAUTIONS). Currently, there are inadequate
data to recommend the use of PRIMAXIN® in
patients undergoing peritoneal dialysis.

Each reconstituted 250 mg or 500 mg dose should
be given by intravenous infusion over twenty to
th irty minutes. Each 1000 mg dose should be
infused over 40 to 60 minutes. In patients who
develop nausea during the infusion, the rate of
infusion may be slowed.

The re com m e nde d to ta l d a ily do sa g e o f
PRIMAXIN® in children and infants 3 months of age
and older is 60 to 100 mg/kg of body weight divided
into 4 equal doses given at six hour intervals. The
higher dosages should be used for infants and
young children. The total daily dosage should not
exceed 2 grams. Clinical data are insufficient to
recommend an optimum dose for infants and
children with impaired renal function.
Administration
CAUTION: CONTENTS OF VIALS NOT FOR
DIRECT INFUSION.

Solutions of PRIMAXIN® range from colourless to
yellow. Variations of colour within this range do not
affect the potency of the product.
PRIMAXIN®, as supplied in vials and reconstituted
as above maintains satisfactory potency fo r four
hours at room temperature and for 24 hours under
refrigeration (4°C). PRIMAXIN® has been found to
be stable in 0.9% Sodium Chloride Injection for
10 hours at room temperature and 48 hours under
refrigeration.

DOSAGE FORMS
AVAILABILITY
PRIMAXIN® is supplied as a sterile powder mixture
in vials co n taining im ipenem a n hydro us and
cilastatin sodium as follows:
3514 Ca - 250 mg imipenem equivalent and 250 mg
cilastatin equivalent in vials.
3516 Ca - 500 mg imipenem equivalent and 500 mg
cilastatin equivalent in vials.
STORAGE
The dry powder should be stored at a temperature
below 30° C.
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H epatic Artery Aneurysm Presenting as
Abdominal Pain and Hemoperitoneum
Gordon E. Searles, OD, MD;* James L. Wellington, MD, FACS, FRCSCt
Rupture of a hepatic artery aneurysm is one of the commonest causes of
hemoperitoneum, second only to abdominal aortic rupture. The authors illustrate
the difficulties of diagnosis and therapy in their description of the case of a
65-year-old man with a ruptured hepatic artery aneurysm. There are no
pathognomonic features, and definitive diagnosis requires selective angiography of
the hepatic artery. Early intervention by ligation or reconstruction may improve
outcome but is associated with a high death rate. Selective embolization under
fluoroscopic control may be preferable.

La rupture d’un anevrisme de l’artere hepatique est une des causes les plus
frequentes de l’hemoperitoine, deuxieme seulement derriere la rupture d’un
anevrisme de l’aorte abdominale. Les auteurs illustrent les difficulties de diagnostic
et de traitement en decrivant le cas d’un homme de 65 ans qui subit une rupture
d’un anevrisme de l’artere hepatique. II n’existe pas de caracteristique pathognomonique et le diagnostic definitif necessite une angiographie selective de l’artere
hepatique. Une intervention rapide par ligature ou reconstruction peut ameliorer le
resultat mais elle s’accompagne d’un haut taux de mortality. II peut etre preferable
de recourir a une embolisation sous surveillance fluoroscopique.

udden cardiovascular instability
associated with clinical findings
of hemoperitoneum usually necessi
tates urgent surgical exploration.
Although ruptured aortic aneurysm
is the commonest cause of such
bleeding in adults, the surgeon
should be aware of other possible
sources of bleeding within the
splanchnic circulation. We present
a case of a ruptured hepatic aneu
rysm presenting as hemoperito
neum.

S

Case Report
A 65-year-old man presented to a
local hospital complaining of epi
gastric pain and vomiting for 1 day.
Four days previously he had experi
enced a constant nonradiating chest
pain without syncope, peripheral
numbness or dyspnea. He had a
history of stable exertional angina.
On examination, he had mild
right upper quadrant tenderness
with guarding. Ultrasonography re
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vealed a cystic lesion in the right
hepatic lobe and a normal gallblad
der. His physical discomfort com
bined with increased abdominal wall
thickness required us to apply mod
erate pressure with the ultrasound
probe. During the examination, he
became hypotensive and required
resuscitation. On repeat ultrasonog
raphy, the cystic lesion had disap
peared and there was free fluid in
the peritoneal cavity.
Laparotomy revealed a bleeding
3-cm defect in the right hepatic
lobe, which was interpreted as a
bleeding hepatic tumour. A wedge
resection was performed and the
base was electrocauterized. Estimat
ed blood loss was 3 L. Postoperatively, acute renal failure developed,
so he was transferred to the Ottawa
General Hospital for hemodialysis.
Results of laboratory investiga
tions indicated a blood urea nitro
gen level of 25.5 mmol/L urea
(normal 3.5 to 9.0 mmol/L urea), a
serum creatinine level of 680
Mmol/L (normal 70 to 130
Mmol/L), serum aspartate amino
transferase level of 837 U/L (nor
mal 7 to 40 U/L), serum alanine
aminotransferase of 2358 U /L
(normal 7 to 40 U/L) and a serum
alkaline phosphatase 272 U/L (nor
mal 30 to 110 U/L). The serum
creatine kinase level was also ab
normal (680 U/L), but the MB frac
tion was only just detectable. A
chest x-ray film showed right lower
lobe atelectasis with a small pleural
effusion.
Computed tomography of the ab-

HEPATIC ARTERY ANEURYSM

domen revealed a fluid-filled lesion
7 cm in diameter in the right hepat
ic lobe, and peripheral calcification.
Needle aspiration yielded no fluid.
Hepatic angiography revealed an
aneurysm of the main right hepatic
artery, 7 cm in diameter, and a
smaller aneurysm from a medial
branch (Fig. 1). Selective intra-arte
rial embolization was performed.

Several days later, the activated
partial thromboplastin time became
prolonged. Hematemesis developed
and endoscopy showed a possible
small gastric ulcer at the cardia.
There was no mention of blood
coming from the region of the
ampulla of Vater, which would sug
gest hematobilia. Liver function test
findings became progressively ab

FIG. 1. Angiogram of hepatic circulation revealing two aneurysmal cavities
(arrows) in right hepatic lobe.

normal, the platelet count fell and
hypovolemic shock developed.
Continued bleeding made laparot
omy mandatory. Exploration re
vealed a large amount of blood in
the left upper quadrant from a small
splenic laceration, which may have
been iatrogenic. Splenectomy was
performed. The stomach was dis
tended with fresh organized clot.
The small ulcer at the cardia was
oversewn, and vagotomy, pyloro
plasty and feeding jejunostomy
were performed. The right hepatic
lobe was encased with fibrin and
was adherent to the diaphragm, but
there was no active bleeding. The
patient remained hemodynamically
unstable throughout the procedure
despite the administration of ino
tropic drugs.
He was transferred to the inten
sive care unit but suffered a cardiac
arrest and died 7 hours postoperatively.
Autopsy revealed two large hem
orrhagic cysts in the right hepatic
lobe measuring 11 X 8 X 8 cm and
extensive surrounding liver necro
sis. The cystic regions correlated
anatomically with the location of
the aneurysms (Fig. 2). No evidence
of hepatic adenoma was found on
microscopic review. Evidence of a
massive gastrointestinal hemorrh
age was found, but no site of
ulceration was detected.

Discussion

FIG. 2. Cross-section showing aneurysm cavities in right hepatic lobe. Note
thrombus inside cavities created after selective arterial embolization.

Aneurysms of the hepatic circula
tion account for about 20% of all
visceral arterial aneurysms, but they
have the highest reported rate of
rupture (44%).1
The mean age of patients with
hepatic artery aneurysms is 40
years, with a male to female ratio of
2:1.2 There is no pathognomonic
physical finding. The classic presen
tation triad of Quinke (abdominal
pain, hematobilia and obstructive
CJS, VOL. 32, NO. 4, JU L Y 1989
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jaundice) is seen in less than onethird of cases. Ultrasonography,
computed tomography or percuta
neous transhepatic cholangiogra
phy suggests the diagnosis, but
definitive diagnosis requires selec
tive angiography of the hepatic ar
tery.3
Chronic inflammatory infections
such as syphilis and tuberculosis
were once the cause of hepatic
artery aneurysms but are now rare.
Zachary and colleagues1 stated that
trauma to the hepatic circulation
was responsible for an increasing
number of cases.
Erskine4 reported the surgical re
sults in 61 patients. Of 38 who had
an extrahepatic hepatic artery aneu
rysm, ligation and excision were
carried out in 23; the remaining 15
had reconstruction. Of the 23 pa
tients who had intrahepatic artery
aneurysms, successful correction of
an intrahepatic aneurysm was re
ported in only 2. The remainder
died of intraperitoneal hemorrhage,
hemobilia or portal hypertension
with variceal hemorrhage.
Several approaches have been ad
vocated. If the aneurysm is located
proximal to the gastroduodenal ar
tery, the artery can be ligated with
or without excision.3 Aneurysms lo
cated distal to the gastroduodenal
artery can be ligated and excised,
and reconstruction carried out to
reinstate the blood supply.3 Recon
struction may not be necessary if
the liver colour does not change on
clamping the distal end of the ar
tery before ligation.1
Liver synthesis of vitamin In
dependent coagulation factors can
be substantially impaired with dearterialization leading to prolonged
prothrombin and partial thrombo
plastin times. It was not reported if
vitamin K supplementation correct
ed this deficiency.5
Hepatic artery aneurysm is un
common. It presents typically with
hemodynamic collapse, hemoperito294
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neum or upper gastrointestinal he
morrhage. Clinical suspicion, early
examination by ultrasonography or
angiography will lead to the correct
diagnosis. Early control of the an
eurysm by ligation or reconstruc
tion can result in a favourable out
come. The surgical death rate from
ruptured intrahepatic artery aneu
rysms remains high, and treatment
by embolization may be preferable.

et al: Hepatic artery aneurysm. Report of
an unusual case and review of the litera
ture. Am Surg 1983: 49: 5 1 - 5 4
3. S alo JA. S almenkivi K, T enhunen A, et
al: Rupture of splanchnic artery aneu
rysms. World J Surg 1986; 10: 1 2 3 -1 2 7
4. E rskine JM: Hepatic artery aneurysm.
Vase Surg 1973; 7: 1 0 6 -1 2 5
5. Almersj O 0 , B encmark S , Hafstrom LO,
et al: Changes in coagulation factors after
hepatic dearterialization in man. Am J
Surg 1968; 116: 4 1 4 -4 1 8
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Giant Salivary Calculi: an Orocervical
Fistula Caused by a Submandibular Gland
Calculus
Sami K. Asfar, MD, FRCS(Edin), FACS; Mustafa R. Steitiyeh, MB, ChB, FRCS(Edin); Raad Abdul-Amir,
DDS, MSc
Large calculi of the salivary glands are rare. They may go undetected for many
years. The authors report three cases of giant submandibular gland calculi. In one
patient, the calculus was an incidental finding. In all patients, the mass was in the
substance of the gland; in one, the configuration of the mass was unusual and it had
eroded through the floor of the buccal cavity forming an orocervical fistula (the first
such report) and in another the mass occupied a small portion of Wharton’s duct.
The histopathologic findings in all three cases were of nonspecific chronic
inflammation. All the patients made a smooth recovery and had no complaints at
follow-up.

Les gros calculs des glandes salivaires sont rares. Ils peuvent demeurer non detectes
pendant plusieurs annees. Les auteurs decrivent trois cas de calculs geants de la
glande sous-mandibulaire. Chez un patient, le calcul fut une decouverte fortuite.
Dans tous les cas, la masse se trouvait dans le corps de la glande; dans un cas, la
masse etait de forme inhabituelle et elle avait erode le plancher de la cavite buccale,
formant une fistule orocervicale (le premier cas a etre signale) et, dans un autre cas,
la masse occupait une petite partie du canal de Wharton. Dans les trois cas, les
observations histopathologiques etaient compatibles avec une inflammation chronique non specifique. Tous les patients ont fait une guerison sans histoire et n’ont
signale aucun symptome a l’examen de rappel.

G

iant salivary gland calculi are
rare. We report three cases,
seen over 7 years, one of which
presented as an orocervical fistula.
We believe this is the first report of
an orocervical fistula caused by a
salivary gland calculus.

Case Reports
Case 1
A 55-year-old man presented with
a painful lump in the right subman
dibular region and discharging si
nuses in the same side of the neck.
These had been present for 1 year.

He appeared healthy and was not
hypertensive or diabetic. The ten
der, firm mass appeared to be an
enlarged right submandibular sali
vary gland (Fig. 1). The two dis
charging sinuses in the right upper
cervical region just below the en
larged gland were discharging clear
fluid.
Inspection of the buccal cavity
revealed a 2.0 X 1 cm defect in the
floor of the mouth medial to the
right molar and premolar teeth.
Through this protruded a darkbrown, hard calculus. A plain later
al x-ray film of the neck showed a
very large calculus in the region of
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the right submandibular salivary
gland (Fig. 2).
Hematologic and biochemical
blood test results were normal.
The diagnosis was orocervical fis
tula caused by a right submandibu
lar gland calculus.
Under general anesthesia and an
tibiotic cover (Ampiclox, 1 g intra
venously with premedication, then
500 mg every 6 hours for 3 days
postoperatively), a transverse ellipti
cal incision was made to include the

FIG. 1. Case 1. Lateral view showing
right submandibular swelling and cer
vical sinuses.

FIG. 2. Case 1. Right lateral x-ray film
of neck and submandibular region
showing submandibular gland calcu
lus.
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fistulous openings. The skin flaps
were dissected around the fistulous
tracts, and the right submandibular
salivary gland together with the
contained calculus was excised after
ligation of Wharton’s duct. The
defect in the floor of the mouth was
closed with 2-0 chromic catgut.
There were no calculi in the duct. A
vacuum drain was left in place and
brought out through a separate
stab wound.
The drain was removed on post
operative day 2 and the patient was
discharged home on day 4.
The gross specimen showed an
enlarged, chronically inflamed gland
with a giant calculus occupying the
gland substance and eroding its
superior surface. The calculus was
in the shape of a question mark and
measured 3.8 X 2.5 cm. Histopa
thologic examination of the gland
showed nonspecific chronic inflam
mation.
At follow-up 7 years later, the
patient had no complaints and clini
cal examination revealed no abnor-

mality except for a hardly visible
scar in the neck.
Case 2

A 43-year-old man with hyperten
sion, ischemic heart disease and
severe angina was admitted for
work-up in the cardiology unit in
preparation for coronary artery by
pass grafting. A tender lump was
noted in the left submandibular re
gion. An occlusive left submandibu
lar x-ray film revealed a large calci
fied shadow in the region of the
submandibular salivary gland (Fig.
3). Blood biochemical profile and
hematologic test results were nor
mal. The submandibular gland was
excised through a curved incision in
the left submandibular region
(along Langer’s lines). The stone
was not in Wharton’s duct but
within the gland substance; it had
an irregular round shape and mea
sured 1.6 X 2.0 cm. Histopatholog
ic findings were chronic nonspecific
inflammation. The patient made a
smooth recovery and was dis
charged on postoperative day 3. At
2-week follow-up he was well and
had no complaints.
Case 3

FIG. 3. Case 2. Occlusive x-ray film of
left submandibular region showing ir
regularly round calculus.

FIG. 4. Case 3. Left lateral oblique film
showing cylindrical calculus (arrows).
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A 75-year-old man presented to
the surgical outpatient department
complaining of a painful swelling in
the left submandibular region which
increased in size during mastica
tion. He was receiving treatment for
mild hypertension. Hematologic test
results and the blood biochemical
profile were normal. A left lateral
oblique x-ray film of the subman
dibular region revealed an oblong
calcular shadow in the region of the
left submandibular salivary gland
(Fig. 4). The gland was excised.
The oblong, slightly curved calcu
lus was partly in Wharton’s duct
but mainly within the gland tissue.
It measured approximately 2.8 X

0. 7 . cm. As in case 2, the excised
gland showed chronic nonspecific
inflammation. Recovery was smooth
and at 2-week follow-up the patient
was well.

Discussion
Small calculi in Wharton’s duct
or in the submandibular salivary
gland are fairly common, but large
calculi are rare.1 The probable rea
son for this is that the discomfort
caused by the small calculi forces
the patient to seek medical advice
early. Large calculi may remain un
noticed for up to 50 years.2 All
three patients reported here delayed
in seeking medical advice. In fact in
case 2 it was found incidentally.
Very large calculi in the subman
dibular duct or gland are extremely
rare.1 The largest reported stone in
the submandibular duct was a
3.6-cm long cylindrical calculus.2
The largest reported stone in the
submandibular gland was 4 X 2.5
cm in diameter.3
The first of our three cases was
an unusual gigantic calculus in the
shape of a question mark, which
occupied the gland substance and
eroded through the floor of the
buccal cavity causing an orocervical
fistula. As far as we are aware, this
is the first report of an orocervical
fistula caused by a submandibular
salivary gland calculus and the sec
ond report in the world literature of
a giant calculus in the submandibu
lar gland with such an unusual
configuration.
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Hepatic Portal Venous Gas in Adults:
Importance of Ultrasonography in Early
Diagnosis and Survival
S. McFadden, MD;* W.E. Dunlop, MD
Hepatic portal venous gas (HPVG) is an ominous radiologic sign and indicates the
need for urgent surgical intervention. The causes are varied, but the commonest
and most serious is infarcted bowel. Because HPVG is difficult to detect on plain
abdominal x-ray films, more reliable methods have been sought. The authors
describe the case of a 31-year-old man to illustrate the need for and benefit of early
detection of HPVG using ultrasonography, which was instrumental in the survival
of the patient.

La presence de gaz dans la veine porte hepatique (GVPH) est un signe radiologique
de mauvais presage. Elle indique la necessite d’une intervention chirurgicale
urgente. Les causes varient, mais la plus frequente et la plus serieuse est l’infarctus
de l’intestin. Comme le GVPH est difficile a detecter sur une radiographie simple de
l’abdomen, on a recherche des techniques plus fiables. Les auteurs decrivent le cas
d’un homme de 31 ans pour illustrer la necessite et les avantages de detecter tot le
GVPH a l’aide de l’echographie, cette technique ayant contribue a sauver le patient.

venous fluids and antibiotics. His
condition worsened and after 24
hours ultrasonography was done.
This revealed evidence of hepatic
portal venous gas (Fig. 1).
At operation, the terminal small
bowel was found to be infarcted
through to the mid-transverse co
lon. The bowel was resected and an
ileostomy established. A pathologic
cause for the infarction was never
determined. He recovered after a
prolonged hospital course.

Discussion
portal venous gas
H epatic
(HPVG) was first reported in
1955 in children who had necrotiz
ing enterocolitis.1 In 1960, the first
cases were reported in adults,2 but
not until 1965 were there reports of
survivors in this age group.3-5 In
adults, HPVG usually indicates an
intra-abdominal catastrophe requir
ing urgent laparotomy.6-9 We de
scribe the case of an adult who had
HPVG and in whom ultrasonogra
phy was used for early detection.

Case Report
A 31-year-old white man was
admitted to the Calgary General

Hospital with a 3-day history of
severe epigastric pain radiating
through to his back associated with
nausea and vomiting. He was a
known heavy drinker and drug
abuser. He had undergone 37 oper
ations, beginning with an appendec
tomy, cholecystectomy and vagoto
my and pyloroplasty. No previous
operations involved a biliary-enteric
anastomosis. Results of physical ex
amination and initial laboratory
tests were in keeping with a diagno
sis of acute pancreatitis. Three
views of the abdomen showed only
nonspecific air fluid levels in the
small and large intestine, in keeping
with an ileus.
The patient was started on intra

This case demonstrates

many
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FIG. 1. Two sonograms of liver show
ing air (arrows) in portal venous sys
tem. This has characteristic bright
area of reflection and echo shadowing
distal to it.
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characteristic findings associated
with detection of HPVG — a mori
bund patient,3 -7-8 a septic focus,
most often necrotic bowel, 5 -9 and
the need for urgent laparotomy. 9 It
also demonstrates the many prob
lems of detection by conventional
methods. The plain abdominal x-ray
films in this case showed evidence
of HPVG only in retrospect, after
the ultrasonography was done. We
have presented this case to illus
trate the need for early detection of
HPVG using adjunctive radiologic
techniques, mainly ultrasonogra
phy. In the past, computed tomog
raphy has been used, 10 but this
method is expensive. One earlier
report of HPVG (in adults) , 11 indi
cated a need to determine if HPVG
could be detected by ultrasonogra
phy early enough to affect the

outcome. The case presented here
clearly indicates that ultrasonogra
phy is a reliable method and can
detect HPVG early enough to affect
treatment and outcome.
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R245
MANAGEMENT OF PYOGENIC LIVER ABSCESSES IN THE CT
ERA. C.J. Swallow, O.D. Rotstein. Department of Surgery, Toronto
General Hospital, Toronto, Ont.

The advent of CT and U /S imaging has facilitated earlier diagnosis and
management of pyogenic liver abscesses. To determine the management
and outcome of pyogenic liver abscess in the CT era, the charts of
patients with this diagnosis seen at a Toronto hospital between 1982
and 1987 were reviewed. Forty patients ranging in age from 20 to 91
years (median 63 years) were identified. Twenty-one patients (53%) had
single abscesses and 19 (47%) multiple abscesses. In four patients,
diagnosis was made at autopsy, and in six it was incidentally made at
laparotomy. In the other 30, diagnosis was made radiologically and
confirmed by needle aspiration. All patients received intravenous
antibiotics. Results: Overall mortality rate was 9 /4 0 (23%). In treated
patients (i.e., not diagnosed at autopsy), mortality was 5 /3 6 (14%).
Success was defined as clinical and radiologic improvement followed by
hospital discharge.

Treatment

N

Success rate

Mortality

IV antibiotics only
Percutaneous drainage (PCD)
Operative drainage (OD)
i) as initial therapy
ii) following PCD failure

5
16

80% (4/5)
75% (12/16)

20% (1/5)
13% (2/16)

15
2

87% (13/15)
100% (2/2)

13% (2/15)
0% (0/2)

Mortality was no different for single or multiple abscesses (14%
versus 11%). Of abscesses treated by PCD. success rate was 7 /8 (88%)
for single abscesses and 5 /8 (63%) for multiple abscesses. For OD,
success rate for single abscesses was 9 /1 0 (90%) and 6 /7 (86%) for
multiple abscesses. Two patients who failed PCD subsequently under
went successful OD. In summary, PCD was equally effective as OD for
solitary pyogenic liver abscesses. For multiple abscesses, PCD had a >
60% success rate, and failures were amenable to OD.

FFA ± SEM,
mmol
Isoproterenol
infusion
Pre-inf
Post-inf
Iso (M)
Pre-inf
Post-inf
Endotoxin
infusion
Pre-inf
Post-inf

SA ± SEM,
CPM//umol

TR (X 103 ± SEM),
/xmol/min

37.3 ± 7.0
18.4
0.63 ± 0.23
16.6 ± 4.5*
40.9
0.95 ± 0.34*
(adipose tissue stimulation)
1 0 -5
10“6
10~7
142 ± 1 3
113 ± 2 1
82 ± 15
64 ± 14*
49 ± 15*
101 ± 20*
24.2 ± 6 .5
18.1
0.46 ± 0.11
0.28 ± 0.08t
49.9 ± 12.0*
9.4
(adipose tissue stimulation)
10“ 5
10“ 6
1(T7
67 ± 18
52 ± 16
47 ± 14
143 ± 20*
70 ± 25
151 ± 33*

Iso (M)
Pre-inf
Post-inf

± 9.4
± 15.4*
1(T8
35 ± 6.4
14 ± 5.7*
± 4 .6
± 3.4 t
10~8
4 ± 6.6
59 ± 37

The isoproterenol infusion increased in-vivo lipolysis as FFA-SA
decreased and the TR doubled. The adipose tissue LF decreased,
indicating decreased betai receptor responsiveness in vitro which
supports increased betai stimulated lipolysis in vivo. The endotoxin
infusion decreased in-vivo lipolysis as SA increased and the TR
decreased. The adipose tissue LF increased indicating increased betai
receptor responsiveness in vitro which supports decreased betai stimu
lated lipolysis in vivo. This study indicates that endotoxemia produces a
decrease in betai stimulated lipolysis and may play a significant role in
the decreased betai stimulated lipolysis in the septic patient.

R247
FIBRINOLYSIS USING TISSUE PLASMINOGEN ACTIVATOR (tPA) PREVENTS INTRA-ABDOMINAL ABSCESS FORMATION. D.I.
McRitchie, O.D. Rotstein. Department of Surgery, University of
Toronto, Toronto, Ont.

R246
DECREASED BETA STIMULATED LIPOLYSIS WITH ENDOTOXEMIA. S. Meterissian, D. Saint-Vil, A. Alaud-din, R.A. Forse. Depart
ment of Surgery, Royal Victoria Hospital, McGill University, Montre
al, PQ

Lipid is a major fuel in trauma and sepsis. Previous studies have
demonstrated increased betai adrenergic stimulated lipolysis in trauma
patients. With sepsis, as with in-vitro studies using Escherichia coli
endotoxin, a decrease in betai stimulated lipolysis occurs. The aim of
this project was to study the effect of endotoxin on lipolysis in vivo.
Eleven swine had operative placement of carotid artery and bilateral
internal jugular catheters. On a separate day the animal was infused
with 14C-palmitate and then with either isoproterenol (0.75 jug/min) or
endotoxin (0.3 mg/kg). Plasma samples were obtained during the
infusion for the determination,, of free fatty acid (FFA) levels, specific
activity (SA) and turnover (TR). Adipose tissue was obtained pre and
post infusion. Betai stimulated lipolysis, using varying concentrations of
isoproterenol (10 s to 10_8M), was assayed in vitro with a dual isotope

Fibrin deposition in response to intraperitoneal infection has been
shown to serve as a nidus for abscess formation. We previously showed
that t-PA administered intraperitoneally simultaneously with the infect
ing inoculum prevented abscess formation. However, in the clinical
setting, intervention is delayed following the onset of peritonitis. The
purpose of these studies was to examine the effect of delayed t-PA
administration on abscess formation. Wistar rats were inoculated
intraperitoneally with Bacteroides fragilis enmeshed within fibrin. At t =
0, 2, 6 and 18 hours, the abdomen was openly lavaged with HBSS or
t-PA. Animals were assessed on day 5.
Tim e o f a d m in istratio n

R a te
H B SS
t-P A .01
t-P A .l

1 2 /1 2
0 /1 2
ND

W t. g
0 .3 5 (0 .0 4 )
NI)

6 h o u rs

2 h o u rs

0 h o u rs

18 h o u rs

Rate

W t. g

R ate

W t. g

R ate

W t. g

1 0 /1 2
8 /1 2
0 /9 *

0 .4 1 (0 .0 2 )
0.0 7 (0.02)*

1 5 /1 5
1 5 /1 5
1 /6 *

0 .3 3 (0.03)
0 .1 8 (0 .0 2 )b
0 .1 9

9 /9
9 /9
9 /9

0 .4 3 (0 .0 5 )
0 .3 6 (0 .0 4 )
0 .2 4 (0 .0 4 )b

a: p < 0.001 vs H B S S b: p < 0 .0 5 v s H BSS. All values: m ean (SEM)
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At t = 0, t-PA (0.01 mg/ml) obviated abscess formation. It had no
effect on abscess rate but reduced abscess size at 2 and 6 hours. Since
fibrin clots dehydrate in vivo, we hypothesized that a higher concentra
tion of t-PA might be necessary. Indeed, high-dose t-PA prevented
abscess formation and reduced mean weight when administered follow
ing a 2- and 6-hour delay. Tissue plasminogen activator after an
18-hour delay lowered abscess size but not rate, indicating partial
fibrinolysis. These studies suggest the clinical efficacy of t-PA when
administered after a bacterial insult. Its use combined with antibiotics
and appropriate surgical intervention may improve outcome in patients
with diffuse fibrinopurulent peritonitis.

R250
IN-VITRO CULTURE OF ISOLATED RAT PANCREATIC ISLETS
DEPLETES DONOR ANTIGEN PRESENTING CELLS AND PRO
LONGS ISLET ALLOGRAFT SURVIVAL. E.D. Skarsgard, R.M.
Meloche. Division of General Surgery, Department of Surgery,
University of British Columbia, Vancouver, BC

R248
ASCENDING CHOLANGITIS: SURGERY VERSUS ENDOSCOPIC
OR PERCUTANEOUS DRAINAGE OF THE COMMON BILE DUCT.
T. Lindsay, H.S. Himal. Department of Surgery, Toronto Western
Hospital, Toronto, Ont.
Ascending cholangitis has traditionally been considered a surgical
emergency. Recently, endoscopic or percutaneous drainage of the
common bile duct has been suggested as alternative therapy. To
determine whether nonsurgical therapy leads to decreased mortality, the
charts of 55 patients admitted to hospital with ascending cholangitis
were reviewed. The mean age in the surgical group (32 patients) was 72
years and 69 years in the nonsurgical group (23 patients). In the
surgical group, 8 patients presented in shock (< 80 mm Hg) and 15
patients had positive blood cultures. Twenty-seven patients underwent
cholecystectomy and common-bile-duct exploration and 5 patients
underwent only common-bile-duct exploration. Operative mortality was
6% (two patients). In the nonsurgical group, 4 patients presented in
shock and 10 patients had positive blood cultures. Thirteen patients
underwent endoscopic drainage, 1 underwent percutaneous drainage
and 9 patients had both procedures. Eight patients also had surgery
because of continuing sepsis. In the nonsurgical group the mortality
was 34% (eight patients). We conclude that surgical intervention
remains the treatment of choice for ascending cholangitis.

R249
INTESTINAL PERMEABILITY AND BACTERIAL TRANSLOCA
TION FOLLOWING ORTHOTOPIC INTESTINAL TRANSPLANTA
TION IN THE RAT. D. Hurlbut, R. Zhong, P. Wang, H. Chen, D.
Lamont, R. Behme, B. Garcia, C. Stiller, J. Duff, D. Grant. University
of Western Ontario, London, Ont.
Intestinal permeability was measured after orthotopic intestinal trans
plantation (IT) in Lewis rats with Lewis X Brown Norway-Fl allografts
(group 1). Lewis rats with isografts (group 2) and Lewis X Brown
Norway-Fl allografts treated with cyclosporine, 6 m g /k g daily, (group
3) served as controls. Pathological examination at the time of sacrifice
on the 7th postoperative day showed advanced rejection in the
untreated allografts and normal histology in the controls. Data on
intestinal permeability, measured by the % urinary clearance of 10 nC'\
of oral 51Cr-EDTA, and the mean ± SEM log of the bacteria plated from
tissue homogenates of donor mesenteric lymph nodes (MLN), liver (LIV)
and spleen (SPL) are presented below:

51C r-E D T A
u p ta k e . %
G R P 1 (n = 6)
G R P 2 (n = 6)
G R P 3 (n = 6)

10.66 ± 1.4 7 *
4 .4 7 ± 0 .5 5
4 .0 3 ± 0 .7 1

B a c t M LN
3 .6 7 ± 0 .2 1 1
1 .3 2 ± 0 .3 7
2 .5 0 ± 0 .2 2

B a c t LIV

B act S P L

3 .3 1 ± 0 .9 1
1 .1 5 ± 0 .7 1
1 .0 7 ± 0 .6 6

3 .6 5 ± 0 .3 8 +
0 .9 6 ± 0 .6 6
2 .0 4 ± 0 .3 3

*p < 0 . 0 1 . t p < 0 .0 5
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Rejection of the rat orthotopic intestinal transplant leads to increased
intestinal permeability to 51Cr-EDTA, with bacterial translocation to the
host’s reticuloendothelial system. Treatment with cyclosporine prevents
these complications. Changes in intestinal permeability may contribute
to the frequent occurrence of sepsis after clinical intestinal transplanta
tion.
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The purpose of this study was to assess the ability of tissue culture to
deplete antigen presenting cells (APCs, characterized by surface expres
sion of major histocompatibility [MHC] class II antigen) from rat
pancreatic islets and to compare the duration of culture required for
APC depletion with that necessary to achieve successful islet allotran
splantation. Sprague Dawley (RTla) rat islets were isolated using a
collagenase digestion and dextran density gradient purification. Islets,
either freshly isolated or after 4 to 14 days of culture in supplemented
Ham's F-12 medium at 37°C in 5% C02/room air, were snap frozen,
cryostat sectioned and indirectly immunostained with a monoclonal
antibody (OX-6), directed against MHC class II antigen. Fresh and
cultured islets were transplanted under the renal capsule of both
syngeneic (control) and allogeneic (Wistar Furth - RT1U) recipients.
Twelve days later the grafts were harvested, paraffin imbedded,
sectioned and stained with hematoxylin and eosin to determine the
duration of culture necessary to permit histologically successful islet
allografting. The results of these studies are summarized in the
following table:

Duration of islet culture, d

Presence of MHC class 11 + cells
Allogeneic graft (Wistar Furth)
islet integrity
mononuclear infiltrate

0

4

7

10

14

yes

yes

yes

no

no

0
+4

0
+4

0
+4

0
+4

+4
+1

As confirmation of in-vivo allograft function, 6 to 800 14-day
cultured, transplanted islets were shown to reverse, indefinitely, hyper
glycemia in recipients rendered diabetic by treatment with intravenous
streptozotocin (50 mg/kg). In conclusion, tissue culture of isolated rat
pancreatic islets results in the depletion of MHC class II positive
“antigen presenting cells”, as determined by immunostaining. The
temporal disparity that exists between duration of culture required for
APC depletion and that which allows successful allografting, suggests
that tissue culture may impose some additional tissue alteration that
results in diminished graft immunogenicity.

R251
THE ROLE OF CLARK’S MEASUREMENT AS A PROGNOSTIC
INDICATOR IN THIN MELANOMA. L.A. Pontikes, W.J. Temple, S.
Cassar, S. Huchcroft, M. Jerry, R. Lafreniere. University of Calgary/
Tom Baker Cancer Centre, Calgary, Alta.
Previous literature has shown that Breslow’s measurement of primary
melanoma depth may be more important than Clark’s level of melanoma
invasion in predicting risk of recurrence. Our study attempts to

CAGS

determine the influence of these two parameters on recurrence risk in
the subgroup of thin melanomas (i.e., less than or equal to 1.0 mm).
We studied 215 cases of stage 1 melanoma of tumour depth less than
or equal to 1.0 mm. In each of these cases, both Clark’s level and
Breslow’s tumour thickness could be determined. Mean follow-up time
was 41 months.
Each case was categorized by level (II to V), depth (from 0 to 1 mm in
0.25-mm increments), site (head and neck, trunk or extremities) and by
sex. Recurrence and metastases were documented and correlated to
these variables.
Overall recurrence rate was 10.7% (23 cases). Risk of recurrence was
influenced by each of the variables of level (p < 0.002), site (p < 0.04)
and depth (p < 0.02) of the primary tumour. Discriminant function
analysis showed that Clark’s level was the single most predictive
variable and that the additive interaction of level with site was the best
prognostic indicator of risk of recurrence. The interactive effect of level
and head and neck location of the primary tumour gave the highest risk
of recurrence. After the effects of level and site, Breslow’s depth failed
to add predictive power.
It appears that measurement of Clark’s levels is an important
prognostic indicator in thin melanoma for identifying a subgroup of
high-risk patients in whom further therapy may be appropriate.

R252
IMMUNE RESPONSES IN SMALL INTESTINAL TRANSPLANTA
TION (SIT). P. Kim, Z. Cohen, M. Craig, G. Levy. Department of
Surgery, University of Toronto, Toronto, Ont.

(LPD, K+ = 4 mmol/L, Dextran-40 = 20 g /L ) is capable of providing
superior immediate lung function compared with the commonly used
Euro-Collins solution following preservation for 12 hours. High potassi
um concentrations cause pulmonary vasospasm and have been implicat
ed in cellular injury during hypothermic storage. Dextran-40 has been
shown to improve microvascular flow under various conditions. This
study was designed to determine the contribution of a low potassium
concentration and dextran to the improved preservation seen with LPD.
The function of canine left lung allografts stored for 12 hours following
pulmonary artery (PA) flush preservation was studied in a randomized,
blinded study. Animals were assigned to groups according to the
composition of the flush solution: I: LPD (n = 6); II: LP - low potassium
(4 mmol/L) without dextran (n = 6); and III: HPD - high potassium
(123 mmol/L) dextran (n = 6).
The LPD solution provided significantly better immediate gas ex
change by the transplanted lung (P02: 519 ± 12 mm Hg, mean ± SEM,
F ^ = 1.0) than the LP (P02: 243 ± 78 mm Hg, p < 0.05) and the HPD
(P02: 176 ± 79 mm Hg, p < 0.01) solutions. There were two early
postoperative deaths in group III related to poor preservation. The P 02
was excellent for all animals on day 3. Pulmonary vascular resistance
and PCO2 were not different among the groups immediately or at day 3.
On histopathological examination, 9 /1 0 airways in the dextran-containing groups (LPD, HPD) were viable, whereas only 2 /6 in the LP group
were viable. These results confirm our hypothesis that Dextran-40 and a
low potassium concentration contribute significantly to the uniformly
excellent function of a transplanted lung preserved for 12 hours with
LPD.

R254
Monocyte procoagulant activity (PCA) has been shown in our laboratory
to be a sensitive marker of rejection in rat SIT. We have now studied
PCA changes in peripheral blood mononuclear cells (PBMs), graft
mesenteric nodes (GM) and graft intraepithelial lymphoid cells (IEC) in
rat SIT in order to study the sequence of this immune response during
rejection. Group 1 consisted of 32 syngeneic transplants (Lew graftsLew hosts). Group 2 consisted of 32 allogeneic transplants using a
unidirectional rejection model of rat SIT (Lew hosts-Lew X BN Fi
graft). Sixteen rats in each group were treated and 16 received
cyclosporine (CsA) 10 m g/kg daily subcutaneously for 7 days. Rats
were serially sacrificed, and complete necropsies performed. Blood,
mesenteric nodes and graft intestine were harvested, and lymphoid cells
from each were isolated and assayed for PCA in a one-stage clotting
assay. In group 1 (syngeneic grafts) PCA levels were not significantly
different for treated and untreated animals. In group 2 untreated
allogeneic transplants, statistically significant changes in PCA occurred
initially in the graft nodes to 278.3 ± 51.3 mU /106 isolated cells on
day 4-5 followed by 3- and 10-fold increases of PCA to 302.3 ± 122
and 1720.0 ± 540 mU /106 isolated cells in PBM and IEC on day 7-8
respectively (p < 0.01 as compared to CsA treated group 2 allogeneic
transplants). Cyclosporine fully suppressed PCA in group 2 allografts to
levels comparable to group 1 syngeneic transplants. In conclusion, (a)
an early rise in PCA level in the graft mesenteric lymph nodes marks the
onset of immune response in intestinal allograft rejection and has a
predictive value for incipient rejection, (b) PCA is a sensitive and
accurate marker of immune response closely correlating with clinical
and histopathological changes of rejection, and (c) CsA fully suppresses
alloantigen activation of PCA in vivo.

GENERAL SURGICAL PROCEDURES AFTER HEART TRANS
PLANTATION. J. Yee, D. Petsikas, M.A. Ricci, A. Guerraty. McGill
University, Royal Victoria Hospital, Montreal, PQ
Seventy-one cardiac transplantations were performed at the Royal
Victoria Hospital between January 1985 and March 1989. Perioperative
mortality was 10.5%. Overall survival was 80.3%. Among the long-term
survivors, a total of 14 patients (24.5%) underwent major noncardiac
surgical procedures under general anesthesia. Seven patients (12.5%)
had emergency laparotomies, of which four were for biliary tract
disease, one for ruptured abdominal aortic aneurysm, one for pancreati
tis and one for Escherichia coli enterocolitis. Elective surgical interven
tions included the repair of symptomatic abdominal wall hernias (two),
hemorrhoids or perianal condylomata (three), hip replacement (one) and
maxillary sinus drainage (one).
Preoperatively, all patients were on oral cyclosporine. Seven of the 14
patients studied were on triple-drug immunosuppression consisting of
cyclosporine, azathioprine and low-dose prednisone. One patient was
only on cyclosporine, while all the remainder used both cyclosporine
and prednisone.
There were no deaths. Complications were limited to residual
choledocholithiasis, treated with percutaneous drainage, and a superfi
cial wound infection. Immunosuppression was lower perioperatively and
acute rejection was monitored by myocardial biopsies. Our experience
indicates that noncardiac surgical procedures under general anesthesia
may be safely performed in heart transplant patients.

R255
R253
THE ROLE OF DEXTRAN-40 AND POTASSIUM IN LUNG PRES
ERVATION FOR TRANSPLANTATION. S.H. Keshavjee, F. Yamazaki, H. Yokomise, P. Cardoso, J.B.M. Mullen, A.S. Slutsky, G.A.
Patterson. Department of Surgery, University of Toronto, Toronto,
Ont.
We have previously demonstrated that a low potassium dextran solution

MANAGEMENT OF LARGE COLORECTAL POLYPS. D. Bernard, S.
Morgan, D. Tasse, R. Wassef. Department of Surgery, Universite de
Montreal, Division of Gastrointestinal Surgery, Hopital St-Luc, Mon
treal, PQ
Before the advent of colonoscopy (Cs), polyps over 1 to 1.2 cm as seen
on barium enemas were candidates for laparotomy. With Cs, nearly all
polyps under 2 cm in size can be removed at endoscopy. What about the
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larger ones? Out of a total of 1743 polyps found at Cs, 167 (9.6%) in
152 patients were > 2 cm in size. Colonoscopic excision was achieved
in 112 (74%) patients: a total of 118 polyps (90 under 3 cm and 28 over
3 cm in size). Pathology revealed adenomas in 107 (13 containing
in-situ and 8 invasive carcinoma), hyperplastic polyps in 4, juvenile in 2,
hamartoma in 1, angioma in 1 and adenocarcinoma in 3. Thirty-eight
percent of adenomas were tubulovillous and 18% villous. Eight required
a piecemeal excision technique during one to four sessions. There were
no perforations or transmural burns, but eight patients presented with
post-polypectomy bleeding (six early, two late); six stopped bleeding
spontaneously and two required recoagulation of the base of the polyp.
None was given blood. Colonoscopic excision was not attempted in 40
patients (26%) because of the following reasons: too large and/or
sessile, 13; suspicion of malignancy, 3; synchronous cancer, 6; divertic
ular disease, 2; multiple, 2; other approaches preferred, 11 (transanal 9,
Kraske 2) and miscellaneous reasons, 3. Conclusion: unless an indica
tion for another approach becomes dominant, because of their size,
location or concomitant pathology, the majority of large adenomas can
be removed through colonoscopy with a lesser risk and disability than
any surgical procedure and with a low complication rate.

R256
LASER FULGURATION FOR RECTAL TUMOURS. P.L. Birnbaum,
C.D. Mercer. Queen’s University, Kingston, Ont.

Nd-YAG laser fulguration of rectal tumours was used for palliation in
15 patients (7 females, 8 males), average age 75 ± 3 years (range 67 to
93 years). Eight required general anesthesia and seven local anesthesia.
Indications for laser treatment include palliation in nine patients with
diffuse metastases; four refused operative therapy and two were
medically unfit for surgery. Ten patients presented with bleeding with
or without tenesmus, 3 had obstruction and 2 were asymptomatic. Four
patients had previous surgery and two received radiotherapy. The
tumours were on average 7.6 ± 1.3 cm (range from 0 to 15 cm) from
anal verge. Adenocarcinoma was present in 14 patients and villous
adenoma in 1. The average energy used was 5525 ± 945 J (range 1000
to 11 000 J). Thirteen patients had successful reversal of preoperative
symptoms immediately after laser treatment. One patient with circum
ferential predominantly extrinsic tumour did not benefit from treatment.
Mean post-laser stay was 4.5 ± 1.2 days (range 0 to 11 days). Seven
patients underwent subsequent treatment at an average of 145 ± 75
days (range 3 to 485 days) following initial procedure. Mean follow-up
was 6.4 months (range 3 to 19 months) in 13 patients. Six patients
were free of local tumour symptoms; three died of carcinomatosis with
good palliation of local symptoms; four developed recurrence of
tenesmus. The Nd-YAG laser provides effective nonoperative palliation
for patients with obstructing or bleeding rectal tumours. Palliation of
tenesmus is not as frequent or lasting.

results are presented, in part, as mean ± SEM (*p < 0.01 versus
preoperative by paired f-test):
Postop
Preoperative
V02. ml/min
227 ± 8
VC02. ml/min
191 ± 6
Serum cortisol, nmol, 1, 463 ± 31
Serum glucose. mmol/L 5.3 ± 0.1
Serum insulin. pmol/L
78 ± 7
WBC. cells/mm3
6.6 ± 0.3
Serum CRP, mg/L
8 ± 2

6h
271
209
881
8.1
99
16.3
18

±
±
±
±
±
±
±

Day 1
11* 264 ±
9*
204 ±
82* 568 ±
0.3* 6.5 ±
13
145 ±
1.4* 11.6 ±
8
77 ±

9
7
51
0.3
18*
0.6
10

Day 2
274
213
528
6.2
100
11.1
119

± 9
± 7
± 29
± 0.2
± 12
± 0.7
± 10*

Day 3
267 ± 8
207 ± 6
5.9
97
9.4
99

±
±
±
±

0.2
8
0.5
9

Mean patient age was 62 ± 2 years (range 43 to 77 years), weight
76.8 ± 2.1 kg and TBW 40.5 ± 1.1 (48% to 60% body weight). Age
was not related to weight, TBW, diagnosis or duration of operation.
Preoperative oxygen consumption (V02) was strongly related to TBW
and age (31.9 + 6.1 X TBW - 0.9 X age, r2 = 0.80. p < 0.001). as
were CO2 production (VCO2) and energy expenditure (EE). Postoperative
(6 hours to day 3) V02 and VCO2 values were not different by ANOVA.
Postoperative V02, VCO2 and peak serum cortisol, glucose, insulin and
C-reactive protein and WBC were all significantly greater than preopera
tive values. V02, VCO2 and EE responses to operation (absolute or %
preoperative) were unrelated to age, diagnosis or duration of operation.
Serum insulin, but not glucose, was increased with age (r2 = 0.29, p <
0.05) 6 hours postoperatively: neither was related to any variable at
other times. Postoperative hospital stay, WBC and serum cortisol and
CRP were unrelated to age. diagnosis or duration of operation.
We conclude that unstressed, preoperative energy expenditure is a
function of TBW and age, which together reflect body cell mass.
Advancing age may be associated with minor changes in postoperative
carbohydrate metabolism, but energy expenditure and other responses
are unaltered. Age effects may be important in patients older than those
studied or in a setting of more severe or prolonged stress.
(Supported by the Medical Research Council of Canada and Ontario
Ministry of Health.)

R258
ALTERED CELLULAR IMMUNE FUNCTION IN THE ATELECTAT
IC LUNG. D. Nguyen, H. Shennib, D.S. Mulder. McGill Lung
Transplant Program, The Montreal General Hospital, Montreal, PQ

Lung atelectasis is a common component of many lung injuries. With
the surge of interest in bronchoalveolar lavage (BAL) as a method of
differentiating types of lung pathology, knowledge of changes in BAL
cell phenotype and function due to atelectasis becomes essential. We
studied cell phenotypes, natural killer (NK) and nonspecific lectinmediated cytotoxicity (CTL) in BAL and peripheral blood (PBL)
monocells from normal and atelectatic lower lobes in two groups of
dogs (n = 8 in each). Results are expressed as percentage of control.

Results:
R257

NK Activity

THE EFFECT OF AGE AND BODY COMPOSITION ON THE
METABOLIC RESPONSES TO ELECTIVE SURGERY. D. Desai,
M.L. Redmond, R.J. March, J.M. Watters. Department of Surgery,
University of Ottawa, Ottawa Civic Hospital, Ottawa, Ont.

To evaluate the effects of age and body composition on the metabolic
responses to surgery, we studied 20 generally healthy, active, independ
ent nondiabetic males undergoing elective colonic resection. Total body
water (TBW) was determined preoperatively in 17 patients by dilution
of ,8oxygen-water. Respiratory gas exchange and other measurements
were made daily at 07:00 hours from the morning prior to surgery until
the third postoperative day, as well as 6 hours postoperatively. The
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Effector/target
50:1
25:1
12:1

BAL*
62.7 ± 9.8
58.1 ± 9.6
48.0 ± 8.6

CTL Activity
PBL*

BAL*

PBL*

166.7 ± 9.2
155.3 ± 12.5
166.0 ± 12.0

61.5 ± 12.8
69.5 ± 17.4
71.1 ± 14.2

144.7 ± 17
145.8 ± 20.8
162.5 ± 6.2

*p < 0.01

While NK and CTL activity in the unaffected contralateral lungs were
comparable to control values, NK and CTL were significantly impaired
in the atelectatic lungs. This was associated with an influx of new cells
predominantly polymorphonuclear leukocytes. The simultaneous signifi
cant increase in NK and CTL activity in PBL in atelectatic animals
signifies the discrepancy in immune response in the systemic and lung

CAGS

compartments. Moreover, such impairment of local pulmonary cellular
defences may render atelectatic lungs more susceptible to infection.

R259
RELIABILITY AND CONSTRUCT VALIDITY OF THE OBJECTIVE
STRUCTURED CLINICAL EXAMINATION (OSCE) IN ASSESSING
SURGICAL RESIDENTS. R. Cohen, R. Reznick, B. Taylor, J. Provan.
Department of Surgery, University of Toronto, Toronto, Ont.

The purpose of this research was to assess reliability and construct
validity of the OSCE for assessing surgical residents. Reliability refers to
precision of the examination and construct validity to the degree to
which the examination can discriminate different levels of training.
Twenty-seven PGY-2 surgical residents took a 38-station OSCE repre
senting eight surgical specialties and testing history-taking, physical
examination, problem solving, technical skills and attitudes. A couplet
methodology was used wherein a simulated patient encounter was
followed by questions aimed at testing problem solving and patient
management capabilities. Thirty-six actors trained as standardized
patients and 34 surgeons served as examiners, marking from structured
checklists. Overall reliability, Cronbach’s Alpha, was 0.89. Construct
validity was examined comparing the scores of the residents to a group
of graduates of foreign medical colleges applying for pre-internship. For
17/19 stations which both groups took, the residents performed
significantly better, p < 0.01. Individual station validity was significant
for 3 2 /3 8 stations, r = 0.36 to 0.82, p < 0.05. The examination took
3.83 hours at a cost of $5293. The OSCE has been shown to be a
reliable method of assessing clinical skills of surgical residents,
construct validity has been established and inter-item validity confirmed.
The reliabilities achieved are in excess of those traditionally required for
both acceptance and promotion decisions.

R260
SKIN/MYOCUTANEOUS FLAP ISCHEMIA AND ALTERED NEU
TROPHIL FUNCTION. C. Lee, C.L. Kerrigan, J.M. Tellado. Mi
crosurgery Laboratory, Royal Victoria Hospital, McGill University,
Montreal, PQ

The neutrophil has been implicated as a source of oxygen-free radicals
in reperfusion injury of ischemic tissue. A two-phase study was
designed (1) to examine neutrophils perfusing ischemic tissue for
superoxide production and (2) to determine neutrophil delivery to
ischemic tissue. Exp. 1: Bilateral isolated latissimus dorsi musculocu
taneous (LD) regions, with thoracodorsal vascular supply, were created
in 17 pigs. One LD in each pig was randomized to a 6- or 8-hour
ischemic period. Neutrophils isolated from LD venous effluent at
reperfusion were assayed for superoxide production with PMA stimula
tion. Exp. 2: Bilateral LD were created in six pigs. One LD in each pig
was randomized to a 6-hour ischemic period. Isolated blood neutrophils
were radiolabelled with indium-111 and autotransfused prior to reperfu
sion. Radioactivity was measured at 24 hours. Results Exp. 1: PMA
stimulated neutrophils from venous effluent of ischemic tissue during
the immediate reperfusion period showed a 64% ± 26% (p = 0.01) and
15% ± 7% (p = 0.02) increase in production of superoxide radical over
control values at 5- and 15-minute incubations respectively. Blood
neutrophil counts from the immediate reperfusion period showed
ischemic LD to sequester more neutrophils per gram hemoglobin
perfusing the tissue than contralateral controls, respectively 22.2 ± 4.2
versus 5.3 =t 5.3 millions of neutrophils/g hemoglobin (p = 0.00006).
Results Exp. 2: Radioactivity in ischemic LD was increased by 101% ±
30% (p = 0.01) over nonischemic LD.
Conclusions: (1) Neutrophil superoxide production exhibited an
accelerated release of superoxide radical to PMA stimulation immediate
ly following an ischemic insult. (2) Neutrophil delivery to ischemic
tissue was increased; this began in the immediate reperfusion period.

The increased delivery and enhanced functional response to neutrophils
induced by ischemia can in part explain the mediation of reperfusion
injury.

R261
IBUPROFEN; POTENT SALVAGE OF ISCHEMIC/REPERFUSED
MUSCLE. C. Lee, C.L. Kerrigan. Microsurgery Research Laboratory,
Royal Victoria Hospital, McGill University, Montreal, PQ

Acute arterial impairment can lead to disastrous results. Short of early
revascularization, there are few effective modalities for salvaging
ischemic tissue. This study examined the drug ibuprofen as a protective
agent in ischemia/reperfusion insults to skeletal muscle and skin.
Two pigs were dosed with 6.25, 12.5 and 25 m g /k g of ibuprofen.
Using HPLC to determine serum drug levels, a crude pharmacokinetic
profile was constructed. The serum half life was 2 hours, and a dose of
25 m g/kg of ibuprofen was selected.
Ten pigs were subjected to two operations so that each pig served as
its own control. At both operations unilateral latissimus dorsi (LD)
myocutaneous flaps and buttock skin flaps were elevated and subjected
to 6 hours of ischemia. Beginning intraoperatively, animals were treated
with either ibuprofen or placebo every 8 hours for 2 days. A 24-hour
“drug-free period” ensued to allow clearing of residual drug. The
alternate treatment was then instituted for the second operation. Skin
survival estimation was aided by intravenous fluorescein injection and
Wood’s lamp illumination. Determinations of muscle viability were aided
by nitroblue tetrazolium staining.
Results: Ibuprofen treatment dramatically improved the area of LD
muscle survival by 30.4% ± 9.3% (p = 0.005). Latissimus dorsi skin
survival was modestly improved by ibuprofen treatment, with a 6.0% ±
3.2% (p = 0.046) measured increase in area survival. Buttock skin
survival was not improved. Survival was unaffected by treatment order.
Conclusions: Ibuprofen showed effective salvage of ischemia/reperfused LD muscle. A modest improvement of LD skin survival without
improvement of buttock skin survival, suggests a primary muscle
salvage with indirect secondary benefit to the overlying LD skin.

R262
RESUSCITATION OF A SWINE HEMORRHAGE MODEL WITH
HYPERTONIC SALINE-DEXTRAN SOLUTION: COMPARISON OF
BIOCHEMICAL PARAMETERS WITH SALINE RESUSCITATION.
H. Chyczij, A. Hayashi, S. Hamilton. Department of Surgery, Universi
ty of Alberta, Edmonton, Alta.

Hypertonic saline (7.5%) and Dextran-70 (6%) solution is being
promoted as an effective fluid for resuscitation of trauma patients.
Using an anesthetized swine hemorrhage model we compared changes
in blood and mesenteric lymph biochemistry during resuscitation
between controls (n = 9), a saline group (NS, n = 7) and a hypertonic
saline and dextran group (HSD, n = 8).
Swine of either sex (30 to 40 kg) were anesthetized with barbituates
and underwent placement of arterial, venous and mesenteric lymphatic
catheters. The animal was bled 20 m l/kg (30%) over 15 minutes and
observed for 6 hours. In the experimental groups resuscitation began
30 minutes after hemorrhage (NS = 60 ml/kg; HSD = 4 m l/kg).
Samples of lymph and venous blood were obtained at 15, 45, 75, 105
and 195 minutes after resuscitation began. The blood and lymph
samples were analysed for sodium (Na), chloride (Cl) and osmolarity
(Osm). A sustained significant rise occurred in the blood Cl in both NS
(107.4 ± 2 versus 97.8 ± 1, p < 0.02) and HSD (105.8 ± 3 versus 97.8
± 1, p < 0.05) resuscitation. There was no significant change in lymph
Cl in either group. Blood Na rose significantly in the HSD group at 105
minutes, but subsequently returned to normal. Lymph Na was un
changed. Blood Osm was significantly decreased in the NS group (248
± 19 mOsm versus 283 ± 8 mOsm, p < 0.03) and unchanged in the
HSD group.
CJS, VOL. 32, NO. 4, JU L Y 1989
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In conclusion, despite its hypertoxicity, HSD does not induce
significant biochemical changes in the blood or in the extracellular fluid
(lymph). It has the advantage over NS in being effective at much smaller
volumes.

R263
INTESTINAL PERMEABILITY IN CRITICAL ILLNESS AND
TRAUMA — EXPERIMENTAL AND CLINICAL OBSERVATIONS.
D. Hurlbut, D. Lamont, R. Zhong, P. Wang, H. Chen, B. Garcia, W.
Vezina, D. Grant, J. Duff. University of Western Ontario, London,
Ont.

Critical illness and trauma may impair gut barrier function (GBF),
resulting in systemic “soiling” by gut bacteria and intraluminal toxins.
Impaired GBF may be a factor in the development of multiorgan failure
(MOF). Gut barrier function was assessed in the following experimental
and clinical studies to test these hypotheses.
Percent 24-hour urinary excretion of a 10-/xCi oral dose of chromium-51 ethylenediaminetetraacetate (51Cr-EDTA) was measured in male
Sprague-Dawley rats after the following insults of graded severity:
normal controls (NL); anesthesia alone (AN); surgical trauma (ST) from
intestinal manipulation; reversible hemorrhagic shock (HS) to MAP of
40 mm Hg X 90 minutes; and S. typhosa endotoxin (ET) 250
intravenous push. Intestinal permeability was significantly increased in
the HS and ET groups compared with NL; AN and ST rats had
intermediate values.
Intestinal permeability was measured in 16 patients with MOF (three
or more failing organ systems), 7 patients 1 day post-aortocoronary
bypass (ACB) and 10 normal subjects (controls). Permeability to 51CrEDTA was greatest for MOF patients (3.68 ± 0.56) versus controls
(1.55 ± 0.18) (p < 0.05). Permeability for ACB was elevated but not
different from controls. There was no correlation between uptake and
MOF severity scores (Goris, Apache II).
Shock in rats and critical illness in man are associated with impaired
GBF. Prospective, sequential measurements in stressed patients may
help to determine if impaired GBF is an etiologic factor in MOF.

R264
ANORECTAL INCONTINENCE MANOMETRY AND SURGICAL
RESULTS. J. Yelle, M. Wells, J. Freeman. Division of General
Surgery, Ottawa General Hospital, University of Ottawa, Ottawa, Ont.

Manometry, electromyography (EMG) and proctography were performed
on 51 incontinent patients over 18 months. Twenty-five had correctable
surgical causes; 26 were treated by physiotherapy and operant condi
tioning. The surgical procedures were: anterior resection for prolapse —
5; anterior external sphincter repair only — 10, with rectovaginal fistula
repair — 6 or with sigmoid colostomy for sphincter trauma — 3;
post-anal repair — 2; and rectocele repair — 1. Manometry and EMG
were performed preoperatively and over a mean 7.1 month postoperative
period.
There were no major complications. No patient was made worse with
respect to continence or manometric readings. Two wound infections
delayed discharge 6 days. One patient required sphincter repair after low
anterior resection for prolapse with incontinence. Two were lost to
follow-up. The remaining 23 improved as follows: completely continent
— 9; continent with occasional straining or urgency — 5; intermittent
incontinence to liquid stool an d /o r gas — 5; incontinent to air — 4.
Mean resting pressure increased from 25 to 30 mm Hg. Average
squeeze pressure improved from 48 to 54 mm Hg. These averages do
not reflect the marked improvements in individuals, particularly those
followed with serial manometry for more than 6 months. Electromyo
graphic mapping detected anterior sphincter weaknesses in patients
with apparent simple rectovaginal fistulas.
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R265
TRIPLE HEMORRHOID BANDING IS A SAFE OFFICE PROCE
DURE. M. Wells, P. Makarewicz, J. Freeman. Division of General
Surgery, Ottawa General Hospital, University of Ottawa, Ottawa, Ont.

Band ligation is the treatment of choice for hemorrhoids. To avoid
complications, many surgeons band only one or two per session. We
postulated that complications are unrelated to the number of hemor
rhoids banded.
Thirty-seven patients had triple band ligation and were studied
prospectively over 6 months. All had hemorrhoids unresponsive to
conservative treatment. After ligation each hemorrhoidal base and its tip
superior to the band were injected with 0.5 ml of sodium tetradecyl
chloride.
There were no major complications. Four of 37 were lost to
follow-up. Eight of 33 (24.2%) had minor complications. Bleeding, alone
or with pain, occurred in 7 /8 8 ; 1 patient had a vasovagal attack. All
eight were managed in the office. At 6 months, 26/33 (78.8%) had
excellent or good results. Results were fair in 3 /3 3 (9.1%). These
patients required local medications only. Results were poor in 4 /3 3
(12.1%). All were cured after further banding. No patient required
surgery. Since study completion 2 years ago, 150 patients have had
triple ligation without incident.
Triple ligation is not associated with complication rates higher than
those previously reported after single or double ligation. Pelvic sepsis is
apparently unrelated to the number of hemorrhoids banded and more
likely caused by grasping rectal wall rather than mucosa.

R266
THE SURGICAL MANAGEMENT OF RADIATION BOWEL INJURY
AS A CONSEQUENCE OF TREATMENT OF CERVICAL CARCINO
MA. A. Covens, G. Thomas, A. DePetrillo, C. Jamieson. University of
Toronto, Toronto, Ont.

A retrospective chart review of 57 patients requiring surgery for
radiation-induced bowel damage as a consequence of treatment of
cervical carcinoma (RIBD-CX) during the years 1968 to 1988 was
performed to determine whether any prognostic factors could be
identified to provide the surgeon with guidelines on which to base
management decisions. Actuarial 5-year survival rates for the various
sites and types of injuries are listed below.

Site of injury

N

Rectosigmoid
Sigmoid
Rectum
Ileum
Multiple

8
14
11
14
9

5-year
survival, % Type of injury
88
67
58
41
22

Stricture
Fistula
Inflammation
Perforation
Multiple

N

5-year
survival, %

18
5
7
11
15

82
75
71
46
23

Age, stage of cervical cancer, previous surgery, year of radiation,
dose of external and intracavitary radiation, number of fractions,
radiation-surgery interval, site and type of bowel injury and type of
surgery were all subjected to univariate and multivariate analysis.
Univariate analysis revealed both site and type of injury to be
statistically significant (p < 0.02, p < 0.001 respectively). The only
independent variable for survival on multivariate analysis was type of
injury (p = 0.0001). Treatment-related mortality in patients requiring
surgery for RIBD-CX was 26%. Of surviving patients, 40% required a
second and third surgical procedure for ongoing radiation damage.
Fifty-eight percent (15/26) of the deaths were due to treatment
complications. Future efforts should be aimed towards prevention of
this disorder.

CSCTS
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R48
PLEUROPULMONARY COMPLICATIONS FOLLOWING CORO
NARY ARTERY BYPASS: INTERNAL THORACIC ARTERY VER
SUS SAPHENOUS VEIN GRAFT. D. Hurlbut, M.L. Myers, M. Lefcoe,
M.M. Goldbach. Victoria Hospital, University of Western Ontario,
London, Ont.

Use of the internal thoracic artery (ITA) as a coronary bypass (CB) graft
results in excellent patency rates and improved symptomatic relief and
survival. Clinical observations at this centre, however, had suggested an
increased incidence of pleuropulmonary complications in patients in
whom the ITA was utilized. One hundred consecutive patients with left
ITA grafts were studied prospectively and compared with a consecutive
retrospective group of 100 patients undergoing CB with saphenous vein
grafts (SVG) only. Preoperative, postoperative day (POD) 2, and POD 6
chest x-rays were scored in a blinded fashion by a radiologist using a 0
to 3 scale for each of atelectasis and effusion. There were no significant
differences between SVG and ITA groups respectively with regard to
percentage male (84%, 91%), number of grafts (2.9 ± 0.1. 2.9 ± 0.1),
ischemic time (43.3 ± 1.3, 47.2 ± 1.6 min) or bypass time (88.1 ± 2.4,
92.3 ± 3.0 min). The mean age of the ITA group was greater: 58.7 ±
0.9 versus 54.7 ± 0.8 years, p < 0.01. The SVG group was ventilated
longer postoperatively (25.7 ± 0.8 versus 21.9 ± 0.6 hours, p < 0.01)
and had more mediastinal chest-tube drainage (1088 ± 48 versus 942 ±
38 ml, p < 0.02). There were no significant differences between the
groups with respect to effusion or atelectasis except a significantly
higher incidence of small effusions at POD 6 in the ITA group (p <
0.05). Thoracentesis and secondary chest-tube insertion for recurrent
large effusion were required in two and one patient respectively in the
ITA group. Postoperative hospital stay was actually shorter in the ITA
group (9.9 ± 0.3 versus 10.9 ± 0.3 days). We conclude that use of the
ITA results in a small increase in postoperative effusion, but this does
not appear to lengthen hospital stay.

reoperation it was 93.5% ± 2.8% for AVR and 83.1% ± 5.1% for MVR
at 4 years. The freedom from the composite of all valve-related
complications at 4 years was 81.1% ± 4.2% for AVR and 75.3% ± 5.8%
for MVR. The Mitral Medical Mitroflow valve has provided satisfactory
clinical performance at the early stage of evaluation of 4 years. The
pericardial prosthesis performance favoured aortic over mitral prostheses with regard to structural valve deterioration.

R50
SPINAL CORD PROTECTION BY BALLOON OCCLUSION OF THE
DISTAL AORTA DURING PROXIMAL AORTIC CROSS-CLAMP
ING. H. Iida, Y.S. Sun, R.M. Lust, P.A. Spence, S.B. Pollock, J.M.
Williams, E.H. Austin. Division of Cardiac Surgery, East Carolina
University School of Medicine, Greenville, NC

Irreversible spinal cord hypoperfusion injury after proximal aortic
cross-clamping remains a major problem. The pressure in the distal
thoracic aorta is low because collaterals are normally poorly developed
and the distal runoff for this limited flow is immense. This experiment
was conducted to assess the effectiveness of restricting the distal aortic
runoff to the thoracic segment by balloon occlusion of the entire
abdominal aorta. After proximal aortic cross-clamping, the abdominal
aorta was occluded by a balloon in 8 of 16 dogs (18 to 25 kg) with the
remaining dogs serving as controls (CON). Mean pressures were
measured in the ascending aorta (ASC), thoracic aorta (TH) and the
cerebrospinal fluid (CSF) at baseline and every 10 minutes after
cross-clamping (XC). The data demonstrate considerably higher TH
pressures and spinal cord perfusion gradients (SCPG) in the animals
with balloon occlusion.

R49
PERICARDIUM FOR AORTIC OR MITRAL VALVULAR SUBSTI
TUTE — THE MITROFLOW EXPERIENCE. W.R.E. Jamieson, C.L.
Pelletier, J. Pomar. Vancouver and Montreal, Canada, and Barcelona,
Spain

The Mitral Medical Mitroflow pericardial prosthesis was implanted in
354 patients between 1983 and 1987 at three centres. The mean age of
the patients was 60.1 years (range 14 to 94 years). The early mortality
was 5.7% and the late mortality was 2.9% per patient-year. The total
cumulative follow-up was 853 years, a mean of 2.4 years. The patient
survival for AVR was 81.5% and for MVR was 74.8% at 4 years. The
overall rate of valve-related complications was 4.8% per patient-year
(41): thromboembolism 15; anti-thromboembolic therapy-related he
morrhage 1; prosthetic valve endocarditis 15; nonstructural dysfunction
3; and structural valve deterioration 7. There were 17 valve-related
reoperations. There were seven valve-related deaths (thromboembolism
1, hemorrhage 1, prosthetic valve endocarditis 4 and structural valve
deterioration 1). The freedom from thromboembolism was 91.5% ±
2.7% for AVR and 91.4% ± 4.0% for MVR at 4 years. The freedom from
prosthetic valve endocarditis at the same time interval was 93.5% ±
2.3% for AVR and 94.0% ± 2.9% for MVR. The freedom from structural
valve deterioration was 97.3% ± 2.1% and 92.6% ± 3.2% for AVR and
MVR, respectively, at 4 years. The freedom from valve-related mortality
was 96.9% ± 1.4% for AVR and 97.5% ± 1.8% for MVR, while for
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We conclude that distal aortic balloon occlusion significantly im
proves thoracic aortic pressure and spinal cord perfusion gradient after
proximal aortic cross-clamping. This may be a simple method to protect
the spinal cord during aortic surgery.

R51
DELAYED CARDIAC TAMPONADE. W.T. Kidd, A.S. Goldstein.
Department of Surgery, University of Calgary, Calgary, Alta.

Delayed cardiac tamponade is a rare but potentially lethal complication
of open-heart surgery. The pathophysiology and management are still
open to question. This review was done in an attempt to answer these
questions.
Fourteen cases of delayed cardiac tamponade after open-heart
surgery were analysed retrospectively from 1978 to the present. The
operations performed included valve replacement in 11 patients, coro
nary artery bypass grafting in 1 and miscellaneous procedures in 2
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patients. In 9 of 14 patients the diagnosis was suspected and confirmed
immediately. However, five patients were treated as “low output
syndrome” while still in hospital and all had a delay in diagnosis.
Coumadin anticoagulation was used in 11 of 14 patients and 7 of these
11 patients had excessively prolonged prothrombin times (greater than
two times normal).
Treatment consisted of an open surgical procedure in 12 patients and
needle pericardiocentesis combined with tube drainage in 2 patients.
The mortality rate in this series was 7% with no deaths in the group
with a delay in diagnosis.
This study confirms that most patients with delayed tamponade are
anticoagulated, but not always excessively. Appropriate management is
open surgical drainage which ensures a low mortality rate.

surgery or death in 97% of the cases (168/173 patients). Postoperative
complications revealed 33 cases of renal failure, 11 cases of respiratory
failure, 11 cases of ischemic colitis, 8 cases of trash foot, 8 cases of
gastrointestinal hemorrhage, 6 cases of septicemia and 3 cases of
myocardial infarction.
Follow-up is complete for 73 of 75 surviving patients who were under
the services of cardiovascular-thoracic surgeon: 42 (56%) are still alive,
31 (41.3%) have since died and 2 (2.7%) have been lost to follow-up.
The 3-year survival rate was 68.5% (50/73 patients). The 5-year
survival rate was 34.2% (25/73 patients).
Despite improvements in technology, the mortality rate remains
constant. This can only be reduced by recognizing the malignant
potential of aneurysms and operating on them electively.

R52

R54

WARM ISCHEMIA INDUCES ALTERATION IN LUNG IMMUNE
CELL FUNCTIONS. D. Nguyen, D.S. Mulder, H. Shennib. McGill
Lung Transplant Program/The Montreal General Hospital, Montreal,
PQ

CLINICAL PERFORMANCE OF THE DUROMEDICS BILEAFLET
PYROLITE MECHANICAL PROSTHESIS. W.R.E. Jamieson, C.L.
Pelletier, J. Pomar. Vancouver and Montreal, Canada and Barcelona,
Spain

During lung transplantation, a period of warm ischemia is inevitable.
We examined the effects of such injury on the local lung immune cells
as harvested by bronchoaiveolar lavage (BAL) and peripheral blood
lymphocytes (PBL). Warm ischemia was induced in dogs by clamping
the left lung hilum for 1 hour (n = 7). Bronchoaiveolar lavage, from the
left and the unaffected right lungs, and PBL were obtained preoperatively, 2 hours, 72 hours and 7 days postoperatively. The prepared
mononuclear cells were subjected to phenotypic analysis, natural killer
(NK) and lectin-dependent cell-mediated cytotoxicity (LDCMC) assays.
Warm ischemia results in significant impairment of NK activity
immediately within 2 hours of reperfusion (49.0% of preoperative
control cytolysis, p < 0.01). Within 3 days, a significant increase in NK
function in the BAL monocells was observed (178.4%, p < 0.01).
Interestingly, these changes were not paralleled in the PBL or the
opposite, nonaffected lung where NK activity appeared significantly
impaired at 72 hours (67.6% and 58.8% respectively, p < 0.01).
Similarly, LDCMC appeared increased in the BAL from the ischemic
lung (179.5%, p < 0.01) but decreased in the BAL from the nonaffected
lung and PBL at 72 hours after injury (74.3% and 61.2% respectively, p
< 0.01). We conclude that warm ischemia results in alteration of
bronchoaiveolar cell function. Nonspecific increase in NK and LDCMC
function of local lung immune cells can be etiologic in the early damage
observed in poorly preserved lung allografts. Furthermore, BAL may
prove to be a useful method for the evaluation of adequacy of lung
preservation techniques.

The Edwards-Duromedics mechanical prosthesis experience of three
centres was examined to determine the influence of valve-related
complications, especially structural valve deterioration, on clinical
performance. The prosthesis was implanted in 486 patients between
1984 and 1988 (Vancouver 131, Montreal 214, Barcelona 141). The
mean age of the patients was 52.2 years (range 14 to 76 years). There
were 174 aortic valve replacements (AVR), 225 mitral valve replace
ments (MVR), 3 tricuspid valve replacements and 78 multiple valve
replacements (MR). The cumulative follow-up was 682 years, mean of
1.4 years. The early mortality was 7.8% (38) and the late mortality was
4.1% per patient-year (28). The patient survival was 87.0% ± 3.7% for
AVR and 81.9% ± 2.9% for MVR at 4 years. The overall valve-related
complication rate was 2.8% per patient-year (47) — thromboembolism
(TE) 19; antithromboembolic related hemorrhage (ATH) 11; prosthetic
valve endocarditis (PVE) 15; nonstructural dysfunction (NSD) 2; and
structural valve deterioration (SVD) 0. There were 19 valve-related
reoperations (two in each of two patients) — TE 1, PVE 9 and NSD 7.
The freedom from thromboembolism at 4 years was 94.3% ± 3.1% for
AVR and 95.1% ± 1.8% for MVR. The freedom from prosthetic valve
endocarditis at the same time interval was 95.3% ± 2.2% for AVR and
96.2% ± 1.6% for MVR. The freedom from structural valve deteriora
tion was 100%. The freedom from valve-related mortality was 98.7% ±
1.3% for AVR and 96.2% ± 1.6% for MVR while for reoperation was
95.3% ± 2.1% for AVR and 92.3% ± 4.3% for MVR at 4 years. The
freedom from the composite of all valve-related complications at 4 years
was 87.7% ± 3.8% for AVR and 85.7% ± 2.9% for MVR.'The
experience with the Edwards-Duromedics prosthesis has been satisfac
tory with no structural valve deterioration at the 4-year interval.

R53
RUPTURED ABDOMINAL AORTIC ANEURYSMS — A 13-YEAR
REVIEW. J. Burgess, E. Busse, T. Boyd, A. Maitland. Plains Health
Centre, Regina, Sask.

One hundred and seventy-three ruptured abdominal aortic aneurysms
presenting to Regina hospitals in a 13-year period have been reviewed.
One hundred and fifty-two patients were treated surgically. Twenty-one
patients had no surgery attempted and died, or died prior to surgery.
There were 154 males and 19 females. Their mean age was 72 years,
with a range of 41 to 100 years. Of the 152 operative patients, there
were 21 intraoperative deaths (13 deaths pre-graft and 8 deaths
post-graft) and 47 postoperative deaths (surgical day and after).
Symptoms on admission revealed 136 patients with abdominal pain, 90
patients with hypotension, 72 patients with back pain and 26 patients
with nausea. Past medical history revealed 49 patients with hyperten
sion, 22 with COPD, 22 with ischemic heart disease, 10 with cancer and
5 with impaired renal function. The correct diagnosis was made prior to
306
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R55
PREGNANCY AND CHILDBEARING WITH PORCINE BIOPROSTHESES. B.R. Badduke, W.R.E. Jamieson, R.T. Miyagishima, A.I.
Munro, A.N. Gerein, J. MacNab, G.F.O. Tyers. University of British
Columbia, Vancouver, BC

Biological valves were implanted in 99 females 35 years of age and
under, between 1975 and 1987. The 99 females (mean age 26.8 years,
range 8 to 35 years) represented 3.3% of total biological population of
3000 patients. The valves implanted were: Carpentier-Edwards Stan
dard, 50 (AVR 10, MVR 32, MR 8); Hancock Standard, 18 (AVR 3,
MVR 10, MR 4, PVR 1); Carpentier-Edwards Supra-Annular, 31 (AVR
3, MVR 21, MR 6, TVR 1); Mitral Medical Mitroflow, 1 (MVR 1).
Sixteen females had 24 births in 29 pregnancies. The patients were
managed without anticoagulants except for one. The total patient

CSCTS

population (99 females) had 31 valve-related complications (5.6% per
patient-year) — structural valve deterioration (SVD) 18, prosthetic valve
endocarditis (PVE) 6, thromboembolism (TE) 5, anticoagulant hemorrh
age (ATH) 1 and nonstructural dysfunction (NSD) 1. Valve-related
mortality (seven) was PVE two, TE two, SVD one, ATH one and sudden
unexplained death one. Valve-related reoperation (23) etiology was SVD
17, PVE 4, NSD 1 and acute dissection 1. The children were born a
mean of 50 months after valve replacement. Three of the 16 patients
had 10 of the 24 births. Four patients (25%) of the 16 subsequently had
reoperation for SVD. Fourteen (16.7%) of the remaining 84 patients had
reoperation for SVD. There was no mortality at reoperation for any
cause, including SVD. Of the 22 patients who had reoperation, the
prostheses utilized were: mechanical prostheses (12) and bioprostheses
( 12 ) .
Biological prostheses provide the opportunity for successful pregnan
cy. Pregnancy contributes to an acceptable increase in structural valve
deterioration. The management of structural valve deterioration is
highly successful in this young female population.

R56
DETERMINATION OF OPERABILITY IN CANDIDATES UNDER
GOING LUNG RESECTION FOR BRONCHOGENIC CARCINOMA.
T.P. Murphy, M.T. Casey. Division of General Surgery, Halifax
Infirmary, Dalhousie University, Halifax, NS

A prospective study was undertaken to determine the effect of lung
resection for bronchogenic carcinoma on ultimate pulmonary function.
We wish to compare the postoperative pulmonary function of higher
risk candidates, i.e., those patients with severe limitations of lung flows
and. thus, those patients more likely to develop severe, progressive
pulmonary failure, with those patients who had acceptable preoperative
parameters.
Preoperative and postoperative pulmonary function tests were per
formed on 20 candidates undergoing various resections for bronchogen
ic carcinoma. Patients who had pneumonectomy had resultant changes
in lung volumes and flows as were expected in a resection of that
magnitude. Those patients having lesser resections, however, had much
more variable postoperative lung volumes and flows.
The patients with the poorest preoperative parameters had the least
change postoperatively with even some improvements in parameters.
These were patients who were most likely to be denied surgery because
of poor preoperative pulmonary function parameters.
We conclude that the operability of each lung resection candidate
must be carefully assessed, and that the guidelines for safe operation
established in the literature must be independently interpreted for each
lung resection candidate.

19.5 months, had ongoing pain, whereas 26 patients were pain-free
with a median follow-up of 30.5 months PT. Pain was reported in 24 of
45 patients more than 1 year PT (55%), 13 of 29 patients greater than 2
years post-surgery (45%) and 3 of 10 patients seen between 4 to 5 years
PT. The intensity of the pain was low with an average VAS score of 3.1.
Fifty-six percent stated that their pain had no impact on their lives, but
the remaining 13 patients (44%) stated their pain “ slightly” or
“moderately” interfered with their lives. Five of the 56 patients had
sufficiently prolonged and severe pain to seek relief with daily analgesic
use, nerve blocks or referral to a pain clinic. We conclude that chronic
chest-wall pain is common PT. It is generally not severe, but a small
portion of patients may experience persistent, moderately disabling pain.

R58
COMPARISON OF DIFFERENT IMMUNOSUPPRESSIVE REGIMEN
FOLLOWING HEART TRANSPLANTATION: EXPERIENCE OF
THE UNIVERSITY OF MONTREAL TRANSPLANTATION GROUP.
L.C. Pelletier, R.L. Beaudet, S. Busque, M. Carrier, C. Chartrand, D.
Doyle, J-C. Fouron, M. Morissette, G. Pelletier, P. Stanley. Depart
ment of Surgery and Department of Medicine, University of Montreal,
Montreal, PQ

From July 1982 to February 1989, 100 patients underwent orthotopic
heart transplantation (OHT) — 84 men and 16 women, aged 4 to 61
years (mean 41 years). Preoperatively, 28 patients required pharmaco
logic (19) or mechanical (9) circulatory support. There were 10 early
and 12 late deaths. The overall actuarial survival at 1 and 5 years was
80% and 73% respectively. Patients were divided into three groups
according to their immunosuppressive regimen (IR) early postoperative
ly: group 1 (36 patients) was given cyclosporine-prednisone (CP): group
II (26 patients) received cyclosporine-prednisone-azathioprine (CPA);
group III (38 patients) was given antilymphocyte or antithymocyte
globulin or monoclonal antibody OKT3 immediately after surgery
followed by CPA (CPAL). There were 85 episodes of acute rejection
(0.85/pt) and 87 episodes of infection (0.87/pt). Only one rejection and
four infection episodes occurred after the 6th postoperative month. The
IR did not influence survival rate. However, rejection and infection
rates, which average 1.2 and 1.3 episodes/pt with CP decreased to 0.6
and 0.7 respectively with CPA and to 0.7 and 0.6 with CPAL. Actuarial
freedom rates from rejection and infection at 3 years were 39% and 50%
with CP, 56% and 64% with CPA and 61% and 70% with CPAL. Thus,
changes in IR to decrease cyclosporine toxicity early postoperatively
have not compromised survival and have resulted in an improved
immunosuppression with a lower incidence of rejection and infection
following OHT.

R59
R57
CHRONIC POST-THORACOTOMY PAIN. E. Dacjzman, A. Gordon,
H. Kreisman, N. Wolkove. Pulmonary Department, Sir Mortimer B.
Davis-Jewish General Hospital, McGill University, Montreal, PQ

Although chest-wall pain is recognized as a significant problem in the
immediate postoperative period, it is less commonly appreciated that
patients may have persistent pain. We have studied retrospectively the
character and occurrence of prolonged pain in post-thoracotomy (PT)
patients. Review of 206 thoracotomies done during the previous 5 years
revealed 64 patients between 2 and 60 months post-surgery who were
alive and well without evidence of progressive carcinoma. Fifty-nine
patients were interviewed, but 3 subsequently developed metastatic
disease and were excluded. A pain questionnaire was administered and
patients were asked to grade their pain from 0 to 10 using a visual
analogue scale (VAS). Thirty patients (54%) with a median follow-up of

TRANSHIATAL ESOPHAGECTOMY — RESULTS OF 120 CASES.
R.J. Finley, R.L Inculet. University of Western Ontario, London, Ont.
and University of British Columbia, Vancouver, BC

Between 1980 and 1988, 120 patients underwent resection of the lesser
curve of the stomach and thoracic esophagus through abdominal and
neck incisions, avoiding a thoracotomy. The esophagus was replaced by
gastric tube (118) or colon (2). Indications for esophagectomy were:
squamous cell carcinoma of the esophagus (26), adenocarcinoma of the
cardia (45), adenocarcinoma in a columnar lined esophagus (36) and
benign end-stage esophageal disease (13). There were 96 males and 24
females ranging in age from 15 to 80 years (median 61 years).
Significant preoperative risks included smoking (94), cardiac disease
(22), chronic obstructive pulmonary disease (32), thromboembolic
disease (6) and diabetes (13).
Hospital mortality was 3 /1 2 0 patients. Early postoperative morbidity
included intraoperative hemorrhage (1), anastomotic leaks which dosed
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spontaneously (20), transient hoarseness (14), myocardial infarction (2),
pulmonary embolus (7). supraventricular tachycardia (42) and atelecta
sis or pneumonia (23). Median time to discharge was 16 days. Late
postoperative complications include delayed gastric emptying (6), symp
tomatic reflux (7), diarrhea (9) and anastomotic strictures (30). Nine of
these 30 patients required more than three esophageal dilatations to
maintain swallowing. Three months after surgery 94% of the patients
were swallowing at least a soft diet.
Esophagectomy without thoracotomy provides a safe effective meth
od of restoring swallowing in patients with obstructive esophageal
disease.

R60
A COMPUTER-BASED PRIORITIZED WAITING LIST MANAGE
MENT SYSTEM FOR CARDIAC SURGERY. J. Pym, J.L. Knight,
E.J.P. Charrette. Queen’s University, Kingston, Ont.

In most provinces, the political reality of finite resources for health care
has led to lengthening waiting lists for surgical procedures. For cardiac
surgery, long delays can result in death, significant morbidity and a
higher rate of emergency surgery which consumes more resources.
We have developed a computer-based prioritized waiting list manage
ment system. Patients are assigned priority scores on the basis of
perceived anatomical risk, symptomatic disability and other factors.
These, together with demographic and clinical data, are entered into a
computer database. Timing of cardiac surgery is dictated primarily by
priority score and time on the waiting list. Reports are automatically
generated for referring cardiologists, and information is sought to
update priorities. High priority patients are readily identified to fill any
vacant operating slots, thus allowing the most efficient use of
resources.
An audit was conducted of 150 consecutive operated patients.
Emergency surgery was performed in 20 (13%) of these, while 130
(87%) were on the waiting list from 3 to 257 (mean 41) days before
surgery. There was a significant negative correlation between assigned
priority scores and time on the waiting list.
Although waiting lists for cardiac surgery are medically undesirable,
they are a fact of life at the present time, and a simple prioritization
system aids in their efficient management.

in the diagnosis of aortic dissection. To assess whether TE can obviate
the need for angiography in this clinical setting, the management of 18
consecutive patients found to have aortic dissection by TE was analysed.
There were 11 men and 7 women with a mean age of 59 years.
Ascending aortic dissection was present in nine patients, of whom six
had surgery with confirmation of TE findings in each case. In two
patients who had surgery, angiography was performed and was falsely
negative in one patient. Angiography was not done in the three patients
who were not surgical candidates. In the nine patients with descending
dissection, two had surgery for expansion. Both had angiograms which
yielded no additional findings. In the seven patients managed medically,
six had angiograms which also showed no additional information to the
TE findings. Autopsy findings available in four patients with descending
dissection confirmed the TE findings.
Thus, TE reliably differentiates ascending from descending aortic
dissection, and angiography appears not to provide additional informa
tion in both types of dissection. In most patients with aortic dissection,
angiography appears not to be indicated if an adequate TE is obtained.

R62
SHOULD EURO-COLLINS SOLUTION BE USED FOR DONOR
HEART TRANSPORTATION? P.J. Hendry, Y.A. Barry, R. Labow,
W.J. Keon. University of Ottawa Heart Institute, Ottawa Civic
Hospital, Ottawa, Ont.

Although Euro-Collins solution (EC) has gained popularity for the
transportation of noncardiac allografts, its usefulness for heart preser
vation is unclear. To assess EC, human right atrial trabeculae
contracting isometrically in vitro were cooled to 12°C, arrested and
maintained in EC for 24 hours. Control conditions were, then resumed
and functional recovery of the trabeculae was followed for 30 minutes
(expressed as % of control) and compared to other crystalloid solutions:

Solution
Euro-Collins
Saline
St. Thomas’s
Modified Krebs’

Developed force (DF)
13.0
5.6
78.1
70.3

±
±
±
±

5.9%
4.5%
11.1%
17.0%

Resting force (RF)
149.6
142.1
126.7
85.4

±
±
±
±

23.8%
13.6%
32.2%
16.2%

R61
DOES TRANSESOPHAGEAL ECHOCARDIOGRAPHY OBVIATE
THE NEED FOR ANGIOGRAPHY IN AORTIC DISSECTION? K-L.
Chan. University of Ottawa Heart Institute, Ottawa, Ont.

Transesophageal echocardiography (TE) has been shown to be reliable
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Trabeculae recovering in EC did not differ significantly from those in
saline, whereas both DF and RF were significantly different from those
attained in St. Thomas’s and modified Krebs’ solutions (p < 0.05).
Euro-Collins solution leads to poor return of function and damage with
contracture. These data indicate that EC should not be used for the
transport of donor hearts.
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As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified advertisements. The deadline is 1
month before issue date. Regular classified rates (for each insertion): $45.00 for the first 40 words or less, additional words 60<f each
(additional $17.00 for frame). Special Display under 100 words, 21/4 in. X 2 in., $110.00. $6.00 charge (first insertion only) for CJS box
numbers. Display rates available on request.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.

GENERAL SURGEON AND ORTHOPEDIC
SURGEON: BC - For thriving BC sunshine
coast community of 20 000 on the doorstep
o f Desolation Sound. Fully accredited
140-bed hospital under construction. Medical
staff includes 17 GPs, 4 GP anesthetists,
internist, pediatrician and 2 surgeons. Excel
lent year round recreation and cultural attrac
tions include boating, fishing, golfing, modern
indoor recreation theatre complex and com
munity college. Frequent daily air and ferry
connections to Vancouver. Contact: Dr. B.K.
Cutler, Department of Surgery, Powell
River General Hospital, 5871 Arbutus
Ave., Powell River, BC V8A 4S3. Tel:
(604) 4 8 3 -3 2 1 1 .
-S89-10

GENERAL SURGEON: BC - Well-estab
lished general surgical practice for sale in
choice lower mainland location. Canadian fel
lowship required. Reply in confidence with
curriculum vitae to: Box 800, Canadian
Journal of Surgery, PO Box 8 6 5 0, O ttaw a,
O NK1G O G 8.
-S 8 9 -1 3
GENERAL SURGEON: BC - General sur
geon to retire to Sechelt, BC, a beautiful
coastal community, 64 km from Vancouver.
Willing to work up to 3 months a year
relieving solo general surgeon during vaca
tion. Reply to: Chief of Staff, St. Mary's
Hospital, Box 7777, Sechelt, BC VON
3A0.
-S 8 9 -2 7

GENERAL SURGEON: BC - St. Joseph s
General Hospital, a fully accredited, modern,
220-bed general hospital, including 75 ex
tended care unit beds, on Vancouver Island,
British Columbia, requires the services of a
general surgeon. The hospital services an
area population of 40 000, including commu
nities of Comox, Courtenay and Cumberland.
The current medical staff includes tw o general
surgeons (one retiring the end of 1989), four
anesthetists, tw o orthopedic surgeons, one
urologist, tw o internists, tw o ophthalmologists,
one otolaryngologist, tw o o b ste tricia n /
gynecologists, one psychiatrist, one pediatri
cian, one pathologist, tw o radiologists, one
dermatologist and twenty-five general practi-

SURGEON-IN-CHIEF
MOUNT SINAI HOSPITAL, TORONTO, ONTARIO
Mount Sinai Hospital, a 526-bed acute care, general teaching hospital, fully affiliated with the Faculty of Medicine,
University of Toronto, requires a Surgeon-in-Chief.
The Department of Surgery consists of four major divisions: general surgery, orthopedic surgery, thoracic surgery
and urology. There is also a single neurosurgeon, plastic surgeon (part of Division of Orthopedics) and vascular
surgeon (part of Division of General Surgery). There are 21 full-time staff surgeons and a complement of 147 ac
tive treatment beds. Clinical and research activities within all divisions have tw o major thrusts: oncology and
transplantation. The planned relocation of the Ontario Cancer Institute/Princess Margaret Hospital next door to
Mount Sinai Hospital has further stimulated development of oncology. The Department has a very active
undergraduate and postgraduate teaching program, and an active research program, with eight staff members of
the Department of Surgery holding peer-reviewed research grants. The Mount Sinai Hospital Research Institute
provides an important research resource for the hospital clinical departments.
The successful candidate will have an FRCSC or equivalent; be eligible to practise medicine in Ontario; will be
recognized as a skilled surgeon and an outstanding teacher; will have had a background in research, and be in
terested in and capable of furthering an existing, successful research program; will have superior leadership
qualities and planning abilities, with previous experience in a senior administrative position.
The successful candidate would be eligible for a senior academic appointment.
In accordance with Canadian immigration regulations, this advertisement is directed to Canadian citizens and per
manent residents of Canada.
Interested candidates should forward their curriculum vitae to:
CHAIRMAN
SEARCH COMMITTEE FOR A SURGEON-IN-CHIEF
MOUNT SINAI HOSPITAL,
C/O ROOM 341
600 UNIVERSITY AVE.
TORONTO, ON
CANADA
M5G1X5

-S-89-18
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tioners. Comox is located 240 km north of
Victoria on beautiful Vancouver Island, and
offers superb recreational opportunities, in
cluding sailing, skiing, salmon fishing, alpine
sports and a full range of outdoor activities.
The communities offer gourmet dining and a
remarkable variety of cultural and theatrical
events. For further information please con
tact: D. Blacklock, MD, Chairman, Search
Committee, St. Joseph's General Hospital,
2 1 3 7 Comox Ave., Comox, BC V9N 4 B 1 .
-S89-26

GENERAL SURGEON: MB - Required to
join a progressive group of twelve general
practitioners, one obstetrician/gynecologist,
and one orthopedic and plastic surgeon.
Guaranteed income provided for first 12
months, and thereafter, if mutually agreeable,
partnership would be offered. Early partner
ship by agreement is available. The clinic
occupies three floors of a modern, downtown
medical facility in a university city of 40 000,
and services a large trading area. A 220-bed
hospital with a 12-bed, intensive care unit, a
201-bed geriatric and rehabilitation hospital, a
large regional laboratory, and an ultrasound
department, is located in the city. Interested

persons are asked to contact: Mrs. D.J.
M istal. Western Medical Clinic, 144 6th
St., Brandon, MB, R7A 3N2, Tel: (204)
7 2 7 -6 4 5 1 .
-S 89-14

SURGICAL ASSISTANT: ON - Surgical assistant/fellow required in cardiovascular and
thoracic surgery operating room. Position
may be permanent or temporary, full or part
time, and may be adapted to meet specific
educational needs, e.g. research, further uni
versity courses, etc. Prior surgical experience
helpful but not a prerequisite. Should have
Ontario licence. Reply to: Dr. F.N. McKenzie,
Chief, Division of CVT Surgery, University
Hospital, PO Box 5339, London, ON N6A
5A5.
-S89-29

GENERAL SURGEON: ON — A general sur
geon is required in late fall 1989 for a
500-bed community hospital in a rapidly
growing city on the outskirts of metropolitan
Toronto. Please send curriculum vitae and
enquiries to: Dr. T. Dickson, Chief of Sur
gery, c/o Program Administration Office,
Peel Memorial Hospital, 20 Lynch St.,
Brampton, ON L6W 2Z8.
-S89-23

PLASTIC SURGERY SEARCH: ON - The
Toronto Hospital is seeking a Head of Division
of Plastic Surgery. This newly created posi
tion will be responsible for the Division of
Plastic Surgery at the Toronto General and the
Toronto Western Hospitals. Clinical activity,
research, undergraduate and postgraduate
education, and long-range planning will be
managed by the Head of Division. The suc
cessful applicant will have an excellent reputa
tion in clinical surgery, research and education
and have shown evidence of leadership abili
ty. In accordance with Canadian immigration
requirements, this advertisement is directed
primarily to Canadian citizens or permanent
residents. Applicants should send a letter and
accompanying curriculum vitae to: Dr. Alan
R. Hudson, Surgeon-in-Chief, Toronto
Hospital, Bell Wing, 1-636, 585 University
Ave., Toronto, ON M5G 2C4.
-S 89-25
SPINAL SURGERY FELLOWSHIP: ON Available July 1, 1989 and July 1, 1990,
Department of Surgery, Division Orthopedic
Surgery, University of Western Ontario, Lon
don. For information contact: Stewart I. Bai
ley, MD, FRCSC, 345 Westminster Ave.,
London, ON N6C 4V 3. Tel: (519)
4 3 9 -0 7 0 1 .
-S 8 9 -1 1

PEDIATRIC TRAUMA RESEARCH FELLOWSHIP
Department of Surgery
Hospital for Sick Children, Toronto and
University of Toronto

A 1 or 2 year research fellowship in pediatric trauma is
available beginning Jan. 1 or July 1,1990.
This fellowship provides an excellent opportunity to
participate in our ongoing epidemiologic, clinical and
basic research program. At present, we have projects
underway on preventable deaths, field triage,
metabolic effects using open-circuit indirect
calorimetry, late sequelae of major trauma and shock.
The successful applicant would be encouraged to
design and implement new ideas in these and related
areas. The applicant would also be encouraged, but
not required, to study for a Masters degree at the
University of Toronto, which could be completed in 1
year.
This fellowship is intended for anyone planning an
academic career in pediatric general surgery or
pediatric emergency medicine with a special emphasis
on trauma.
Send enquiries and resume to:
Dr. D.E. Wesson, MD, FRCSC
The Hospital for Sick Children
555 University Ave.
Toronto, ON Canada
M 5 G 1X8
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The Cold Lake Regional Hospital is a modern, multi
level progressive facility with the potential bed capacity
of 150. We seek an additional

Psychiatrist
Surgeon
GP / A nesthetist
GP / O bstetrician / G ynecologist
The Tri-town area in which the hospital is located is,
approximately 300 kilometers East of Edmonton. Pri
mary care and specialty referral care is offered to a
growing population.
The successful candidates must be eligible for licensure
in Alberta. In accordance with Canadian immigration
requirements, priority will be given to Canadian citizens
and permanent residents of Canada.
Please forward your confidential resume, including refer
ences, to:
The Search Committee
Cold Lake Regional Hospital

Postal Service “A”
COLD LAKE, Alberta
TOA 0V0
Tel: (403) 639-3322, Ext. 280.

-s-8 9-19

Cold Lake Regional Hospital

CLASSIFIED ADVERTISING

ORDER FORM_________ ___________________________________________________
ADVERTISEMENT:______________ NO. OF INSERTIONS: ____________

BOX NO.: YES □ NO □

INVOICE:

ALL ADVERTISEMENTS FROM OUTSIDE CANADA M UST BE PREPAID.
ADDRESS ORDERS TO: Classified Advertising,
Canadian Journal of Surgery, P O Box 8650, Ottawa, ON K1G 0G8
CHAIRM AN, DEPARTMENT OF SUR
GERY: SK - The College of Medicine, Univer
sity of Saskatchewan, invites applications for
the position of Chairman of the Department of
Surgery. The successful candidate will also be
Head of the Department of Surgery at the
University Hospital and will be responsible for
providing academic leadership in undergradu
ate and postgraduate teaching, research and
service. The Department of Surgery includes
general surgery, orthopedic surgery, neuro
surgery, cardiovascular surgery, plastic sur
gery, urology and otolaryngology. The aca
demic rank will be that commensurate with
the successful candidate's qualifications and
experience. Associated with the headship will
be a tenure track academic appointment. In
accordance with Canadian immigration re
quirements, this advertisement is directed to
Canadian citizens and permanent residents.
Interested candidates should send a letter of
application, curriculum vitae and the names of
three referees, by July 15, 1989, to: I.M.
McDonald MD, Dean of M edicine, Univer
sity o f Saskatchewan, Saskatoon, SK S7N
0W 0.

Clinical practice will be conducted within our
600-bed teaching hospital, which is the terti
ary care centre for the northern half of the
province. In accordance with Canadian immi
gration requirements, this advertisement is
directed to Canadian citizens and permanent
residents. An application accompanied by a
detailed curriculum vitae, together w ith the
names of three referees, should be forwarded
to: Dr. Charles J. W rig h t, Chairman, De
partm ent of Surgery, University o f Sas
katchew an, Saskatoon, SK S7N 0 W 8 .
Deadline: August 15, 1989.
-S89-28

LOCUM TENEN AVAILABLE: - Experienced
Canadian fellowship surgeon eligible and will
ing to work anywhere in the Commonwealth.
Available late summer for locums of any
length. Reply Box 838, CM A Journal, PO
Box 86 5 0, O ttawa, ON K1G 0G8.
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Cipro
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SURGEONS
NEUROSURGEON, ACADEMIC APPOINT
MENT: SK — The Department of Surgery,
University of Saskatchewan, invites applica
tions for a geographic full-time neurosurgeon
in the Division of Neurosurgery. The incum
bent will hold a joint appointment in the
College of Medicine and University Hospital.
Academic rank and salary will be commensu
rate with experience. Candidates must be
eligible for licensure in the province of Sas
katchewan and hold or be eligible for special
ist certification by the Royal College of Physi
cians and Surgeons of Canada. The success
ful candidate will be expected to teach at the
undergraduate and postgraduate levels, and
engage in ongoing and new research projects.

Ref. # 8 9 0 1 5 - GENERAL SURGEON
A busy clinic in Southern Ontario
specializing in colon and rectal
surgery
Ref. # 8 8 0 2 8 - GENERAL SURGEON
A community hospital in Vancou
ver Island, B.C.

Rhone-Poulenc Pharma Inc.
Stemetil

298

For further information about these positions and
other opportunities for associates, locums and
sale of practices, please contact:
jg i
jAfc
E==l J lj p

CanMed Careers
659 M ississauga Crescent
Mississauga, Ontario L5H 1Z9
Tel. (416) 274-0707
Fax (41 6) 274-5211
-S 89-21

INTERNATIONAL CONSULTANTS TO EXECUTIVES
AND PROFESSIONALS IN THE
HEALTH CARE SECTOR

Smith Kline & French Canada Ltd.
Cefizox

248, 249, Inside Front
Cover
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NEW FROM MILES

DC

3L
ciprofloxacin hydrochloride

A REVOLUTIONARY
ORAL ANTIBIOTIC

THE POWER OF RARENTERALS.
THE FREEDOM OF TABLETS.

►
►
j
►

►

AND FREEDOM

►

►
►
►

■ WIDE RANGE OF INDICATIONS

f►

■ BROAD SPECTRUM

t
►
►

f

— lower respiratory tract
— skin/soft tissue

— urinary tract
— bone and joint

Highly active* in vitro against a broad range of gram-positive and gram-negative
pathogens, “...the most potent anti -pseudomonas agent...”1
Editorial, The Lancet.

■ HIGH TISSUE PENETRATION
Serum, tissue and fluid levels well above inhibitory levels.2

■ EXCELLENT PATIENT COMPLIANCE
Convenient B.I.D. dosage. Well tolerated — low incidence of side effects.2

pf
►
►

CIPRO HOT LINE
For more information,
please call

NEW

TABLETS

1 - 800- 227-7766
>

*ln vitro activity does not necessarily
imply a correlation with in vivo results.

I

M IL E S

POTENT
YETPO.

►
'
I

.

For prescribing information see page 274

Improved Cardiovascular Needles
Special highly adherent silicone
lubricant further reduces
resistance...first pass, last pass
Securely attached to the suture

Needles Resist Bending
New, stronger needle configuration
Superior sharpness
Lower penetration force reduces
strain on needle - minimizes
bending and breaking

J

• 0 W \~ .

CARDIOVASCULAR SUTURES
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